JPS6348312B2 - - Google Patents
Info
- Publication number
- JPS6348312B2 JPS6348312B2 JP11667682A JP11667682A JPS6348312B2 JP S6348312 B2 JPS6348312 B2 JP S6348312B2 JP 11667682 A JP11667682 A JP 11667682A JP 11667682 A JP11667682 A JP 11667682A JP S6348312 B2 JPS6348312 B2 JP S6348312B2
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- layer
- reagent
- element according
- analytical element
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims description 143
- 239000003446 ligand Substances 0.000 claims description 112
- 238000009739 binding Methods 0.000 claims description 68
- 230000027455 binding Effects 0.000 claims description 67
- 230000005855 radiation Effects 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 41
- 230000009870 specific binding Effects 0.000 claims description 39
- 230000004044 response Effects 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 34
- 102000004190 Enzymes Human genes 0.000 claims description 33
- 108090000790 Enzymes Proteins 0.000 claims description 33
- 229940088598 enzyme Drugs 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 33
- 238000004458 analytical method Methods 0.000 claims description 26
- 230000003993 interaction Effects 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 17
- 238000001514 detection method Methods 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 239000000049 pigment Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 12
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical group O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 10
- 238000000159 protein binding assay Methods 0.000 claims description 8
- 108010006591 Apoenzymes Proteins 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 230000002255 enzymatic effect Effects 0.000 claims description 5
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 claims description 5
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 claims description 5
- 239000011714 flavin adenine dinucleotide Substances 0.000 claims description 5
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical group [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 4
- 150000008064 anhydrides Chemical class 0.000 claims description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical group [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 4
- 150000001875 compounds Chemical group 0.000 claims description 4
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 108090000854 Oxidoreductases Proteins 0.000 claims description 2
- 102000004316 Oxidoreductases Human genes 0.000 claims description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical group [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical group [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 2
- 239000011787 zinc oxide Substances 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims 1
- 239000010410 layer Substances 0.000 description 197
- 238000012360 testing method Methods 0.000 description 92
- 239000000523 sample Substances 0.000 description 37
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 21
- -1 cryoglobins Substances 0.000 description 16
- 238000009792 diffusion process Methods 0.000 description 14
- 229960000278 theophylline Drugs 0.000 description 14
- 229920000936 Agarose Polymers 0.000 description 13
- 239000000306 component Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 238000002372 labelling Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000012491 analyte Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 238000010998 test method Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 229910010413 TiO 2 Inorganic materials 0.000 description 9
- 230000008859 change Effects 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
- NGBYKZGOXFIONW-UHFFFAOYSA-N 4-(1,3-dimethyl-2,6-dioxo-7h-purin-8-yl)butanoic acid Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC(CCCC(O)=O)=N2 NGBYKZGOXFIONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000005670 electromagnetic radiation Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000002452 interceptive effect Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- DLKVBPCRSZSIKI-UHFFFAOYSA-N 8-(3-aminopropyl)-1,3-dimethyl-7h-purine-2,6-dione Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC(CCCN)=N2 DLKVBPCRSZSIKI-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 102000005936 beta-Galactosidase Human genes 0.000 description 4
- 108010005774 beta-Galactosidase Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 231100000673 doseâresponse relationship Toxicity 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000000984 immunochemical effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 102000003914 Cholinesterases Human genes 0.000 description 2
- 108090000322 Cholinesterases Proteins 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 108010025076 Holoenzymes Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000007327 Protamines Human genes 0.000 description 2
- 108010007568 Protamines Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex⢠Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 102000011923 Thyrotropin Human genes 0.000 description 2
- 108010061174 Thyrotropin Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 229940013640 flavin mononucleotide Drugs 0.000 description 2
- 239000011768 flavin mononucleotide Substances 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000010944 pre-mature reactiony Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 2
- 229960000244 procainamide Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229940070353 protamines Drugs 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- QJJDJWUCRAPCOL-UHFFFAOYSA-N 1-ethenoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOC=C QJJDJWUCRAPCOL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 description 1
- 102000004567 6-phosphogluconate dehydrogenase Human genes 0.000 description 1
- 108020001657 6-phosphogluconate dehydrogenase Proteins 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 102400000344 Angiotensin-1 Human genes 0.000 description 1
- 101800000734 Angiotensin-1 Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102100021809 Chorionic somatomammotropin hormone 1 Human genes 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 108010049140 Endorphins Proteins 0.000 description 1
- 102000009025 Endorphins Human genes 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 101710142246 External core antigen Proteins 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 102000014702 Haptoglobin Human genes 0.000 description 1
- 108050005077 Haptoglobin Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 102000002704 Leucyl aminopeptidase Human genes 0.000 description 1
- 108010004098 Leucyl aminopeptidase Proteins 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 239000005041 Mylar⢠Substances 0.000 description 1
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- KEECCEWTUVWFCV-UHFFFAOYSA-N N-acetylprocainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(NC(C)=O)C=C1 KEECCEWTUVWFCV-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical class NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 239000000381 Placental Lactogen Substances 0.000 description 1
- 108010003044 Placental Lactogen Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 102000007584 Prealbumin Human genes 0.000 description 1
- 108010071690 Prealbumin Proteins 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 102100024819 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 102000013009 Pyruvate Kinase Human genes 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 229930192786 Sisomicin Natural products 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 102000002248 Thyroxine-Binding Globulin Human genes 0.000 description 1
- 108010000259 Thyroxine-Binding Globulin Proteins 0.000 description 1
- 102000011409 Transcobalamins Human genes 0.000 description 1
- 108010023603 Transcobalamins Proteins 0.000 description 1
- 102000014034 Transcortin Human genes 0.000 description 1
- 108010011095 Transcortin Proteins 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- KIPLYOUQVMMOHB-MXWBXKMOSA-L [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O Chemical compound [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O KIPLYOUQVMMOHB-MXWBXKMOSA-L 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 239000007998 bicine buffer Substances 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005081 chemiluminescent agent Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229960003914 desipramine Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
- 229960000648 digitoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960005426 doxepin Drugs 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012992 electron transfer agent Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- HAPOVYFOVVWLRS-UHFFFAOYSA-N ethosuximide Chemical compound CCC1(C)CC(=O)NC1=O HAPOVYFOVVWLRS-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WOLATMHLPFJRGC-UHFFFAOYSA-N furan-2,5-dione;styrene Chemical compound O=C1OC(=O)C=C1.C=CC1=CC=CC=C1 WOLATMHLPFJRGC-UHFFFAOYSA-N 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- AFQIYTIJXGTIEY-UHFFFAOYSA-N hydrogen carbonate;triethylazanium Chemical compound OC(O)=O.CCN(CC)CC AFQIYTIJXGTIEY-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960000808 netilmicin Drugs 0.000 description 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- DQMZLTXERSFNPB-UHFFFAOYSA-N primidone Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NCNC1=O DQMZLTXERSFNPB-UHFFFAOYSA-N 0.000 description 1
- 229960002393 primidone Drugs 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229960005456 sisomicin Drugs 0.000 description 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940063650 terramycin Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- BJORNXNYWNIWEY-UHFFFAOYSA-N tetrahydrozoline hydrochloride Chemical compound Cl.N1CCN=C1C1C2=CC=CC=C2CCC1 BJORNXNYWNIWEY-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229960000874 thyrotropin Drugs 0.000 description 1
- 230000001748 thyrotropin Effects 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-S tobramycin(5+) Chemical compound [NH3+][C@@H]1C[C@H](O)[C@@H](C[NH3+])O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H]([NH3+])[C@H](O)[C@@H](CO)O2)O)[C@H]([NH3+])C[C@@H]1[NH3+] NLVFBUXFDBBNBW-PBSUHMDJSA-S 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 108010079570 uropepsin Proteins 0.000 description 1
- 229940102566 valproate Drugs 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 229940028445 visine Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- SFVVQRJOGUKCEG-OPQSFPLASA-N β-MSH Chemical compound C1C[C@@H](O)[C@H]2C(COC(=O)[C@@](O)([C@@H](C)O)C(C)C)=CCN21 SFVVQRJOGUKCEG-OPQSFPLASA-N 0.000 description 1
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãæååã³èªåã®èšºæç³»ã«ãããŠæçš
ã§ãããããªåæè©ŠéšçŽ ååã³è©Šéšæ¹æ³ã®åéã«
é¢ããæŽã«è©³ããã¯ãäœæ¶²äžã«ååšããäœæ¶²æå
åã³ãããäœæ¶²äžã®è¬ç©ã®å®æ§åã³å®éåæã«æ
çšãªå€éå±€åæçŽ åã«é¢ããã
ã§ãããããªåæè©ŠéšçŽ ååã³è©Šéšæ¹æ³ã®åéã«
é¢ããæŽã«è©³ããã¯ãäœæ¶²äžã«ååšããäœæ¶²æå
åã³ãããäœæ¶²äžã®è¬ç©ã®å®æ§åã³å®éåæã«æ
çšãªå€éå±€åæçŽ åã«é¢ããã
è©Šéšçåã³åæ§ã®åºäœç¶æ
ã®åæçŽ åã®åœ¢ãã
ãè©Šéšå ·ã¯ãçš®ã ã®ã¿ã€ãã®è©Šæããšãã«çç©åŠ
ç液äœã®åæã«ãããŠã¯ãããµãããã®ã«ãªã€ãŠ
ããŠãããè¡æž åã³å°¿ã®ãããªçç©åŠç液äœäžã®
èšåºäžéèŠãªç©è³ªãæ€ç¥ããããã«è£œäœãããè©Š
éšçã¯ãçŸç ã®èšºæã«ãããŠæçã«ãªã€ãŠããã
ãè©Šéšå ·ã¯ãçš®ã ã®ã¿ã€ãã®è©Šæããšãã«çç©åŠ
ç液äœã®åæã«ãããŠã¯ãããµãããã®ã«ãªã€ãŠ
ããŠãããè¡æž åã³å°¿ã®ãããªçç©åŠç液äœäžã®
èšåºäžéèŠãªç©è³ªãæ€ç¥ããããã«è£œäœãããè©Š
éšçã¯ãçŸç ã®èšºæã«ãããŠæçã«ãªã€ãŠããã
åçš®ã®è©Šéšçã¯ãæã芪ãã¿æ·±ãPHè©ŠéšçŽå
·ã
ããã°ã«ã³ãŒã¹ãèçœãæœè¡ãªã©ïŒäŸãã°ãç±³åœ
ç¹èš±ç¬¬3164534ïŒ3485587åã³3012976å·ã«èšèŒã
ããŠãããããªïŒã®çš®ã ã®å°¿äžåã³è¡äžæåã®ç
äœå€èšºæè©Šéšå ·ã«å°ããŸã§ãåºæ±ãªåéã«ãã
ãŠã氞幎ã«ãããç¥ããããã€ã䜿çšãããŠã
ãããã®ãããªè©Šéšçäžã«èŠãåºãããè©Šè¬çµæ
ç©ã¯ãã°ãã°éãããæ床ãæãããã®ã§ã¯ãã
ããçŽæ¥çãªååŠåå¿ã«ãã€ãŠã枬å®ãããã¹ã
äžæååã¯è€æ°æåãšçžäºã«äœçšãåãããã
ãŠãããªã¢ã«é ååã¯ãã以äžã®æ¿åºŠã§æ¶²äœè©Šæ
äžã«ååšããç©è³ªã®æ€ç¥ã«é©çšãããŠããã
ããã°ã«ã³ãŒã¹ãèçœãæœè¡ãªã©ïŒäŸãã°ãç±³åœ
ç¹èš±ç¬¬3164534ïŒ3485587åã³3012976å·ã«èšèŒã
ããŠãããããªïŒã®çš®ã ã®å°¿äžåã³è¡äžæåã®ç
äœå€èšºæè©Šéšå ·ã«å°ããŸã§ãåºæ±ãªåéã«ãã
ãŠã氞幎ã«ãããç¥ããããã€ã䜿çšãããŠã
ãããã®ãããªè©Šéšçäžã«èŠãåºãããè©Šè¬çµæ
ç©ã¯ãã°ãã°éãããæ床ãæãããã®ã§ã¯ãã
ããçŽæ¥çãªååŠåå¿ã«ãã€ãŠã枬å®ãããã¹ã
äžæååã¯è€æ°æåãšçžäºã«äœçšãåãããã
ãŠãããªã¢ã«é ååã¯ãã以äžã®æ¿åºŠã§æ¶²äœè©Šæ
äžã«ååšããç©è³ªã®æ€ç¥ã«é©çšãããŠããã
(a) åºæ¬çãªå€éå±€ã®äžäœçåæçŽ åã¯ãç±³åœç¹
蚱第3092465å·ã«èšèŒãããŠããããã®ãããª
å€éå±€çŽ åã§ã¯ãç¹ã«ãçºè²å€ãå«ããïŒçš®å
ã¯ãã以äžã®è©Šè¬ãå«æµžããåžåæ§ã®ç¹ç¶è³ªæ
äœã§ãã€ãŠããã®äžã«åéèã被èŠãããã®ã
çšããããŠãããè©Šéšæ¶²ã«æ¥è§Šãããšãåæ察
象ç©ã¯èãééããŠç¹ç¶è³ªã®æ äœã«å°ãããã®
çµæãåæ察象ç©ã®æ¿åºŠã«é¢ä¿ããéã®è²ãçº
ããããã®èã¯ãè©ŠéšçµæãšããŠåŸããããã®
è²ã®æ£ç¢ºãªèªã¿ã劚害ããå¯èœæ§ããããèµ€è¡
çã®ãããªãããçš®ã®åŠšå®³æåã®ééåã³åžå
ãé²æ¢ããã
蚱第3092465å·ã«èšèŒãããŠããããã®ãããª
å€éå±€çŽ åã§ã¯ãç¹ã«ãçºè²å€ãå«ããïŒçš®å
ã¯ãã以äžã®è©Šè¬ãå«æµžããåžåæ§ã®ç¹ç¶è³ªæ
äœã§ãã€ãŠããã®äžã«åéèã被èŠãããã®ã
çšããããŠãããè©Šéšæ¶²ã«æ¥è§Šãããšãåæ察
象ç©ã¯èãééããŠç¹ç¶è³ªã®æ äœã«å°ãããã®
çµæãåæ察象ç©ã®æ¿åºŠã«é¢ä¿ããéã®è²ãçº
ããããã®èã¯ãè©ŠéšçµæãšããŠåŸããããã®
è²ã®æ£ç¢ºãªèªã¿ã劚害ããå¯èœæ§ããããèµ€è¡
çã®ãããªãããçš®ã®åŠšå®³æåã®ééåã³åžå
ãé²æ¢ããã
ä»ã®å€éå±€ã®äžäœçåæçŽ åã¯ãç±³åœç¹èš±ç¬¬
3992158å·ã«èšèŒãããŠããããããçŽ åã¯ã
液äœè©Šæãå容ããŠã該詊æãè©²çŽ åã®å±éå±€
å ã«å±éãããã®çµæãè©²çŽ åå ã«åæ察象
ç©ãä»ã®ãããã¹ãè©Šææååã¯åæ察象ç©ã®
çæç©ãåŸããããŠãåæ察象ç©ã®ååšäžã«ã
åå å 床æ³ãè¢å æ³çã®ãããªææ³ãçšããŠèª
åè£ çœ®ã«ããå®éçã«æž¬å®ããããšãã§ããå
æçµæãããããããã®ãããªçŽ åã¯ãå±éå±€
ãšããã®æŽ»æ§ã«ãããè©²çŽ åå ã§è²ã®å€åã®ã
ããªå 枬å®çã«æ€ç¥å¯èœãªå€åãä¿é²ããåå¿
æ§ã®ãããªãã°çžäºäœçšæ§ã®ç©è³ªãå«ãè©Šè¬å±€
ãšããæ§æããããšãã§ããã
3992158å·ã«èšèŒãããŠããããããçŽ åã¯ã
液äœè©Šæãå容ããŠã該詊æãè©²çŽ åã®å±éå±€
å ã«å±éãããã®çµæãè©²çŽ åå ã«åæ察象
ç©ãä»ã®ãããã¹ãè©Šææååã¯åæ察象ç©ã®
çæç©ãåŸããããŠãåæ察象ç©ã®ååšäžã«ã
åå å 床æ³ãè¢å æ³çã®ãããªææ³ãçšããŠèª
åè£ çœ®ã«ããå®éçã«æž¬å®ããããšãã§ããå
æçµæãããããããã®ãããªçŽ åã¯ãå±éå±€
ãšããã®æŽ»æ§ã«ãããè©²çŽ åå ã§è²ã®å€åã®ã
ããªå 枬å®çã«æ€ç¥å¯èœãªå€åãä¿é²ããåå¿
æ§ã®ãããªãã°çžäºäœçšæ§ã®ç©è³ªãå«ãè©Šè¬å±€
ãšããæ§æããããšãã§ããã
ç±³åœç¹èš±ç¬¬4042335å·ã¯ã(1)åæ察象ç©ãšå
å¿ããŠãæ¡æ£æ§ã§æ€ç¥å¯èœãªçš®ïŒspeciesïŒã
圢æããè©Šè¬å±€ïŒ(2)æ€ç¥å¯èœãªçš®ã«å¯ŸããŠã¯é
éæ§ã§ãã€äžéæåå€ãæããéç¹ç¶è³ªã®å é®
ãžãå±€ïŒåã³(3)æ€ç¥å¯èœãªçš®ãæ€ç¥ãããéç¹
ç¶è³ªã§å ééæ§ã®è¡šç€ºå±€ãåããçŽ åã«é¢ã
ãããã®èŠçŽ ã¯ãããããŠã以äžã«èªãŸããã
å¿ããŠãæ¡æ£æ§ã§æ€ç¥å¯èœãªçš®ïŒspeciesïŒã
圢æããè©Šè¬å±€ïŒ(2)æ€ç¥å¯èœãªçš®ã«å¯ŸããŠã¯é
éæ§ã§ãã€äžéæåå€ãæããéç¹ç¶è³ªã®å é®
ãžãå±€ïŒåã³(3)æ€ç¥å¯èœãªçš®ãæ€ç¥ãããéç¹
ç¶è³ªã§å ééæ§ã®è¡šç€ºå±€ãåããçŽ åã«é¢ã
ãããã®èŠçŽ ã¯ãããããŠã以äžã«èªãŸããã
ç±³åœç¹èš±ç¬¬4066403å·ïŒRe30267ïŒã¯ã(1)å
æ察象ç©ãšåå¿ããŠå解çæç©ãçæããè©Š
è¬ïŒåã³(2)å解çæç©åã¯äžéäœãšåå¿ããŠæ€
ç¥å¯èœãªå€åãçããè©Šè¬ãå«æãããããŠã
ã®æ¹è¯ãšããŠãè©Šè¬(1)ãè©Šè¬(2)ããåé¢ããé
å£çµæç©ãæããå解çæç©ã«å¯ŸããŠã¯å®è³ªç
ã«å質ã«ééæ§ã§åŠšå®³ç©ã«å¯ŸããŠã¯äºè³ªçäžé
éæ§ã§ããçŽ åã«é¢ããããããããããããª
ããŠããããšã¯ããè©Šè¬ãå±€ãšã衚瀺ãå±€ã®é
ã«ãéãå±€ãå ããŠããããšã§ããã
æ察象ç©ãšåå¿ããŠå解çæç©ãçæããè©Š
è¬ïŒåã³(2)å解çæç©åã¯äžéäœãšåå¿ããŠæ€
ç¥å¯èœãªå€åãçããè©Šè¬ãå«æãããããŠã
ã®æ¹è¯ãšããŠãè©Šè¬(1)ãè©Šè¬(2)ããåé¢ããé
å£çµæç©ãæããå解çæç©ã«å¯ŸããŠã¯å®è³ªç
ã«å質ã«ééæ§ã§åŠšå®³ç©ã«å¯ŸããŠã¯äºè³ªçäžé
éæ§ã§ããçŽ åã«é¢ããããããããããããª
ããŠããããšã¯ããè©Šè¬ãå±€ãšã衚瀺ãå±€ã®é
ã«ãéãå±€ãå ããŠããããšã§ããã
ç±³åœç¹èš±ç¬¬4144306å·ã¯ãè©Šè¬å±€ããåæ察
象ç©ã®ååšäžã«ãéé¢ããæ¡æ£æ§ãšãªããåã
ã€ãŠåœ¢æãããæ€ç¥å¯èœãªéšåïŒmoietyïŒã
å«æããéæ¡æ£æ§ã®ç©è³ªãæããçŽ åã«é¢ã
ãã衚瀺局ã¯æ¡æ£æ§ã®çš®ãå容ãããçŽ åå ã®
å±€ã¯ãè©Šè¬å±€ããéé¢ããããäºã圢æããæ€
ç¥å¯èœãªéšåãè©²çŽ åå ã§éžæçã«æ€ç¥ããåŸ
ãããã«æ§æãããŠããã
象ç©ã®ååšäžã«ãéé¢ããæ¡æ£æ§ãšãªããåã
ã€ãŠåœ¢æãããæ€ç¥å¯èœãªéšåïŒmoietyïŒã
å«æããéæ¡æ£æ§ã®ç©è³ªãæããçŽ åã«é¢ã
ãã衚瀺局ã¯æ¡æ£æ§ã®çš®ãå容ãããçŽ åå ã®
å±€ã¯ãè©Šè¬å±€ããéé¢ããããäºã圢æããæ€
ç¥å¯èœãªéšåãè©²çŽ åå ã§éžæçã«æ€ç¥ããåŸ
ãããã«æ§æãããŠããã
ç±³åœç¹èš±ç¬¬4166093å·ã¯ã(1)åæ察象ç©ãšå
å¿ããŠæ€ç¥å¯èœãªçš®ãçæãã茻å°ç·ééæ§ã®
è©Šè¬å±€ãš(2)åæ察象ç©ã«å¯ŸããŠã¯ééæ§ã§ãã
å€å質ã®èŒ»å°ç·é®ãžãå±€ãæããçŽ åã«é¢ã
ãããã®æ¹è¯ç¹ãšããŠãããã¯æŽã«ã(3)è©Šè¬å±€
ãšå€å質ã®èŒ»å°ç·é®ãžãå±€ã®éã«èŒ»å°ç·ééæ§
ã§ãæ€ç¥å¯èœãªçš®ã®ç§»åãé²æ¢ããå±€ãæã
ãããã®ç§»åé²æ¢å±€ã¯åæ察象ç©ã«å¯ŸããŠã¯é
éæ§ã§ããããæ€ç¥å¯èœãªçš®ã®èŒ»å°ç·é®ãžãå±€
ãžã®ç§»åã¯é²æ¢ããã
å¿ããŠæ€ç¥å¯èœãªçš®ãçæãã茻å°ç·ééæ§ã®
è©Šè¬å±€ãš(2)åæ察象ç©ã«å¯ŸããŠã¯ééæ§ã§ãã
å€å質ã®èŒ»å°ç·é®ãžãå±€ãæããçŽ åã«é¢ã
ãããã®æ¹è¯ç¹ãšããŠãããã¯æŽã«ã(3)è©Šè¬å±€
ãšå€å質ã®èŒ»å°ç·é®ãžãå±€ã®éã«èŒ»å°ç·ééæ§
ã§ãæ€ç¥å¯èœãªçš®ã®ç§»åãé²æ¢ããå±€ãæã
ãããã®ç§»åé²æ¢å±€ã¯åæ察象ç©ã«å¯ŸããŠã¯é
éæ§ã§ããããæ€ç¥å¯èœãªçš®ã®èŒ»å°ç·é®ãžãå±€
ãžã®ç§»åã¯é²æ¢ããã
(b) åºçžè©Šéšå
·ããäžåäžç³»çµååææ³ã«é©çšã
ããå¿ ãåé¢å·¥çšãçµãªããã°ãªããªããšãã
äžäŸ¿ãåã³æ¬ ç¹ãå æããåªåããªãããŠã
ããäžè¬ã«äœ¿çšãããŠãããã®åã®åºçžã®è©Šéš
å ·ã¯ãè©Šéšç®¡åã¯ä»ã®å®¹åšã®å éšè¡šé¢ã®ãããª
åã®ãªãè¡šé¢ããæããããã«æäœãåºå®ãã
ãŠãããåã¯åžçè¥ããã¯å ±æçµåã«ãã€ãŠå¡
çãããŠãããç±³åœç¹èš±ç¬¬3826619å·ïŒ4001583
å·ïŒ4017597å·ïŒåã³4105410å·ã¯ã茻å°å ç«å
æïŒã©ãžãªã€ã ãã¢ãã»ãŒïŒã«ããããæäœå¡
çè©Šéšç®¡ã®äœ¿çšã«é¢ãããåºçžè©Šéšå ·ã¯ãåã
äžåäžç³»é µçŽ å ç«åæïŒç±³åœç¹èš±ç¬¬4016043å·
åã³4147752å·ïŒåã³äžåäžç³»è¢å å ç«åæ
ïŒç±³åœç¹èš±ç¬¬4025310å·åã³4056724å·ïŒåã³è±
åœç¹èš±ç¬¬1552374å·ïŒã«äœ¿çšãããŠããŠããã
ãã®ãããªäžåäžç³»ç¹ç°ççµååæçšè©Šéšå ·ã®
䜿çšã¯ããããããã¬ã³ãã¹ãã€ãã¯
ïŒgamma stickïŒãã«é¢ããç±³åœç¹èš±ç¬¬4135884
å·ã®æ¹æ³ã«ãã€ãŠäŸç€ºãããŠããããã®è©Šéšå ·
ã¯ãæäœè©Šè¬ãå å«ãããããã液äœè©Šæåã³
åå¿ç³»ã®æ®çè©Šè¬é¡ãåºæ¬çã«ã¯æšèè€åäœãš
æ¥è§Šãããããããäžå®ã®æŸçœ®æéåŸãåºçžè©Š
éšå ·ã¯åå¿æº¶æ¶²ããç©ççã«åãå€ããã溶液
äžãåã¯è©Šéšå ·äžã®ã©ã¡ããã®æšèïŒlabelïŒ
ã枬å®ãããã
ããå¿ ãåé¢å·¥çšãçµãªããã°ãªããªããšãã
äžäŸ¿ãåã³æ¬ ç¹ãå æããåªåããªãããŠã
ããäžè¬ã«äœ¿çšãããŠãããã®åã®åºçžã®è©Šéš
å ·ã¯ãè©Šéšç®¡åã¯ä»ã®å®¹åšã®å éšè¡šé¢ã®ãããª
åã®ãªãè¡šé¢ããæããããã«æäœãåºå®ãã
ãŠãããåã¯åžçè¥ããã¯å ±æçµåã«ãã€ãŠå¡
çãããŠãããç±³åœç¹èš±ç¬¬3826619å·ïŒ4001583
å·ïŒ4017597å·ïŒåã³4105410å·ã¯ã茻å°å ç«å
æïŒã©ãžãªã€ã ãã¢ãã»ãŒïŒã«ããããæäœå¡
çè©Šéšç®¡ã®äœ¿çšã«é¢ãããåºçžè©Šéšå ·ã¯ãåã
äžåäžç³»é µçŽ å ç«åæïŒç±³åœç¹èš±ç¬¬4016043å·
åã³4147752å·ïŒåã³äžåäžç³»è¢å å ç«åæ
ïŒç±³åœç¹èš±ç¬¬4025310å·åã³4056724å·ïŒåã³è±
åœç¹èš±ç¬¬1552374å·ïŒã«äœ¿çšãããŠããŠããã
ãã®ãããªäžåäžç³»ç¹ç°ççµååæçšè©Šéšå ·ã®
䜿çšã¯ããããããã¬ã³ãã¹ãã€ãã¯
ïŒgamma stickïŒãã«é¢ããç±³åœç¹èš±ç¬¬4135884
å·ã®æ¹æ³ã«ãã€ãŠäŸç€ºãããŠããããã®è©Šéšå ·
ã¯ãæäœè©Šè¬ãå å«ãããããã液äœè©Šæåã³
åå¿ç³»ã®æ®çè©Šè¬é¡ãåºæ¬çã«ã¯æšèè€åäœãš
æ¥è§Šãããããããäžå®ã®æŸçœ®æéåŸãåºçžè©Š
éšå ·ã¯åå¿æº¶æ¶²ããç©ççã«åãå€ããã溶液
äžãåã¯è©Šéšå ·äžã®ã©ã¡ããã®æšèïŒlabelïŒ
ã枬å®ãããã
æäœè©Šè¬ãã²ã«åã¯çŽè£œã®ãŠãšããã®ãããªã
ããªãã¯ã¹äžã«ä¿æãããåæ§ã®è©Šéšå ·ã¯ãç±³åœ
ç¹èš±ç¬¬3925017å·ïŒ3970429å·ïŒ4138474å·ïŒ
3966897å·ïŒ3981981å·åã³3888629å·ã®åå ¬å ±äžŠ
ã³ã«è¥¿ç¬åœåºé¡å ¬é2241646å·å ¬å ±ã«èšèŒãããŠ
ãããåæ§ã«ãéæµæ§ã®ã«ã©ã ã®äžã«ä¿æããã
ãããªãã¯ã¹ã«ãæäœãåºå®ãããŠãããäžåäž
ç³»ç¹ç°ççµååæçšè©Šéšå ·ãç¥ãããŠããïŒç±³åœ
ç¹èš±ç¬¬4036947å·ïŒ4039652å·ïŒ4059684å·ïŒ
4153675å·ïŒåã³4166102å·ïŒããã®è©Šéšå ·ã«ã¯ã
éåžžãåæãéè¡ããããã®å¿ èŠè©Šè¬é¡ã®ãã¹ãŠ
ãå å«ãããŠããããã§ã¯ãªããããã¯ãå¿ èŠãª
åé¢å·¥çšããã簡䟿ã«ããããã®åãªãæ段ã«ã
ããªãã
ããªãã¯ã¹äžã«ä¿æãããåæ§ã®è©Šéšå ·ã¯ãç±³åœ
ç¹èš±ç¬¬3925017å·ïŒ3970429å·ïŒ4138474å·ïŒ
3966897å·ïŒ3981981å·åã³3888629å·ã®åå ¬å ±äžŠ
ã³ã«è¥¿ç¬åœåºé¡å ¬é2241646å·å ¬å ±ã«èšèŒãããŠ
ãããåæ§ã«ãéæµæ§ã®ã«ã©ã ã®äžã«ä¿æããã
ãããªãã¯ã¹ã«ãæäœãåºå®ãããŠãããäžåäž
ç³»ç¹ç°ççµååæçšè©Šéšå ·ãç¥ãããŠããïŒç±³åœ
ç¹èš±ç¬¬4036947å·ïŒ4039652å·ïŒ4059684å·ïŒ
4153675å·ïŒåã³4166102å·ïŒããã®è©Šéšå ·ã«ã¯ã
éåžžãåæãéè¡ããããã®å¿ èŠè©Šè¬é¡ã®ãã¹ãŠ
ãå å«ãããŠããããã§ã¯ãªããããã¯ãå¿ èŠãª
åé¢å·¥çšããã簡䟿ã«ããããã®åãªãæ段ã«ã
ããªãã
æåŸã«ãäžåäžç³»ç¹ç°ççµååæçšè©Šéšå
·ãé
瀺ãããŠããããããã«ããã°ãå¿ èŠè©Šè¬é¡ã®ã»
ãšãã©åã¯å šãŠãåãæ äœçŽ åã«å å«ãããè©Šè¬
ãšè©Šæã®æ¥è§Šåã³éé¢çžãšçµåçžã®åé¢ãæ äœçŽ
åã«æ²¿ã€ãæ¯çŽ°ç®¡å ã®ç§»åã«ãã€ãŠãªãããïŒç±³
åœç¹èš±ç¬¬3641235å·ïŒ4094647å·åã³4168146å·ïŒã
ãããã®ç¹èš±ã«èšèŒãããŠããè©Šéšå ·ã¯ãæŠã
ãŠã補é ããããããããŸããåæã®é²è¡äžã«æ
äœçŽ åã«æ²¿ã€ãŠèµ·çããå€ãã®ååŠçåã³ç©çç
çžäºäœçšã®è€éãªæ§è³ªã®æ ã«ãåçŸæ§ãåŸããé£
ããšèããããŠãããæŽã«ãäžåäžç³»å ç«åæçŽ
åãžã®ä»ã®è©Šã¿ã¯ã欧å·ç¹èš±åºé¡0013156ãšããŠ
å ¬éãããç±³åœåºé¡ç¬¬973669å·ã«äŸç€ºãããŠã
ãã
瀺ãããŠããããããã«ããã°ãå¿ èŠè©Šè¬é¡ã®ã»
ãšãã©åã¯å šãŠãåãæ äœçŽ åã«å å«ãããè©Šè¬
ãšè©Šæã®æ¥è§Šåã³éé¢çžãšçµåçžã®åé¢ãæ äœçŽ
åã«æ²¿ã€ãæ¯çŽ°ç®¡å ã®ç§»åã«ãã€ãŠãªãããïŒç±³
åœç¹èš±ç¬¬3641235å·ïŒ4094647å·åã³4168146å·ïŒã
ãããã®ç¹èš±ã«èšèŒãããŠããè©Šéšå ·ã¯ãæŠã
ãŠã補é ããããããããŸããåæã®é²è¡äžã«æ
äœçŽ åã«æ²¿ã€ãŠèµ·çããå€ãã®ååŠçåã³ç©çç
çžäºäœçšã®è€éãªæ§è³ªã®æ ã«ãåçŸæ§ãåŸããé£
ããšèããããŠãããæŽã«ãäžåäžç³»å ç«åæçŽ
åãžã®ä»ã®è©Šã¿ã¯ã欧å·ç¹èš±åºé¡0013156ãšããŠ
å ¬éãããç±³åœåºé¡ç¬¬973669å·ã«äŸç€ºãããŠã
ãã
åäžç³»ç¹ç°ççµååæè©Šè¬ç³»ã®ãåºäœç¶è©Šéšå
·
ãžã®å¿çšã¯ããã®ãããªåæç³»ãæ¥åžžäœ¿çšããè
ã«ãšã€ãŠã¯å€§ããªå©çãããããã§ãããã液äœ
è©Šæäžã«éåžžãªäœæ¿åºŠã§ååšããé äœåïŒãªã¬ã³
ããligandïŒã®æž¬å®ã¯ãè©Šéšå ·ãè©Šæã«æ¥è§Šãã
èçŒèŠ³å¯ã«ããããåã¯ãæ©åšæ段ã«ããããã©
ã¡ããã®æ¹æ³ã§åŸãããä¿¡å·ã枬å®ããå·¥çšãžãš
ç°¡ç¥åãããã§ããããè©Šè¬ã¯åºäœç¶æ ã§äŸçµŠã
ããå è¡æè¡ã®è©Šéšããããçšãããšãã«èŠæ±ã
ãããããªæ¶²äœè©Šè¬ã®è²¯èµã調ååã¯æ··åãå¿ èŠ
ãšããªããåºäœç¶æ ã®è©Šéšå ·ã¯ãæŽã«ãå è¡æè¡
ã®æ¶²äœç³»ã«æ¯ã¹ãŠãèªååãžã®ã¯ããã«å€§ããªé©
åæ§ãæããã ããã
ãžã®å¿çšã¯ããã®ãããªåæç³»ãæ¥åžžäœ¿çšããè
ã«ãšã€ãŠã¯å€§ããªå©çãããããã§ãããã液äœ
è©Šæäžã«éåžžãªäœæ¿åºŠã§ååšããé äœåïŒãªã¬ã³
ããligandïŒã®æž¬å®ã¯ãè©Šéšå ·ãè©Šæã«æ¥è§Šãã
èçŒèŠ³å¯ã«ããããåã¯ãæ©åšæ段ã«ããããã©
ã¡ããã®æ¹æ³ã§åŸãããä¿¡å·ã枬å®ããå·¥çšãžãš
ç°¡ç¥åãããã§ããããè©Šè¬ã¯åºäœç¶æ ã§äŸçµŠã
ããå è¡æè¡ã®è©Šéšããããçšãããšãã«èŠæ±ã
ãããããªæ¶²äœè©Šè¬ã®è²¯èµã調ååã¯æ··åãå¿ èŠ
ãšããªããåºäœç¶æ ã®è©Šéšå ·ã¯ãæŽã«ãå è¡æè¡
ã®æ¶²äœç³»ã«æ¯ã¹ãŠãèªååãžã®ã¯ããã«å€§ããªé©
åæ§ãæããã ããã
è±åœç¹èš±ç¬¬1552607å·æ现æžã¯ãããã§äžè¬ç
ã«åŒãåãã«åºãããŠããããã«ãååŠçºå æ§æš
èãé µçŽ åºè³ªæšèåã³è£é µçŽ æšèãã¯ãããšãã
åçš®ã®æ°ããæšèãçšããåäžç³»ç¹ç°ççµååæ
ç³»ãé瀺ããŠããããã®ç¹èš±ã®23é ã12è¡ç®ä»¥äž
ã«ã¯ãåæçšè©Šè¬ã液äœå容æ§ã®å®¹åšè¥ããã¯äž
溶æ§ã§ãå€å質ã§ããããŠå¥œãŸããã¯åžåæ§ã®ã
ããªãã¯ã¹ãããªãŒã¹åã¯ç¹ç¶ããïŒã²ã«æïŒç
ãã¯ãããšããåçš®ã®æ äœã«å å«ãããããšã瀺
åãããŠãããããã¯ãåäžç³»ç¹ç°ççµååæè©Š
è¬ç³»ãããã«ããŠãåºäœç¶è©Šéšå ·ã«é©çšãããã«
ã€ããŠã®è©³çŽ°ãªæ瀺ã«æ¬ ããŠããã
ã«åŒãåãã«åºãããŠããããã«ãååŠçºå æ§æš
èãé µçŽ åºè³ªæšèåã³è£é µçŽ æšèãã¯ãããšãã
åçš®ã®æ°ããæšèãçšããåäžç³»ç¹ç°ççµååæ
ç³»ãé瀺ããŠããããã®ç¹èš±ã®23é ã12è¡ç®ä»¥äž
ã«ã¯ãåæçšè©Šè¬ã液äœå容æ§ã®å®¹åšè¥ããã¯äž
溶æ§ã§ãå€å質ã§ããããŠå¥œãŸããã¯åžåæ§ã®ã
ããªãã¯ã¹ãããªãŒã¹åã¯ç¹ç¶ããïŒã²ã«æïŒç
ãã¯ãããšããåçš®ã®æ äœã«å å«ãããããšã瀺
åãããŠãããããã¯ãåäžç³»ç¹ç°ççµååæè©Š
è¬ç³»ãããã«ããŠãåºäœç¶è©Šéšå ·ã«é©çšãããã«
ã€ããŠã®è©³çŽ°ãªæ瀺ã«æ¬ ããŠããã
西ç¬åœåºé¡å
¬é2537275å·ã¯ãåäžç³»ç¹ç°ççµ
ååæè©Šè¬ç³»ãèšèŒãããã€ãåæãè¡ãªãã«ã
ãã€ãŠæäœãå å«ãã现çåã¯ã¹ã©ã€ãã®äœ¿çšå¯
èœæ§ã«ã€ãè¿°ã¹ãŠããããã®ç€ºåã«ãããŠã¯ãæš
èè€åäœãæåã«è©Šæãšæ··åããããã®åŸãæäœ
ãå«ãè©Šéšå ·ãåå¿æ··åç©ãšæ¥è§Šããããããé©
åœãªæž©çœ®æéåŸãè©Šéšå ·ãç·©è¡æ¶²ã§æŽæµãã也ç¥
ããã€ãã§ä¿¡å·ïŒè¢å ïŒã枬å®ããããšãææ¡ã
ããŠããããã®ããã«ããã®è¥¿ç¬åœåºé¡å ¬éå ¬å ±
ã¯ãè©Šéšå ·ã液äœåå¿æ··åç©äžã«æµžæŒ¬ããå¹é€ã
ãã®ã¡ãåãåºããŠæŽæµããæåŸã«èªã¿ãšããè¡
ãªãäžåäžç³»ç¹ç°ççµååææè¡ã«ã€ããŠæ¢ã«ã
ãç¥ãããŠããè©Šéšå ·åã³åææ¹æ³ãæ瀺ããŠã
ããæŽã«ãããã§ææ¡ãããŠããè©Šéšå ·ã¯ãçµå
åæè©Šè¬ã®å šãŠãæ äœçŽ åã«å å«ãããŠã¯ããª
ããå ·äœçã«ã¯ãæäœã®ã¿ãæ äœã«å å«ãããã
ã«ææ¡ãããæšèè€åäœã¯ãææ¡ãããè©Šéšå ·ãš
ã®æ¥è§Šã«å ç«ã€ãŠãè©Šéšãã¹ãè©Šæã«æ·»å ãã
ãã
ååæè©Šè¬ç³»ãèšèŒãããã€ãåæãè¡ãªãã«ã
ãã€ãŠæäœãå å«ãã现çåã¯ã¹ã©ã€ãã®äœ¿çšå¯
èœæ§ã«ã€ãè¿°ã¹ãŠããããã®ç€ºåã«ãããŠã¯ãæš
èè€åäœãæåã«è©Šæãšæ··åããããã®åŸãæäœ
ãå«ãè©Šéšå ·ãåå¿æ··åç©ãšæ¥è§Šããããããé©
åœãªæž©çœ®æéåŸãè©Šéšå ·ãç·©è¡æ¶²ã§æŽæµãã也ç¥
ããã€ãã§ä¿¡å·ïŒè¢å ïŒã枬å®ããããšãææ¡ã
ããŠããããã®ããã«ããã®è¥¿ç¬åœåºé¡å ¬éå ¬å ±
ã¯ãè©Šéšå ·ã液äœåå¿æ··åç©äžã«æµžæŒ¬ããå¹é€ã
ãã®ã¡ãåãåºããŠæŽæµããæåŸã«èªã¿ãšããè¡
ãªãäžåäžç³»ç¹ç°ççµååææè¡ã«ã€ããŠæ¢ã«ã
ãç¥ãããŠããè©Šéšå ·åã³åææ¹æ³ãæ瀺ããŠã
ããæŽã«ãããã§ææ¡ãããŠããè©Šéšå ·ã¯ãçµå
åæè©Šè¬ã®å šãŠãæ äœçŽ åã«å å«ãããŠã¯ããª
ããå ·äœçã«ã¯ãæäœã®ã¿ãæ äœã«å å«ãããã
ã«ææ¡ãããæšèè€åäœã¯ãææ¡ãããè©Šéšå ·ãš
ã®æ¥è§Šã«å ç«ã€ãŠãè©Šéšãã¹ãè©Šæã«æ·»å ãã
ãã
1981幎ïŒæ20æ¥ã«åºé¡ããåºé¡ã«ä¿å±ããŠãã
ç±³åœç¹èš±ç¬¬255521å·ã¯ã液äœè©Šéšè©Šæäžã®é äœå
ã®ååšåã¯é äœåã«çµåããèœåïŒä»¥äžãé äœå
çµåèœããšããïŒã枬å®ããããã®æ¹æ³ãé瀺
ãããã®æ¹æ³ã¯ã(1)液äœè©Šæã«ãé äœååã¯æšè
ã«ååŠçã«çµåããããã®çµåæ§é¡çžäœãå«ãé
äœåè€åäœãæ·»å ãã(2)è©Šæããæšèè€åäœãšå
ããããšããé äœååã¯é äœåçµåèœã®ååšã®é¢
æ°ã§ããæ€ç¥å¯èœãªå¿çãçããåäžç³»ç¹ç°ççµ
ååæç³»ãçæãããã®ããšã«ããå¿çãçãã
è©Šè¬ãå å«ãããæ äœãããªãã¯ã¹ããæãè©Šéš
å ·ã«æ¥è§ŠããããããŠ(3)ãã®å¿çã枬å®ããå·¥çš
ããæ§æãããããšãç¹åŸŽãšããã
ç±³åœç¹èš±ç¬¬255521å·ã¯ã液äœè©Šéšè©Šæäžã®é äœå
ã®ååšåã¯é äœåã«çµåããèœåïŒä»¥äžãé äœå
çµåèœããšããïŒã枬å®ããããã®æ¹æ³ãé瀺
ãããã®æ¹æ³ã¯ã(1)液äœè©Šæã«ãé äœååã¯æšè
ã«ååŠçã«çµåããããã®çµåæ§é¡çžäœãå«ãé
äœåè€åäœãæ·»å ãã(2)è©Šæããæšèè€åäœãšå
ããããšããé äœååã¯é äœåçµåèœã®ååšã®é¢
æ°ã§ããæ€ç¥å¯èœãªå¿çãçããåäžç³»ç¹ç°ççµ
ååæç³»ãçæãããã®ããšã«ããå¿çãçãã
è©Šè¬ãå å«ãããæ äœãããªãã¯ã¹ããæãè©Šéš
å ·ã«æ¥è§ŠããããããŠ(3)ãã®å¿çã枬å®ããå·¥çš
ããæ§æãããããšãç¹åŸŽãšããã
1980幎10æ30æ¥ã«åºé¡ãããåºé¡ã«ä¿å±ããŠã
ãç±³åœåºé¡ç¬¬202378å·ã¯ãåäžç³»ç¹ç°ççµåè©Šéš
å ·ããã®è£œé æ¹æ³åã³æ¶²äœè©Šæäžã®é äœååã¯é
äœåçµåèœã枬å®ããããã®ããã®äœ¿çšæ¹æ³ãé
瀺ããŠãããããã¯ãäŸãã°ã(a)è©Šæäžã®é äœå
åã¯é äœåçµåèœã®ååšã®é¢æ°ã§ããæ€ç¥å¯èœãª
å¿çãçããåäžç³»ç¹ç°ççµåè©Šéšç³»çšã®è©Šè¬å
ã³(b)è©Šè¬ãå å«ããåºäœç¶ã®æ äœéšæãšããæã
液äœè©Šæäžã®é äœååã¯é äœåçµåèœã枬å®ãã
ããã®è©Šéšå ·ãå«ãã
ãç±³åœåºé¡ç¬¬202378å·ã¯ãåäžç³»ç¹ç°ççµåè©Šéš
å ·ããã®è£œé æ¹æ³åã³æ¶²äœè©Šæäžã®é äœååã¯é
äœåçµåèœã枬å®ããããã®ããã®äœ¿çšæ¹æ³ãé
瀺ããŠãããããã¯ãäŸãã°ã(a)è©Šæäžã®é äœå
åã¯é äœåçµåèœã®ååšã®é¢æ°ã§ããæ€ç¥å¯èœãª
å¿çãçããåäžç³»ç¹ç°ççµåè©Šéšç³»çšã®è©Šè¬å
ã³(b)è©Šè¬ãå å«ããåºäœç¶ã®æ äœéšæãšããæã
液äœè©Šæäžã®é äœååã¯é äœåçµåèœã枬å®ãã
ããã®è©Šéšå ·ãå«ãã
1981幎ïŒæ10æ¥ã«åºé¡ããåºé¡ã«ä¿å±ããŠãã
ç±³åœåºé¡ç¬¬253147å·ã¯ã(a) (i)é äœååã¯ãã®ç¹
ç°ççµåé¡çžäœã«çµåããæšèæåããæãæšè
è€åäœãš(ii)é äœåã«å¯Ÿããç¹ç°ççµå察æãšã®ã³
ã³ãã¬ãã¯ã¹ãå«ãè©Šè¬çµæç©ïŒããã§ãæšèã¯
æ€ç¥å¯èœãªå¿çåã¯æ€ç¥ç³»ãšçžäºäœçšããŠæ€ç¥å¯
èœãªå¿çâããã¯ãæšèè€åäœãçµåæ§ã®çžæå€
ã«ãã€ãŠçµåããããšãã¯ãããã§ãªããšãã«æ¯
ã¹ãŠçžç°ããâãçããïŒåã³(b)該ã³ã³ãã¬ãã¯
ã¹ãå å«ããæ äœãšããæ§æãããã液äœè©Šæäž
ã®é äœåã枬å®ããããã«äœ¿çšããåäžç³»ç¹ç°ç
çµåè©Šéšå ·ãé瀺ããŠããã
ç±³åœåºé¡ç¬¬253147å·ã¯ã(a) (i)é äœååã¯ãã®ç¹
ç°ççµåé¡çžäœã«çµåããæšèæåããæãæšè
è€åäœãš(ii)é äœåã«å¯Ÿããç¹ç°ççµå察æãšã®ã³
ã³ãã¬ãã¯ã¹ãå«ãè©Šè¬çµæç©ïŒããã§ãæšèã¯
æ€ç¥å¯èœãªå¿çåã¯æ€ç¥ç³»ãšçžäºäœçšããŠæ€ç¥å¯
èœãªå¿çâããã¯ãæšèè€åäœãçµåæ§ã®çžæå€
ã«ãã€ãŠçµåããããšãã¯ãããã§ãªããšãã«æ¯
ã¹ãŠçžç°ããâãçããïŒåã³(b)該ã³ã³ãã¬ãã¯
ã¹ãå å«ããæ äœãšããæ§æãããã液äœè©Šæäž
ã®é äœåã枬å®ããããã«äœ¿çšããåäžç³»ç¹ç°ç
çµåè©Šéšå ·ãé瀺ããŠããã
å
è¡æè¡ã®çŽ åã«ååšããè«žåé¡ã¯ãæ¬çºæã®
å€éå±€åæçŽ åã«ãã€ãŠèªèãããããŠåé¿åã¯
å æããããçŽ åã®å¿çãè©Šè¬å±€ããé¢ããçŽ å
è¡šé¢ãããªãã¡ãæ¯æ局衚é¢ããèªã¿åãããã®
ã§ãå è¡æè¡ã®çŽ åã§çšããããé®ãžãå±€ã¯ãé
äœåãè©Šè¬å±€ã®è©Šè¬åã¯ãããã®çžäºåå¿ã«ãã
çæç©ã«å¯ŸããŠééæ§ã§ããããšãèŠæ±ãããã
å€éå±€åæçŽ åã«ãã€ãŠèªèãããããŠåé¿åã¯
å æããããçŽ åã®å¿çãè©Šè¬å±€ããé¢ããçŽ å
è¡šé¢ãããªãã¡ãæ¯æ局衚é¢ããèªã¿åãããã®
ã§ãå è¡æè¡ã®çŽ åã§çšããããé®ãžãå±€ã¯ãé
äœåãè©Šè¬å±€ã®è©Šè¬åã¯ãããã®çžäºåå¿ã«ãã
çæç©ã«å¯ŸããŠééæ§ã§ããããšãèŠæ±ãããã
ãã®åé¡ã¯ãåå°åã³è¢å
ã®ç³»ã§æŸåºãããã
ããªé»ç£èŒ»å°ç·ããããªã¹ãã¬ã³åã¯ããªãšã¹ã
ã«å±€ã®ãããªæ¯æå±€ïŒå è¡æè¡ã®çŽ åã«ãããŠ
ã¯ã茻å°ç·ã¯ãæ¯æå±€ãééããªããã°ãªããª
ãïŒã«ãã€ãŠåœ±é¿ãåãããšããç¹ã«ãããæ¯æ
å±€ãééããå ã®ãããªé»ç£èŒ»å°ç·ã®äžéšã¯ãå±€
å ã§æä¿ãããããã®ãããããã¯ãæ¬è³ªçã«
ã¯ãå åŠç¹ç¶ãšããŠæåãããããããŠå ã®ãã
ãªé»ç£èŒ»å°ç·ã®æ€ç¥ãããéã¯ãçŽ åå ã§èµ·ã€ã
åå¿ããåŸãããéãæ£ç¢ºã«ã¯æ瀺ããªããå¿ç
ç·éã®çµæãªã©ã¯ããããããè©Šè¬å±€å ã®é äœå
ã«å¯Ÿããå¿çããã®é»ç£èŒ»å°ç·ã®éãå®å šã«ã¯ç€º
ããªããè¢å ç³»ãçšããŠèªã¿ãšãããçŽ åã®å Žå
ã«ãããŠã¯ãæŸåºãããå ã®äžå®éããæä¿ã
ãããã®ããã«ãã®åé¡ã¯ãé äœåæ¿åºŠãäœãå Ž
åã«åŸãããçµæã®ä¿¡é Œæ§ã«é¡èãªåœ±é¿ãäžã
ããåå°ç³»ãçšããŠèªã¿ãšãããçŽ åã®å Žåã«
ã¯ããã®åé¡ã¯é äœåæ¿åºŠãé«ãå Žåã«äžå±€æ·±å»
ã§ããã
ããªé»ç£èŒ»å°ç·ããããªã¹ãã¬ã³åã¯ããªãšã¹ã
ã«å±€ã®ãããªæ¯æå±€ïŒå è¡æè¡ã®çŽ åã«ãããŠ
ã¯ã茻å°ç·ã¯ãæ¯æå±€ãééããªããã°ãªããª
ãïŒã«ãã€ãŠåœ±é¿ãåãããšããç¹ã«ãããæ¯æ
å±€ãééããå ã®ãããªé»ç£èŒ»å°ç·ã®äžéšã¯ãå±€
å ã§æä¿ãããããã®ãããããã¯ãæ¬è³ªçã«
ã¯ãå åŠç¹ç¶ãšããŠæåãããããããŠå ã®ãã
ãªé»ç£èŒ»å°ç·ã®æ€ç¥ãããéã¯ãçŽ åå ã§èµ·ã€ã
åå¿ããåŸãããéãæ£ç¢ºã«ã¯æ瀺ããªããå¿ç
ç·éã®çµæãªã©ã¯ããããããè©Šè¬å±€å ã®é äœå
ã«å¯Ÿããå¿çããã®é»ç£èŒ»å°ç·ã®éãå®å šã«ã¯ç€º
ããªããè¢å ç³»ãçšããŠèªã¿ãšãããçŽ åã®å Žå
ã«ãããŠã¯ãæŸåºãããå ã®äžå®éããæä¿ã
ãããã®ããã«ãã®åé¡ã¯ãé äœåæ¿åºŠãäœãå Ž
åã«åŸãããçµæã®ä¿¡é Œæ§ã«é¡èãªåœ±é¿ãäžã
ããåå°ç³»ãçšããŠèªã¿ãšãããçŽ åã®å Žåã«
ã¯ããã®åé¡ã¯é äœåæ¿åºŠãé«ãå Žåã«äžå±€æ·±å»
ã§ããã
ãããã®åé¡ã¯ãæ¬çºæã®å€éå±€åæçŽ åã«ã
ããŠåé¿åã¯å æãããããããã®åé¡ãå æã
ãããšã«ãããŠãæ¬çºæã®çŽ åã¯ãå è¡çŽ åã«æ¯
ã¹ãŠã匷ããããé»ç£æ³¢çå¿çåã¯ä¿¡å·ãçºã
ããæŽã«äžå±€æ³šç®ãã¹ãããšã¯ãæŸåºããããã
ã¯ã°ã©ã³ãã®èŒ»å°ç·ïŒ¢ã«å¯Ÿããä¿¡å·èŒ»å°ç·ïŒ³ã®æ¯
ãé«ãããã劚害ããããã¯ã°ã©ã³ãã®èŒ»å°ç·ã
ãªããªãããã®æ¯ã¯ã以äžã®äŸã§ç€ºããããã
ã«ãå°ãªããšã10åã®ãªãŒãã«ãªãã
ããŠåé¿åã¯å æãããããããã®åé¡ãå æã
ãããšã«ãããŠãæ¬çºæã®çŽ åã¯ãå è¡çŽ åã«æ¯
ã¹ãŠã匷ããããé»ç£æ³¢çå¿çåã¯ä¿¡å·ãçºã
ããæŽã«äžå±€æ³šç®ãã¹ãããšã¯ãæŸåºããããã
ã¯ã°ã©ã³ãã®èŒ»å°ç·ïŒ¢ã«å¯Ÿããä¿¡å·èŒ»å°ç·ïŒ³ã®æ¯
ãé«ãããã劚害ããããã¯ã°ã©ã³ãã®èŒ»å°ç·ã
ãªããªãããã®æ¯ã¯ã以äžã®äŸã§ç€ºããããã
ã«ãå°ãªããšã10åã®ãªãŒãã«ãªãã
ãã®ããã«ãæ¬çºæã«ããã°ã液äœè©Šæäžã®é
äœååã¯é äœåçµåèœãæ€ç¥ããããã«ãè©Šæäž
ã®é äœååã¯é äœåçµåèœã«å¿çããŠæ€ç¥å¯èœãª
å¿çã瀺ãè©Šè¬ãå å«ããè©Šè¬å±€ã茻å°ç·ã®æ¡
æ£ã»é®ãžãå±€ã䞊ã³ã«æ¯æå±€ãæããã¿ã€ãã®å€
éå±€åæçŽ åã§ãã€ãŠããã®æ¹è¯ç¹ã茻å°ç·æ¡
æ£ã»é®ãžãå±€ã(a)è©Šè¬å±€ãšæ¯æå±€ã®éã«ä»åšã
ãïŒ(b)é äœåãè©Šè¬å±€ã®è©Šè¬ãåã³ãããã®çžäº
åå¿ã«ããçæç©ã«å¯ŸããŠäžééæ§ã§ïŒãããŠ(c)
é äœåãè©Šè¬å±€ã®è©Šè¬åã³ãããçžäºåå¿ã®çæ
ç©ã«å¯ŸãäžæŽ»æ§ã§ããç¹ã«ããå€éå±€åæçŽ åã
æäŸãããã
äœååã¯é äœåçµåèœãæ€ç¥ããããã«ãè©Šæäž
ã®é äœååã¯é äœåçµåèœã«å¿çããŠæ€ç¥å¯èœãª
å¿çã瀺ãè©Šè¬ãå å«ããè©Šè¬å±€ã茻å°ç·ã®æ¡
æ£ã»é®ãžãå±€ã䞊ã³ã«æ¯æå±€ãæããã¿ã€ãã®å€
éå±€åæçŽ åã§ãã€ãŠããã®æ¹è¯ç¹ã茻å°ç·æ¡
æ£ã»é®ãžãå±€ã(a)è©Šè¬å±€ãšæ¯æå±€ã®éã«ä»åšã
ãïŒ(b)é äœåãè©Šè¬å±€ã®è©Šè¬ãåã³ãããã®çžäº
åå¿ã«ããçæç©ã«å¯ŸããŠäžééæ§ã§ïŒãããŠ(c)
é äœåãè©Šè¬å±€ã®è©Šè¬åã³ãããçžäºåå¿ã®çæ
ç©ã«å¯ŸãäžæŽ»æ§ã§ããç¹ã«ããå€éå±€åæçŽ åã
æäŸãããã
æ確åã®ããã«ã以äžã®èšèŒã§ã¯ç¹ç°ãªçšèªã
䜿ããããããããã¯ãäŸç€ºã®ããã«éžæããã
æ¬çºæã®ç¹å¥ãªæ æ§ãã®ã¿è¡šãããã®ã§ãã€ãŠã
æ¬çºæã®ç¯å²ãéå®ãããã®ã§ã¯ãªãã
䜿ããããããããã¯ãäŸç€ºã®ããã«éžæããã
æ¬çºæã®ç¹å¥ãªæ æ§ãã®ã¿è¡šãããã®ã§ãã€ãŠã
æ¬çºæã®ç¯å²ãéå®ãããã®ã§ã¯ãªãã
ïŒ é
äœå
é
äœåãªãèªã¯ãäœæ¶²æååã³è¬ç©åã¯ãã®
ãããªäœæ¶²äžã«ååšããä»ã®ç©è³ªãè¡šããã以
äžã«ãå€ãã®ãã®ãããªå¯èœãªé äœåãäŸç€ºã
ãã
ãããªäœæ¶²äžã«ååšããä»ã®ç©è³ªãè¡šããã以
äžã«ãå€ãã®ãã®ãããªå¯èœãªé äœåãäŸç€ºã
ãã
è©Šè¬çµæç©ãã¢ã¹ã³ã«ãã³é
žãèæ±é
žé¡ãã
ãªã«ãã³ãã³ã¬ã¹ãããŒã«ãã¯ã¬ã¢ããã³ãã°
ã«ã³ãŒã¹ãä¹³é žãããè質é¡ãããªã°ãªã»ãªã
é¡ãå°¿çŽ çªçŽ ïŒBUNïŒåã³å°¿é žã®ãããªè¡æ¶²ã
è¡æŒ¿åã¯è¡æž é äœåã«å¯Ÿãç¥ãããŠãããæŽ
ã«ãã¢ãã©ãŒãŒãã³ãªã³ãšã¹ãã©ãŒãŒãã¯ã¬ã¢
ãã³ã»ãã¹ããããŒãŒïŒCPKïŒãããããã²ã
ãŒãŒé¡ïŒããããã·é ªé žãã€ãœã¯ãšã³é žãä¹³é ž
åã³ãªã³ãŽé žãè±æ°ŽããïŒããªããŒãŒãããšã
ã«ã¢ã©ãã³ããã©ã³ã¹ã¢ãããŒãŒé¡ïŒã°ã«ã¿ã
ã³é žããªãã¶ãé ¢é žã«ããŸãã°ã«ã¿ãã³é žãã
ã«ãã³é žã«ããïŒãé žåã³ã¢ã«ã«ãªãã¹ãã¢ã¿
ãŒãŒé¡ãγâã°ã«ã¿ãã«ã»ãã©ã³ã¹ãããããŒ
ãŒããã€ã·ã³ã¢ãããããããŒãŒåã³ãšãªã¹ã
ãµã€ãé µçŽ é¡ïŒã°ã«ã³ãŒã¹âïŒâãªã³é žå¡©ãã
ããã²ããŒãŒãïŒâãã¹ãã°ã«ã³é žå¡©ãããã
ã²ããŒãŒãã°ã«ã¿ããªã³éå é µçŽ åã³ãã«ãã³
é žå¡©ãããŒãŒïŒã®ãããªè¡æ¶²ååŠã«ãããé µçŽ
é äœåã®æž¬å®ãéèŠã§ãããã¢ã«ããã³ãã¯ãª
ãªã°ããã³é¡ïŒcryoglobinsïŒãåçµåã³ç·ç¶çŽ
溶解系ã®æåãè£äœå å䞊ã³ã«ã€ã³ã¿ãŒããšã
ã³åã³ã€ã ãã°ããã³é¡ã®åŠã现èæ§åã³è¡æž
æ§å ç«äœçšäœã®ãããªè¡æ¶²èçœé äœåã«ã€ããŠ
ãè©Šéšãå¯èœã§ãããããã¯åäžç³»ç¹ç°ççµå
è©Šéšã«é¢é£ããŠä»¥äžã«è©³çŽ°ã«è«ããããã
ãªã«ãã³ãã³ã¬ã¹ãããŒã«ãã¯ã¬ã¢ããã³ãã°
ã«ã³ãŒã¹ãä¹³é žãããè質é¡ãããªã°ãªã»ãªã
é¡ãå°¿çŽ çªçŽ ïŒBUNïŒåã³å°¿é žã®ãããªè¡æ¶²ã
è¡æŒ¿åã¯è¡æž é äœåã«å¯Ÿãç¥ãããŠãããæŽ
ã«ãã¢ãã©ãŒãŒãã³ãªã³ãšã¹ãã©ãŒãŒãã¯ã¬ã¢
ãã³ã»ãã¹ããããŒãŒïŒCPKïŒãããããã²ã
ãŒãŒé¡ïŒããããã·é ªé žãã€ãœã¯ãšã³é žãä¹³é ž
åã³ãªã³ãŽé žãè±æ°ŽããïŒããªããŒãŒãããšã
ã«ã¢ã©ãã³ããã©ã³ã¹ã¢ãããŒãŒé¡ïŒã°ã«ã¿ã
ã³é žããªãã¶ãé ¢é žã«ããŸãã°ã«ã¿ãã³é žãã
ã«ãã³é žã«ããïŒãé žåã³ã¢ã«ã«ãªãã¹ãã¢ã¿
ãŒãŒé¡ãγâã°ã«ã¿ãã«ã»ãã©ã³ã¹ãããããŒ
ãŒããã€ã·ã³ã¢ãããããããŒãŒåã³ãšãªã¹ã
ãµã€ãé µçŽ é¡ïŒã°ã«ã³ãŒã¹âïŒâãªã³é žå¡©ãã
ããã²ããŒãŒãïŒâãã¹ãã°ã«ã³é žå¡©ãããã
ã²ããŒãŒãã°ã«ã¿ããªã³éå é µçŽ åã³ãã«ãã³
é žå¡©ãããŒãŒïŒã®ãããªè¡æ¶²ååŠã«ãããé µçŽ
é äœåã®æž¬å®ãéèŠã§ãããã¢ã«ããã³ãã¯ãª
ãªã°ããã³é¡ïŒcryoglobinsïŒãåçµåã³ç·ç¶çŽ
溶解系ã®æåãè£äœå å䞊ã³ã«ã€ã³ã¿ãŒããšã
ã³åã³ã€ã ãã°ããã³é¡ã®åŠã现èæ§åã³è¡æž
æ§å ç«äœçšäœã®ãããªè¡æ¶²èçœé äœåã«ã€ããŠ
ãè©Šéšãå¯èœã§ãããããã¯åäžç³»ç¹ç°ççµå
è©Šéšã«é¢é£ããŠä»¥äžã«è©³çŽ°ã«è«ããããã
åæ§ã«ãå°¿ååŠã«ããšãã枬å®çšã®è©Šè¬çµæ
ç©ãç¥ãããŠãããå°¿ååŠã®åéã§ã¯ããã®ã
ããªé äœåã¯äžè¬ã«ãã¢ã¹ã³ã«ãã³é žãã¢ã«ã
ãã³ãã¯ã¬ã¢ãã³ãã¯ã¬ã¢ããã³ãã°ã«ã³ãŒ
ã¹ãèæ±é žé¡ãããªã«ãã³ãèçœè³ªãã±ãã³
é¡ãæœè¡ãäºç¡é žå¡©ãã¢ãã©ãŒãŒåã³ããšãã«
ãã«ãã³é žãå å«ããã
ç©ãç¥ãããŠãããå°¿ååŠã®åéã§ã¯ããã®ã
ããªé äœåã¯äžè¬ã«ãã¢ã¹ã³ã«ãã³é žãã¢ã«ã
ãã³ãã¯ã¬ã¢ãã³ãã¯ã¬ã¢ããã³ãã°ã«ã³ãŒ
ã¹ãèæ±é žé¡ãããªã«ãã³ãèçœè³ªãã±ãã³
é¡ãæœè¡ãäºç¡é žå¡©ãã¢ãã©ãŒãŒåã³ããšãã«
ãã«ãã³é žãå å«ããã
æ¬çºæã®åæçŽ åã¯ãæŽã«ãç¹ç°ççµåçžæ
ãååšããå šãŠã®é äœåã®æ€ç¥åã³ãéã«ãã
ã°ã液ç¶åªäœã®ãé äœåã«çµåããèœåïŒé
åžžãåªäœäžã«é äœåã«å¯Ÿããçµåçžæãååšã
ãããã«ïŒã®æ€ç¥ã«é©çšããããšãã§ãããã
ã®é äœåã¯ãéåžžããããããããªããããã
èçœè³ªãçæ°Žåç©ãç³èçœïŒã°ãªã³ãããã€
ã³ïŒãã¹ããã€ããåã¯ãããç¹ç°ççµåçžæ
ãçååŠç³»ã«ååšãè¥ããã¯åæããåŸãä»ã®
ææ©ååã§ããããã®é äœåã¯ãæ©èœçãªèšè
ã§è¡šããã°ãéåžžãæåé¡åã³ãããã«å¯Ÿãã
æäœé¡ïŒãããã³é¡åã³ãããã«å¯Ÿããæäœ
é¡ïŒäžŠã³ã«ããã«ã¢ã³é¡ããã¿ãã³é¡ã代è¬ç£
ç©é¡ãšè¬å€é¡ãããã³ãããã®å容äœãšçµåæ§
ç©è³ªããæã矀ããéžã°ãããéåžžãé äœå
ã¯ãæäœè¥ããã¯æåæ§ããªããããã®ãããª
ååé1000ã10000000ã®å ç«åŠçã«æŽ»æ§ãªããª
ããããåã¯èçœè³ªããããã¯ååé100ã
1500ã®ãããã³ã§ããã
ãååšããå šãŠã®é äœåã®æ€ç¥åã³ãéã«ãã
ã°ã液ç¶åªäœã®ãé äœåã«çµåããèœåïŒé
åžžãåªäœäžã«é äœåã«å¯Ÿããçµåçžæãååšã
ãããã«ïŒã®æ€ç¥ã«é©çšããããšãã§ãããã
ã®é äœåã¯ãéåžžããããããããªããããã
èçœè³ªãçæ°Žåç©ãç³èçœïŒã°ãªã³ãããã€
ã³ïŒãã¹ããã€ããåã¯ãããç¹ç°ççµåçžæ
ãçååŠç³»ã«ååšãè¥ããã¯åæããåŸãä»ã®
ææ©ååã§ããããã®é äœåã¯ãæ©èœçãªèšè
ã§è¡šããã°ãéåžžãæåé¡åã³ãããã«å¯Ÿãã
æäœé¡ïŒãããã³é¡åã³ãããã«å¯Ÿããæäœ
é¡ïŒäžŠã³ã«ããã«ã¢ã³é¡ããã¿ãã³é¡ã代è¬ç£
ç©é¡ãšè¬å€é¡ãããã³ãããã®å容äœãšçµåæ§
ç©è³ªããæã矀ããéžã°ãããéåžžãé äœå
ã¯ãæäœè¥ããã¯æåæ§ããªããããã®ãããª
ååé1000ã10000000ã®å ç«åŠçã«æŽ»æ§ãªããª
ããããåã¯èçœè³ªããããã¯ååé100ã
1500ã®ãããã³ã§ããã
代衚çãªããªããããé
äœåã¯ãã¢ã³ãžãªã
ã³ã·ã³ïŒ©åã³ãâããããããªãã·ãã·
ã³ãããœãã¬ã¹ã·ã³ãããŠããã€ã·ã³ãã¬ã¹ã
ãªã³ãã»ã¯ã¬ãã³ããã©ãžããã³äžŠã³ã«ã°ã«ã«
ãŽã³ã§ããã
ã³ã·ã³ïŒ©åã³ãâããããããªãã·ãã·
ã³ãããœãã¬ã¹ã·ã³ãããŠããã€ã·ã³ãã¬ã¹ã
ãªã³ãã»ã¯ã¬ãã³ããã©ãžããã³äžŠã³ã«ã°ã«ã«
ãŽã³ã§ããã
代衚çãªèçœè³ªé
äœåã«ã¯ãããã¿ãã³é¡ã
ã ã³ãããã€ã³é¡ãã°ãªã³ãããã€ã³é¡ãã°ã
ããªã³é¡ãã¢ã«ããã³é¡ãã¹ã¯ã¬ããããã€ã³
é¡ããã¹ããããã€ã³é¡ããã¹ãã³é¡ããªãã
ããã€ã³é¡ãã¯ãã¢ãããã€ã³é¡åã³ãã¯ã¬ãª
ãããã€ã³é¡ãå«ãŸãããç¹ç°ãªãããã€ã³é¡
ã®äŸãšããŠã¯ããã¬ã¢ã«ããã³ãα1âãªããã
ãã€ã³ã人è¡æž ã¢ã«ããã³ãα1âã°ãªã³ããã
ã€ã³ããã©ã³ã¹ã³ã«ãã³ããããã·ã³çµåæ§ã°
ãããªã³ããããã°ããã³ããã¢ã°ããã³ãã
ã°ããã³ãã»ã«ããã©ã¹ãã³ãα2âãªãããã
ã€ã³ãα2âãã¯ãã°ãããªã³ãβâãªãããã
ã€ã³ããšãªããããšãã³ããã©ã³ã¹ããšãªã³ã
ãã¢ããã·ã³ããã€ããªããŒã²ã³ãIgGã
IgMãIgAãIgDåã³IgE䞊ã³ã«ãããã®ãã©
ã°ã¡ã³ãïŒæçïŒãäŸãã°Fcåã³Fabã®ãããª
å ç«ã°ãããªã³é¡ãè£äœé¡ãããã©ã¯ãã³ãã
ã€ããªããŒã²ã³ãããã³ãã³çã ã®ãããªåè¡
å åãã€ã³ã·ãŠãªã³ãã¡ã©ããããã³ããœãã
ãããã³ããããããã³ãå°å åºæ¿ãã«ã¢ã³
ïŒfollicle stipulated hormoneïŒãleutinizingã
ã«ã¢ã³ããŽãããããã³ãç²ç¶è ºåºæ¿ãã«ã¢
ã³ãèç€æ§ã©ã¯ãã²ã³ãå åšå åããã©ã³ã¹ã³
ãã©ãã³ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒé¡ãã³ãª
ãã¹ãã©ãŒãŒé¡ãã°ã«ã¿ãã³é žã»ãªããµãé ¢é ž
ãã©ã³ã¹ã¢ãããŒãŒãã°ã«ã¿ãã³é žã»ãã«ãã³
é žãã©ã³ã¹ã¢ãããŒãŒåã³ãŠãããã·ã³ã®ãã
ãªè¡æž é µçŽ ããšã³ãã«ãã€ã³é¡ããšã³ã±ãã¢ãª
ã³é¡ãããã¿ãã³ãçµç¹æ§æåé¡ã现èæ§æå
é¡ã䞊ã³ã«èçé¢é£æåïŒäŸãã°HBsAgã
HBcAgåã³HBeAgïŒã®ãããªãŠã€ã«ã¹æ§æ
åã§ããã
ã ã³ãããã€ã³é¡ãã°ãªã³ãããã€ã³é¡ãã°ã
ããªã³é¡ãã¢ã«ããã³é¡ãã¹ã¯ã¬ããããã€ã³
é¡ããã¹ããããã€ã³é¡ããã¹ãã³é¡ããªãã
ããã€ã³é¡ãã¯ãã¢ãããã€ã³é¡åã³ãã¯ã¬ãª
ãããã€ã³é¡ãå«ãŸãããç¹ç°ãªãããã€ã³é¡
ã®äŸãšããŠã¯ããã¬ã¢ã«ããã³ãα1âãªããã
ãã€ã³ã人è¡æž ã¢ã«ããã³ãα1âã°ãªã³ããã
ã€ã³ããã©ã³ã¹ã³ã«ãã³ããããã·ã³çµåæ§ã°
ãããªã³ããããã°ããã³ããã¢ã°ããã³ãã
ã°ããã³ãã»ã«ããã©ã¹ãã³ãα2âãªãããã
ã€ã³ãα2âãã¯ãã°ãããªã³ãβâãªãããã
ã€ã³ããšãªããããšãã³ããã©ã³ã¹ããšãªã³ã
ãã¢ããã·ã³ããã€ããªããŒã²ã³ãIgGã
IgMãIgAãIgDåã³IgE䞊ã³ã«ãããã®ãã©
ã°ã¡ã³ãïŒæçïŒãäŸãã°Fcåã³Fabã®ãããª
å ç«ã°ãããªã³é¡ãè£äœé¡ãããã©ã¯ãã³ãã
ã€ããªããŒã²ã³ãããã³ãã³çã ã®ãããªåè¡
å åãã€ã³ã·ãŠãªã³ãã¡ã©ããããã³ããœãã
ãããã³ããããããã³ãå°å åºæ¿ãã«ã¢ã³
ïŒfollicle stipulated hormoneïŒãleutinizingã
ã«ã¢ã³ããŽãããããã³ãç²ç¶è ºåºæ¿ãã«ã¢
ã³ãèç€æ§ã©ã¯ãã²ã³ãå åšå åããã©ã³ã¹ã³
ãã©ãã³ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒé¡ãã³ãª
ãã¹ãã©ãŒãŒé¡ãã°ã«ã¿ãã³é žã»ãªããµãé ¢é ž
ãã©ã³ã¹ã¢ãããŒãŒãã°ã«ã¿ãã³é žã»ãã«ãã³
é žãã©ã³ã¹ã¢ãããŒãŒåã³ãŠãããã·ã³ã®ãã
ãªè¡æž é µçŽ ããšã³ãã«ãã€ã³é¡ããšã³ã±ãã¢ãª
ã³é¡ãããã¿ãã³ãçµç¹æ§æåé¡ã现èæ§æå
é¡ã䞊ã³ã«èçé¢é£æåïŒäŸãã°HBsAgã
HBcAgåã³HBeAgïŒã®ãããªãŠã€ã«ã¹æ§æ
åã§ããã
代衚çãªãããã³é
äœåã«ã¯ãäžè¬çãªè¬å€
é¡ã代è¬ç©è³ªé¡ããã«ã¢ã³é¡ããã¿ãã³é¡åã³
é¡äŒŒã®ææ©ååç©é¡ãå«ãŸããããããã³ç³»ã
ã«ã¢ã³é¡ã«ã¯ããããã·ã³ãšããªã€ãªããµã€ã
ãã³ãããããã¿ãã³é¡ã«ã¯ããã¿ãã³ïŒ¡ã
ãäŸãã°B12ãããåã³ïŒ«ãèé žäžŠã³
ã«ãã¢ãã³ãå«ãŸãããè¬å€é¡ã«ã¯ãäŸãã°ã²
ã³ã¿ãã€ã·ã³ãããã©ãã€ã·ã³ãã¢ãã«ã·ã³ã
ã·ãœãã€ã·ã³ãã«ããã€ã·ã³åã³ããã«ãã€ã·
ã³ã®ãããªã¢ããã°ãªã³ã·ãé¡ãããã·ãªã³ã
ããã©ãµã€ã¯ãªã³ããã©ãã€ã·ã³ãã¯ãããã€
ã»ãã³ïŒäžŠã³ã«ã¢ã¯ãããã€ã»ãã³ã®ãããªæ
çç©è³ªïŒãã¯ã¬ãªã·ãé¡ïŒnucleosidesïŒäžŠã³
ã«ã¢ããã·ã³äºãªã³é žå¡©ïŒADPïŒãã¢ããã·ã³
äžãªã³é žå¡©ïŒATPïŒããã©ãã³ã¢ããã¯ã¬ãªã
ãïŒFMNïŒããã³ãã³ã¢ããã¢ããã³ãžãã¯
ã¬ãªããïŒNADïŒåã³ãã®ãªã³é žå¡©èªå°äœ
ïŒNADPïŒããããžã³ãã°ã¢ãã·ã³äžŠã³ã«ã¢ã
ãã·ã³ã®ãããªãã¯ã¬ãªããé¡
ïŒnucleotidesïŒãããã¹ã¿ã°ã©ã³ãžã³é¡ïŒäŸã
ã°ãšã¹ããªãªãŒã«åã³ãšã¹ãã©ãžãªãŒã«ã®ãã
ãªãšã¹ããã²ã³é¡ãã¹ãããŒã²ã³é¡ãã¢ã³ãã
ã²ã³é¡ããžãŽãã·ã³ããžã®ããã·ã³ã䞊ã³ã«å
å¯è åºæ¿æ§ã¹ããã€ãé¡ãªã©ã®ã¹ããã€ãé¡ïŒ
ããšããã«ãã¿ãŒã«ãããšããã€ã³ãããªãã
ã³ããšããµã¯ã·ããïŒethosuximideïŒãã«ã«ã
ããŒãã³ããã«ãããšãŒããããªãã€ãªã³ãã«
ããšã€ã³ããããã©ãããŒã«ãããã«ã€ã³ã¢ã
ãããããžã³ãã¢ãããªãããªã³ãã³ã«ããŸãŒ
ã«ããã·ãã©ãã³ããžãœãã«ã¢ããããã¯ã»ã
ã³ããã¯ãœã«ãã·ã³ããã«ããªãããªã³ãã¡ã
ãã¬ãã»ãŒããã€ãœãã©ãã³ããªãã«ã€ã³ãã
ãã«ã€ã³ã¢ãããâã¢ã»ãã«ããã«ã€ã³ã¢ã
ããã¢ã³ããšã¿ãã³é¡ãã«ãã³ãŒã«ã¢ãã³é¡å
ã³æãã¹ã¿ãã³é¡ã®ãããªä»ã®ãã®ãå«ãŸã
ãã
é¡ã代è¬ç©è³ªé¡ããã«ã¢ã³é¡ããã¿ãã³é¡åã³
é¡äŒŒã®ææ©ååç©é¡ãå«ãŸããããããã³ç³»ã
ã«ã¢ã³é¡ã«ã¯ããããã·ã³ãšããªã€ãªããµã€ã
ãã³ãããããã¿ãã³é¡ã«ã¯ããã¿ãã³ïŒ¡ã
ãäŸãã°B12ãããåã³ïŒ«ãèé žäžŠã³
ã«ãã¢ãã³ãå«ãŸãããè¬å€é¡ã«ã¯ãäŸãã°ã²
ã³ã¿ãã€ã·ã³ãããã©ãã€ã·ã³ãã¢ãã«ã·ã³ã
ã·ãœãã€ã·ã³ãã«ããã€ã·ã³åã³ããã«ãã€ã·
ã³ã®ãããªã¢ããã°ãªã³ã·ãé¡ãããã·ãªã³ã
ããã©ãµã€ã¯ãªã³ããã©ãã€ã·ã³ãã¯ãããã€
ã»ãã³ïŒäžŠã³ã«ã¢ã¯ãããã€ã»ãã³ã®ãããªæ
çç©è³ªïŒãã¯ã¬ãªã·ãé¡ïŒnucleosidesïŒäžŠã³
ã«ã¢ããã·ã³äºãªã³é žå¡©ïŒADPïŒãã¢ããã·ã³
äžãªã³é žå¡©ïŒATPïŒããã©ãã³ã¢ããã¯ã¬ãªã
ãïŒFMNïŒããã³ãã³ã¢ããã¢ããã³ãžãã¯
ã¬ãªããïŒNADïŒåã³ãã®ãªã³é žå¡©èªå°äœ
ïŒNADPïŒããããžã³ãã°ã¢ãã·ã³äžŠã³ã«ã¢ã
ãã·ã³ã®ãããªãã¯ã¬ãªããé¡
ïŒnucleotidesïŒãããã¹ã¿ã°ã©ã³ãžã³é¡ïŒäŸã
ã°ãšã¹ããªãªãŒã«åã³ãšã¹ãã©ãžãªãŒã«ã®ãã
ãªãšã¹ããã²ã³é¡ãã¹ãããŒã²ã³é¡ãã¢ã³ãã
ã²ã³é¡ããžãŽãã·ã³ããžã®ããã·ã³ã䞊ã³ã«å
å¯è åºæ¿æ§ã¹ããã€ãé¡ãªã©ã®ã¹ããã€ãé¡ïŒ
ããšããã«ãã¿ãŒã«ãããšããã€ã³ãããªãã
ã³ããšããµã¯ã·ããïŒethosuximideïŒãã«ã«ã
ããŒãã³ããã«ãããšãŒããããªãã€ãªã³ãã«
ããšã€ã³ããããã©ãããŒã«ãããã«ã€ã³ã¢ã
ãããããžã³ãã¢ãããªãããªã³ãã³ã«ããŸãŒ
ã«ããã·ãã©ãã³ããžãœãã«ã¢ããããã¯ã»ã
ã³ããã¯ãœã«ãã·ã³ããã«ããªãããªã³ãã¡ã
ãã¬ãã»ãŒããã€ãœãã©ãã³ããªãã«ã€ã³ãã
ãã«ã€ã³ã¢ãããâã¢ã»ãã«ããã«ã€ã³ã¢ã
ããã¢ã³ããšã¿ãã³é¡ãã«ãã³ãŒã«ã¢ãã³é¡å
ã³æãã¹ã¿ãã³é¡ã®ãããªä»ã®ãã®ãå«ãŸã
ãã
è©Šéšãããã¹ã液ç¶åªäœã¯ãèªç¶ã«ååšãã
ãåã¯äººå·¥çã«åœ¢æããããé äœåãå«æãã
ãšèãããã液äœã§ãã€ãŠãããæ®éãçååŠ
ç液äœåã¯ãã®çšé液ã§ãããè©Šéšã§ããçå
åŠç液äœã«ã¯ãè¡æž ããã©ã¹ããå°¿ãåŸæ¶²äžŠã³
ã«çŸèåã³è³èé«æ¶²ãå«ãŸããã
ãåã¯äººå·¥çã«åœ¢æããããé äœåãå«æãã
ãšèãããã液äœã§ãã€ãŠãããæ®éãçååŠ
ç液äœåã¯ãã®çšé液ã§ãããè©Šéšã§ããçå
åŠç液äœã«ã¯ãè¡æž ããã©ã¹ããå°¿ãåŸæ¶²äžŠã³
ã«çŸèåã³è³èé«æ¶²ãå«ãŸããã
ïŒ èŒ»å°ç·æ£ä¹±ã»é®ãžãå±€
è©Šè¬å±€åã³æ¯æå±€ãšã«é¢ä¿ããŠã茻å°ç·ã®æ£
ä¹±ã»é®ãžãå±€ã®äœçœ®ã¯ãæ¬çºæã§ã¯éèŠã§ã
ãã茻å°ç·æ£ä¹±ã»é®ãžãå±€ã®æ§è³ªã¯ããã調補
ãããæåã«ãã€ãŠçãããã®ã§ããããã®æ§
質ã¯ãåæ§ã«æ¬çºæã§ã¯éèŠã§ããã
ä¹±ã»é®ãžãå±€ã®äœçœ®ã¯ãæ¬çºæã§ã¯éèŠã§ã
ãã茻å°ç·æ£ä¹±ã»é®ãžãå±€ã®æ§è³ªã¯ããã調補
ãããæåã«ãã€ãŠçãããã®ã§ããããã®æ§
質ã¯ãåæ§ã«æ¬çºæã§ã¯éèŠã§ããã
æ¬çºæã®èŒ»å°ç·é®ãžãå±€ã¯ãè©Šè¬å±€åã³æ¯æ
å±€ã®éã«ä»åšããã茻å°ç·æ£ä¹±ã»é®ãžãå±€ã§ã
ããããã¯ãè©Šè¬å±€ã®äžæ¹ã®é¢ã«çŽæ¥æ¥è§Šãã
ãããšãã§ãïŒè©Šè¬å±€ããæŸåºãããä¿¡å·ãã
ã®ãšãè©Šè¬å±€ã®ä»æ¹ã®é¢ããèªã¿ãšããããã
ã®ããã«ã茻å°ç·ä¿¡å·ã¯ããããæŸåºãããè©Š
è¬å±€ã®ä»ã«æ€ç¥çšã®ä»ã®å±€åã¯ç©è³ªãééãã
ããšãäžèŠãšãªããè©Šè¬å±€ã茻å°ç·æ£ä¹±ã»é®ãž
ãå±€ã«ããçµåããŠããªããšãã«ã¯ã茻å°ç·æ£
ä¹±ã»é®ãžãå±€ããäŸãã°æ°Žé žåãããªãŠã ã§ã®
åŠçã®ãããªé©åœãªåŠçãæœããŠã茻å°ç·ã®æ£
ä¹±ã»é®ãžãå±€ã®è¡šé¢ãåŠçåã¯æŽ»æ§åããŠãè©Š
è¬å±€äžŠã³ã«èŒ»å°ç·æ£ä¹±ã»é®ãžãå±€ã®éã®çµåã
æ¹åããããšãããšããšããŠãå¯èœã§ãããå¥
æ³ãšããŠãããäžå¡ãå±€ïŒsubbinglayerïŒã茻
å°ç·æ£ä¹±ã»é®ãžãå±€ãšè©Šè¬å±€ã®éã«é 眮ããŠè©Š
è¬å±€ã®çµåæ§åã¯æ¥çæ§ãåäžããããšãã§ã
ãã
å±€ã®éã«ä»åšããã茻å°ç·æ£ä¹±ã»é®ãžãå±€ã§ã
ããããã¯ãè©Šè¬å±€ã®äžæ¹ã®é¢ã«çŽæ¥æ¥è§Šãã
ãããšãã§ãïŒè©Šè¬å±€ããæŸåºãããä¿¡å·ãã
ã®ãšãè©Šè¬å±€ã®ä»æ¹ã®é¢ããèªã¿ãšããããã
ã®ããã«ã茻å°ç·ä¿¡å·ã¯ããããæŸåºãããè©Š
è¬å±€ã®ä»ã«æ€ç¥çšã®ä»ã®å±€åã¯ç©è³ªãééãã
ããšãäžèŠãšãªããè©Šè¬å±€ã茻å°ç·æ£ä¹±ã»é®ãž
ãå±€ã«ããçµåããŠããªããšãã«ã¯ã茻å°ç·æ£
ä¹±ã»é®ãžãå±€ããäŸãã°æ°Žé žåãããªãŠã ã§ã®
åŠçã®ãããªé©åœãªåŠçãæœããŠã茻å°ç·ã®æ£
ä¹±ã»é®ãžãå±€ã®è¡šé¢ãåŠçåã¯æŽ»æ§åããŠãè©Š
è¬å±€äžŠã³ã«èŒ»å°ç·æ£ä¹±ã»é®ãžãå±€ã®éã®çµåã
æ¹åããããšãããšããšããŠãå¯èœã§ãããå¥
æ³ãšããŠãããäžå¡ãå±€ïŒsubbinglayerïŒã茻
å°ç·æ£ä¹±ã»é®ãžãå±€ãšè©Šè¬å±€ã®éã«é 眮ããŠè©Š
è¬å±€ã®çµåæ§åã¯æ¥çæ§ãåäžããããšãã§ã
ãã
茻å°ç·ã®æ¡æ£ã»é®ãžãå±€ã®ç¹æ§åã¯æ§è³ªã¯ã
äžéæã§ãæ¯èŒçèããããŠé äœåãè©Šè¬å±€ã®
è©Šè¬åã³ãããã®çžäºåå¿ã®çæç©ã«å¯Ÿãäžé
éæ§ã§ãã€äžæŽ»æ§ã§ããããšã§ããã茻å°ç·ã®
æ¡æ£ã»é®ãžãå±€ã¯ã奜ãŸããã¯è©²å±€ã®äžå šäœã«
åã¯å°ãªããšãè©Šè¬å±€è¥ããã¯äžå¡ãå±€ã«è¿æ¥
ãã該局ã®è¡šé¢ã«å質ã«åæ£ããããçœåã¯ã
ããè²ã®é¡æãå«æãããæŽã«è©³ããã¯ã茻å°
ç·ã®æ¡æ£ã»é®ãžãå±€ã¯ãäžæ¹ã§ã¯åºæåã¯æ¯æ
æãããŠä»æ¹ã§ã¯è©Šè¬å±€åã¯äžå¡ãå±€ãšçžå ¥ã
åŸãé©åœãªæš¹èåã¯é«ååæã®äžã«å å«ããã
茻å°ç·äžééæ§é¡æããæ§æããããšãã§ã
ããããæ§è³ªã«ãããŠãé«ååæã§ãããªã
ã°ã茻å°ç·ã®æ¡æ£ã»é®ãžãå±€ã¯ãã¢ããªããŒå
ã¯ã³ããªããŒã§ããã
äžéæã§ãæ¯èŒçèããããŠé äœåãè©Šè¬å±€ã®
è©Šè¬åã³ãããã®çžäºåå¿ã®çæç©ã«å¯Ÿãäžé
éæ§ã§ãã€äžæŽ»æ§ã§ããããšã§ããã茻å°ç·ã®
æ¡æ£ã»é®ãžãå±€ã¯ã奜ãŸããã¯è©²å±€ã®äžå šäœã«
åã¯å°ãªããšãè©Šè¬å±€è¥ããã¯äžå¡ãå±€ã«è¿æ¥
ãã該局ã®è¡šé¢ã«å質ã«åæ£ããããçœåã¯ã
ããè²ã®é¡æãå«æãããæŽã«è©³ããã¯ã茻å°
ç·ã®æ¡æ£ã»é®ãžãå±€ã¯ãäžæ¹ã§ã¯åºæåã¯æ¯æ
æãããŠä»æ¹ã§ã¯è©Šè¬å±€åã¯äžå¡ãå±€ãšçžå ¥ã
åŸãé©åœãªæš¹èåã¯é«ååæã®äžã«å å«ããã
茻å°ç·äžééæ§é¡æããæ§æããããšãã§ã
ããããæ§è³ªã«ãããŠãé«ååæã§ãããªã
ã°ã茻å°ç·ã®æ¡æ£ã»é®ãžãå±€ã¯ãã¢ããªããŒå
ã¯ã³ããªããŒã§ããã
茻å°ç·ã®æ£ä¹±ã»é®ãžãå±€ã¯é©å®ãªåã¿ã«ã§ã
ãããéåžžãçŽ0.0002ãçŽ0.02ã€ã³ãã®åã¿ã§
ããã ããã
ãããéåžžãçŽ0.0002ãçŽ0.02ã€ã³ãã®åã¿ã§
ããã ããã
䜿çšã§ãã茻å°ç·äžééæ§é¡æã®äŸãšããŠ
ã¯ãäºé žåãã¿ããŠã ãç¡«é žããªãŠã ãé žåäº
éãé žåãã°ãã·ãŠã ãäºé žåãžã«ã³ããŠã å
ã³ãã®é¡äŒŒç©ãããããããæ®éãååšããé¡
æã®éã®äžéã¯40ïŒ æªæºåºäœå«æéã§ãäžéã¯
ïŒïŒ ãè¶ ããåºäœå«æéã§ããã ããã
ã¯ãäºé žåãã¿ããŠã ãç¡«é žããªãŠã ãé žåäº
éãé žåãã°ãã·ãŠã ãäºé žåãžã«ã³ããŠã å
ã³ãã®é¡äŒŒç©ãããããããæ®éãååšããé¡
æã®éã®äžéã¯40ïŒ æªæºåºäœå«æéã§ãäžéã¯
ïŒïŒ ãè¶ ããåºäœå«æéã§ããã ããã
茻å°ç·ã®æ¡æ£ã»é®ãžãå±€ã«çšããããšã®ã§ã
ãé©åœãªæš¹èã®äŸãšããŠã¯ãã¡ãã«ããã«ãšãŒ
ãã«ã»ç¡æ°Žãã¬ã€ã³é žå ±éåäœïŒãšãã¬ã³ã»ç¡
æ°Žãã¬ã€ã³é žå ±éåäœïŒãªã¯ã¿ãã»ãã«âïŒã»
ç¡æ°Žãã¬ã€ã³é žå ±éåäœïŒãªã¯ã¿ãã·ã«ããã«
ãšãŒãã«ã»ç¡æ°Žãã¬ã€ã³é žå ±éåäœïŒã¹ãã¬
ã³ã»ç¡æ°Žãã¬ã€ã³é žå ±éåäœãªã©ãå«ãç¡æ°Žç©
æš¹èããããããã
ãé©åœãªæš¹èã®äŸãšããŠã¯ãã¡ãã«ããã«ãšãŒ
ãã«ã»ç¡æ°Žãã¬ã€ã³é žå ±éåäœïŒãšãã¬ã³ã»ç¡
æ°Žãã¬ã€ã³é žå ±éåäœïŒãªã¯ã¿ãã»ãã«âïŒã»
ç¡æ°Žãã¬ã€ã³é žå ±éåäœïŒãªã¯ã¿ãã·ã«ããã«
ãšãŒãã«ã»ç¡æ°Žãã¬ã€ã³é žå ±éåäœïŒã¹ãã¬
ã³ã»ç¡æ°Žãã¬ã€ã³é žå ±éåäœãªã©ãå«ãç¡æ°Žç©
æš¹èããããããã
茻å°ç·ã®æ¡æ£ã»é®ãžãå±€ã«çšããããšã®ã§ã
ãä»ã®é«ååæã®äŸãšããŠã¯ãããªããã«ã¢ã»
ããŒããããªããã«ã¡ã¿ã¯ãªã¬ãŒããããªãã¿
ãžãšã³ãããªã¯ãããã¬ã³ãããªããã«ãããª
ãã³ãªã©ããããããã
ãä»ã®é«ååæã®äŸãšããŠã¯ãããªããã«ã¢ã»
ããŒããããªããã«ã¡ã¿ã¯ãªã¬ãŒããããªãã¿
ãžãšã³ãããªã¯ãããã¬ã³ãããªããã«ãããª
ãã³ãªã©ããããããã
ïŒ åäžç³»ç¹ç°ççµåè©Šéš
å
šãŠã®åäžç³»ç¹ç°ççµåè©Šéšç³»çšã®è©Šè¬ã¯ã
æ¬çºæè©Šéšå ·ã«å å«ããããšãã§ãããäžè¬
ã«ãåäžç³»ç¹ç°ççµåè©Šéšã®æè¡ã¯ã(1)çµåæ
åãšæšèã®è€åäœãš(2)è€åäœäžã®çµåæ§æåã«
察ããŠçµå察æãšã®éã®ç¹æ®ãªçžäºäœçšã§ãã€
ãŠãæšèè€åäœãçµå察æïŒçžæïŒã«ãã€ãŠçµ
åããããšãããã®è€åäœããã®ããã«çµåã
ããªããšãã«æ¯ã¹ãŠæšèç¹æ§ãçžéãããããª
ç¹æ®ãªçžäºäœçšã«åºã¥ããã®ã§ãããæšèã®ã
圱é¿ãåããç¹æ§ã¯ãäŸãã°æšèã®ååŠçåã¯
ç©ççæ§ç¶ã®ãããªå šãŠã®æž¬å®å¯èœãªæ§è³ªã®ã
ã®ã§ãã€ãŠãããããã€ãã®å Žåã§ã¯ã圱é¿ã
åããç¹æ§ã¯ãååŠçµåãå ±æåã¯éå ±æçµå
ã®åœ¢æåã¯ç Žå£ãå«ãäºã決ããããåå¿ã«ã
ããååŠçãªåå¿æ§ã§ãããä»ã®å Žåã§ã¯ã圱
é¿ãåããç¹æ§ã¯ãååŠåå¿ãªãã§æž¬å®ã§ãã
æšèã®ç©ççç¹æ§ã§ããã
æ¬çºæè©Šéšå ·ã«å å«ããããšãã§ãããäžè¬
ã«ãåäžç³»ç¹ç°ççµåè©Šéšã®æè¡ã¯ã(1)çµåæ
åãšæšèã®è€åäœãš(2)è€åäœäžã®çµåæ§æåã«
察ããŠçµå察æãšã®éã®ç¹æ®ãªçžäºäœçšã§ãã€
ãŠãæšèè€åäœãçµå察æïŒçžæïŒã«ãã€ãŠçµ
åããããšãããã®è€åäœããã®ããã«çµåã
ããªããšãã«æ¯ã¹ãŠæšèç¹æ§ãçžéãããããª
ç¹æ®ãªçžäºäœçšã«åºã¥ããã®ã§ãããæšèã®ã
圱é¿ãåããç¹æ§ã¯ãäŸãã°æšèã®ååŠçåã¯
ç©ççæ§ç¶ã®ãããªå šãŠã®æž¬å®å¯èœãªæ§è³ªã®ã
ã®ã§ãã€ãŠãããããã€ãã®å Žåã§ã¯ã圱é¿ã
åããç¹æ§ã¯ãååŠçµåãå ±æåã¯éå ±æçµå
ã®åœ¢æåã¯ç Žå£ãå«ãäºã決ããããåå¿ã«ã
ããååŠçãªåå¿æ§ã§ãããä»ã®å Žåã§ã¯ã圱
é¿ãåããç¹æ§ã¯ãååŠåå¿ãªãã§æž¬å®ã§ãã
æšèã®ç©ççç¹æ§ã§ããã
å€ãã®å Žåã«ãããŠãæ¬çºæã®è©Šéšå
·ã«ã¯ã
è©Šæäžã®é äœååã¯ãã®çµåèœãšå ç«ååŠçæ¹
æ³ã§çžäºäœçšããåäžç³»ç¹ç°ççµåè©Šéšè©Šè¬ã
å å«ãããŠããã ãããããªãã¡ãè©Šæäžã®ã
è©Šè¬é¡åã³ïŒåã¯è©Šæäžã®é äœåè¥ããã¯ãã®
çµåèœãšã®éã«æåâæäœåã¯ä»çäœâæäœã®
é¢ä¿ãååšããã ãããããããããã®ãããª
è©Šéšã¯å ç«è©ŠéšïŒã€ã ãã¢ãã»ãŒïŒãšåã¥ãã
ããæšèè€åäœãšãã®çµåçžæãšã®ç¹æ®ãªçžäº
äœçšã¯å ç«ååŠççµåã§ãããããããŠãã®ã
ããªäŸã«ãããŠã¯ãæšèè€åäœã®çµåæ§æå
ã¯ãæåããããã³åã¯æäœïŒåã¯ãã®ãã©ã°
ã¡ã³ãïŒã§ããããã®çµåçžæã¯ããã«å¯Ÿå¿ã
ãå ç«ååŠçãªçµåçžæã§ãããããããªã
ããåŸæ¥ãæšèè€åäœãšçµåçžæãšã®éã®ä»ã®
çµåæ§çžäºäœçšãããã«ã¢ã³é¡ããã¿ãã³é¡ã
代è¬ç£ç©é¡åã³è¬å€é¡ãšãããã®ããããã®å
容äœåã³çµåæ§ç©è³ªãšã®éã®çµåæ§çžäºäœçšã
å«ãåäžç³»ç¹ç°ççµåè©Šéšã®åºç€ãšããŠåãã
ãšã¯ããç¥ãããŠããã
è©Šæäžã®é äœååã¯ãã®çµåèœãšå ç«ååŠçæ¹
æ³ã§çžäºäœçšããåäžç³»ç¹ç°ççµåè©Šéšè©Šè¬ã
å å«ãããŠããã ãããããªãã¡ãè©Šæäžã®ã
è©Šè¬é¡åã³ïŒåã¯è©Šæäžã®é äœåè¥ããã¯ãã®
çµåèœãšã®éã«æåâæäœåã¯ä»çäœâæäœã®
é¢ä¿ãååšããã ãããããããããã®ãããª
è©Šéšã¯å ç«è©ŠéšïŒã€ã ãã¢ãã»ãŒïŒãšåã¥ãã
ããæšèè€åäœãšãã®çµåçžæãšã®ç¹æ®ãªçžäº
äœçšã¯å ç«ååŠççµåã§ãããããããŠãã®ã
ããªäŸã«ãããŠã¯ãæšèè€åäœã®çµåæ§æå
ã¯ãæåããããã³åã¯æäœïŒåã¯ãã®ãã©ã°
ã¡ã³ãïŒã§ããããã®çµåçžæã¯ããã«å¯Ÿå¿ã
ãå ç«ååŠçãªçµåçžæã§ãããããããªã
ããåŸæ¥ãæšèè€åäœãšçµåçžæãšã®éã®ä»ã®
çµåæ§çžäºäœçšãããã«ã¢ã³é¡ããã¿ãã³é¡ã
代è¬ç£ç©é¡åã³è¬å€é¡ãšãããã®ããããã®å
容äœåã³çµåæ§ç©è³ªãšã®éã®çµåæ§çžäºäœçšã
å«ãåäžç³»ç¹ç°ççµåè©Šéšã®åºç€ãšããŠåãã
ãšã¯ããç¥ãããŠããã
è©Šæããã®äžã®ç¹å®ã®é
äœåã®ååšåã¯éã
枬å®ããããã«è©ŠéšãããŠããå Žåãåäžç³»ç¹
ç°ççµåè©Šéšæè¡çšã®è©Šè¬ã¯ãéåžžã(1)æšèã«
ååŠçã«çµåãããé äœååã¯ãã®çµåæ§é¡çž
äœãããªãæšèè€åäœã(2)äŸãã°æäœåã¯ãã®
ãã©ã°ã¡ã³ãã倩ç¶ã®å容äœãããã€ã³ã®ãã
ãªé äœåã«å¯Ÿããçµåçžæã䞊ã³ã«(3)æšèè€å
äœã®äžã®æšèç©è³ªã枬å®ããããã«å¿ èŠãªå šãŠ
ã®è£å©è©Šè¬ããæ§æããããçµåæ§ç©è³ªã®ãã
å¶ééã®çµåæ§ç©ãå°å ¥ããããã®çµæãè©Šæ
äžã®å šãŠã®é äœåãçµåçžæã«çµåããããã«
æšèè€åäœãšç«¶åããã ãããçµåçš®ãšéé¢çš®
ãšã®éã®æšèã®ååžã¯ããããããæšèããã®
æ€ç¥å¯èœãªå¿çã®çšåºŠã決å®ããããã¯ã次
ã«ãé äœåã®ååšã®é¢æ°ã§ããã ãããé äœå
ã枬å®ããä»ã®æ¹æ³ã¯ãæšèè€åäœããé äœå
ã®æšèãããçµåçžæããæããé äœåã«çµå
ãããšæšèããã®æ€ç¥å¯èœãªå¿çã«å¿ããŠåœ±é¿
ãåãããããªå Žåã«ãäžãããããè©Šæã®é
äœåçµåèœãè©Šéšããå Žåã«ã¯ãæšèè€åäœã¯
æšèã«ååŠçã«çµåãããé äœååã¯ãã®çµå
æ§é¡çžäœããæ§æããããã®ããšã«ãã€ãŠãæš
èè€åäœãçµåãã¹ãè©Šæã®èœåã¯ãäŸãã°è©Š
æäžé äœåã®çµåçžæã®ååšæ ã«ãæšèããã®
æ€ç¥å¯èœãªä¿¡å·ã«å¯Ÿããå¹æã枬å®ããã
枬å®ããããã«è©ŠéšãããŠããå Žåãåäžç³»ç¹
ç°ççµåè©Šéšæè¡çšã®è©Šè¬ã¯ãéåžžã(1)æšèã«
ååŠçã«çµåãããé äœååã¯ãã®çµåæ§é¡çž
äœãããªãæšèè€åäœã(2)äŸãã°æäœåã¯ãã®
ãã©ã°ã¡ã³ãã倩ç¶ã®å容äœãããã€ã³ã®ãã
ãªé äœåã«å¯Ÿããçµåçžæã䞊ã³ã«(3)æšèè€å
äœã®äžã®æšèç©è³ªã枬å®ããããã«å¿ èŠãªå šãŠ
ã®è£å©è©Šè¬ããæ§æããããçµåæ§ç©è³ªã®ãã
å¶ééã®çµåæ§ç©ãå°å ¥ããããã®çµæãè©Šæ
äžã®å šãŠã®é äœåãçµåçžæã«çµåããããã«
æšèè€åäœãšç«¶åããã ãããçµåçš®ãšéé¢çš®
ãšã®éã®æšèã®ååžã¯ããããããæšèããã®
æ€ç¥å¯èœãªå¿çã®çšåºŠã決å®ããããã¯ã次
ã«ãé äœåã®ååšã®é¢æ°ã§ããã ãããé äœå
ã枬å®ããä»ã®æ¹æ³ã¯ãæšèè€åäœããé äœå
ã®æšèãããçµåçžæããæããé äœåã«çµå
ãããšæšèããã®æ€ç¥å¯èœãªå¿çã«å¿ããŠåœ±é¿
ãåãããããªå Žåã«ãäžãããããè©Šæã®é
äœåçµåèœãè©Šéšããå Žåã«ã¯ãæšèè€åäœã¯
æšèã«ååŠçã«çµåãããé äœååã¯ãã®çµå
æ§é¡çžäœããæ§æããããã®ããšã«ãã€ãŠãæš
èè€åäœãçµåãã¹ãè©Šæã®èœåã¯ãäŸãã°è©Š
æäžé äœåã®çµåçžæã®ååšæ ã«ãæšèããã®
æ€ç¥å¯èœãªä¿¡å·ã«å¯Ÿããå¹æã枬å®ããã
ããã€ãã®ç°ãªã€ãåäžç³»ç¹ç°ççµåè©Šéšç³»
ãåŸæ¥ããç¥ãããŠããã以äžã¯ãæ¬çºæã®ç¯
å²ãéå®ããããšãªãã«ãæ¬çºæã®è©Šéšå ·ã®äœ¿
çšã«å¯Ÿãæãããããã€ãã®ãã®ãããªç³»ã®äŸ
ã§ããã以äžã®ç³»ã¯ãçšããããæšèã®æ§è³ªã«
ããè¡šèšãããã
ãåŸæ¥ããç¥ãããŠããã以äžã¯ãæ¬çºæã®ç¯
å²ãéå®ããããšãªãã«ãæ¬çºæã®è©Šéšå ·ã®äœ¿
çšã«å¯Ÿãæãããããã€ãã®ãã®ãããªç³»ã®äŸ
ã§ããã以äžã®ç³»ã¯ãçšããããæšèã®æ§è³ªã«
ããè¡šèšãããã
(a) é
µçŽ è£æ¬ ååææšè
ãã®ç³»ã«ãããŠãæšèã¯é
µçŽ ã®è£æ¬ ååæ
ã§ãããè£æ¬ ååææšèãšäžäœãšãªã€ãŠæŽ»æ§
é µçŽ ïŒããé µçŽ ïŒãçæããã觊åªçã«äžæŽ»
æ§ãªã¢ãé µçŽ ã®èœåã¯ãæšèè€åäœããã®çµ
åçžæãšçµåããããšã«ãã€ãŠåœ±é¿ãåã
ããåŸãããããé µçŽ ã®æŽ»æ§ã¯ãåŸæ¥ã®æ€ç¥
ç³»ã«ãã€ãŠæž¬å®ãããæçµçã«æ€ç¥å¯èœãªä¿¡
å·ãçããããã®ã¿ã€ãã®è©Šéšç³»ã¯ã1979幎
ïŒæïŒæ¥ã«åºé¡ãããåºé¡ã«ä¿å±äžã®ç±³åœåº
é¡ç¬¬45423å·ïŒè±åœç¹èš±ç¬¬2023607å·æ现æžã«
察å¿ããïŒã®äžã«èšèŒãããŠãããç¹ã«å¥œãŸ
ãããè£æ¬ ååæã§æšèãããè©Šéšæ¹æ³ã¯ã
æšèãšããŠãã©ãã³ã¢ããã³ãžãã¯ã¬ãªãã
ïŒFADïŒåã³ã¢ãé µçŽ ãšããŠã¢ãã°ã«ã³ãŒã¹
ãªãã·ããŒãŒãçšããŠãããåŸãããã°ã«ã³
ãŒã¹ãªãã·ããŒãŒã®æŽ»æ§ã¯ãã°ã«ã³ãŒã¹ãã
ã«ãªãã·ããŒãŒåã³éé žåæ°ŽçŽ ã«å¿çããŠè²
å€åãçããæ瀺è¬ç³»ããæãæ¯è²æ€ç¥ç³»ã«
ãã€ãŠæž¬å®ã§ããã
ã§ãããè£æ¬ ååææšèãšäžäœãšãªã€ãŠæŽ»æ§
é µçŽ ïŒããé µçŽ ïŒãçæããã觊åªçã«äžæŽ»
æ§ãªã¢ãé µçŽ ã®èœåã¯ãæšèè€åäœããã®çµ
åçžæãšçµåããããšã«ãã€ãŠåœ±é¿ãåã
ããåŸãããããé µçŽ ã®æŽ»æ§ã¯ãåŸæ¥ã®æ€ç¥
ç³»ã«ãã€ãŠæž¬å®ãããæçµçã«æ€ç¥å¯èœãªä¿¡
å·ãçããããã®ã¿ã€ãã®è©Šéšç³»ã¯ã1979幎
ïŒæïŒæ¥ã«åºé¡ãããåºé¡ã«ä¿å±äžã®ç±³åœåº
é¡ç¬¬45423å·ïŒè±åœç¹èš±ç¬¬2023607å·æ现æžã«
察å¿ããïŒã®äžã«èšèŒãããŠãããç¹ã«å¥œãŸ
ãããè£æ¬ ååæã§æšèãããè©Šéšæ¹æ³ã¯ã
æšèãšããŠãã©ãã³ã¢ããã³ãžãã¯ã¬ãªãã
ïŒFADïŒåã³ã¢ãé µçŽ ãšããŠã¢ãã°ã«ã³ãŒã¹
ãªãã·ããŒãŒãçšããŠãããåŸãããã°ã«ã³
ãŒã¹ãªãã·ããŒãŒã®æŽ»æ§ã¯ãã°ã«ã³ãŒã¹ãã
ã«ãªãã·ããŒãŒåã³éé žåæ°ŽçŽ ã«å¿çããŠè²
å€åãçããæ瀺è¬ç³»ããæãæ¯è²æ€ç¥ç³»ã«
ãã€ãŠæž¬å®ã§ããã
ãã®å¥œãŸããè©Šéšæ¹æ³ã§ã¯ãFADâæšè
è€åäœã¯ã奜ãŸããã¯ã åŒïŒ ïŒåŒäžãRiboflavinïŒâPhosâïŒ2Riboseã¯FAD
äžã®ãªããã©ãã³âãããªã³é žå¡©âãªããŒã¹
æ®åºãè¡šãããã¯çµååºã§ãã¯äŸãã°é
äœååã¯ãã®é¡çžäœã®ãããªçµåæ§æåã§ã
ããïŒ ããæãããã®ãããªè€åäœã®äŸã¯ã1980幎
10æ30æ¥ã«åºé¡ãããåºé¡ã«ä¿å±äžã®ç±³åœåº
é¡ç¬¬202378å·ã§é瀺ãããFADâããªãã€
ãªã³è€åäœã§ããã
è€åäœã¯ã奜ãŸããã¯ã åŒïŒ ïŒåŒäžãRiboflavinïŒâPhosâïŒ2Riboseã¯FAD
äžã®ãªããã©ãã³âãããªã³é žå¡©âãªããŒã¹
æ®åºãè¡šãããã¯çµååºã§ãã¯äŸãã°é
äœååã¯ãã®é¡çžäœã®ãããªçµåæ§æåã§ã
ããïŒ ããæãããã®ãããªè€åäœã®äŸã¯ã1980幎
10æ30æ¥ã«åºé¡ãããåºé¡ã«ä¿å±äžã®ç±³åœåº
é¡ç¬¬202378å·ã§é瀺ãããFADâããªãã€
ãªã³è€åäœã§ããã
(b) é
µçŽ åºè³ªæšè
ãã®ç³»ã§ãæšèã¯ãæšèè€åäœãé
µçŽ ã«å¯Ÿ
ããåºè³ªã§ããããããŠããã®åºè³ªâæšèè€
åäœã«äœçšãããé µçŽ ã®ãèœåã¯ãæšèè€å
äœããã®çµåçžæãšçµåããããšã«ãããæ£
åã¯è² ã®ãããã®æå³ã«ãããŠã圱é¿ãåã
ãããã«éžæããããåºè³ªâæšèè€åäœãžã®
é µçŽ ã®äœçšã¯ãããã€ãã®æ æ§ïŒç¹æ§ïŒãã
ãªãã¡ãæ瀺è¬åå¿ã«ãããååŠçäžæŽ»æ§ã
åã¯äŸãã°è¢å è¥ããã¯å åžåïŒè²ïŒã®åŠã
枬å åŠçæ§è³ªã®ãããªååŠçåã¯ç©ççãªé
åžžã®ç¹æ§ã«ãããŠèå¥å¯èœãªçæç©ãçæã
ãããã®ã¿ã€ãã®è©Šéšç³»ã¯ã1978幎ïŒæ10æ¥
ã«åºé¡ãããåºé¡ã«ä¿å±äžã®ç±³åœåºé¡ç¬¬
894836å·ïŒè¥¿ç¬åœå ¬é第2618511å·ã«å¯Ÿå¿ã
ãïŒãåã³1979幎10æ23æ¥ã«åºé¡ãããç±³åœ
åºé¡ç¬¬87819å·ïŒäžŠã³ã«Anal.Chem.48ïŒ1933
ïŒ1976ïŒãAnal.Biochem.77ïŒ55ïŒ1977ïŒåã³
Clin.Chem.23ïŒ1402ïŒ1977ïŒã«èšèŒãããŠã
ãã
ããåºè³ªã§ããããããŠããã®åºè³ªâæšèè€
åäœã«äœçšãããé µçŽ ã®ãèœåã¯ãæšèè€å
äœããã®çµåçžæãšçµåããããšã«ãããæ£
åã¯è² ã®ãããã®æå³ã«ãããŠã圱é¿ãåã
ãããã«éžæããããåºè³ªâæšèè€åäœãžã®
é µçŽ ã®äœçšã¯ãããã€ãã®æ æ§ïŒç¹æ§ïŒãã
ãªãã¡ãæ瀺è¬åå¿ã«ãããååŠçäžæŽ»æ§ã
åã¯äŸãã°è¢å è¥ããã¯å åžåïŒè²ïŒã®åŠã
枬å åŠçæ§è³ªã®ãããªååŠçåã¯ç©ççãªé
åžžã®ç¹æ§ã«ãããŠèå¥å¯èœãªçæç©ãçæã
ãããã®ã¿ã€ãã®è©Šéšç³»ã¯ã1978幎ïŒæ10æ¥
ã«åºé¡ãããåºé¡ã«ä¿å±äžã®ç±³åœåºé¡ç¬¬
894836å·ïŒè¥¿ç¬åœå ¬é第2618511å·ã«å¯Ÿå¿ã
ãïŒãåã³1979幎10æ23æ¥ã«åºé¡ãããç±³åœ
åºé¡ç¬¬87819å·ïŒäžŠã³ã«Anal.Chem.48ïŒ1933
ïŒ1976ïŒãAnal.Biochem.77ïŒ55ïŒ1977ïŒåã³
Clin.Chem.23ïŒ1402ïŒ1977ïŒã«èšèŒãããŠã
ãã
ç¹ã«å¥œãŸããåºè³ªâæšèè©Šéšæ¹æ³ã¯ãæ§é
åŒïŒ ïŒåŒäžãã¯çµååºã§ïŒ¬ã¯äŸãã°é äœååã¯
ãã®é¡çžäœã®ãããªçµåæ§æåã§ãããïŒ ã®æšèè€åäœãçšãããã®ã§ãããã«ããã
ãã®è¢å ã«ãã€ãŠèå¥å¯èœãªçæç©ãçãã
å ±åœ¹äœã«ãŸã€ãããé µçŽ Î²âã¬ã©ã¯ãã·ããŒ
ãŒã®ã該è€åäœãåæããŠããã®è¢å ã«ãã
èå¥ãããçæç©ã圢æããèœåã¯ãè€åäœ
ããã®çµåçžæãšçµåããããšã«ããé²æ¢ã
ããã
åŒïŒ ïŒåŒäžãã¯çµååºã§ïŒ¬ã¯äŸãã°é äœååã¯
ãã®é¡çžäœã®ãããªçµåæ§æåã§ãããïŒ ã®æšèè€åäœãçšãããã®ã§ãããã«ããã
ãã®è¢å ã«ãã€ãŠèå¥å¯èœãªçæç©ãçãã
å ±åœ¹äœã«ãŸã€ãããé µçŽ Î²âã¬ã©ã¯ãã·ããŒ
ãŒã®ã該è€åäœãåæããŠããã®è¢å ã«ãã
èå¥ãããçæç©ã圢æããèœåã¯ãè€åäœ
ããã®çµåçžæãšçµåããããšã«ããé²æ¢ã
ããã
(c) è£é
µçŽ æšèé¡
ãã®ç³»ã«ãããæšèè€åäœã¯ããã®æšèéš
åã¯ãè£é µçŽ 掻æ§ãæããå®èœéšåãããª
ãããããè£é µçŽ æšèã®ãé µçŽ åå¿ã«é¢äžã
ãèœåã¯ã該æšèã®ããã®çµåçžæãšã®çµå
ã«ãã€ãŠåœ±é¿ãåãããçèµ·ããé µçŽ åå¿ã®
é床ã¯ãæçµçã«åŸãããæ€ç¥å¯èœãªä¿¡å·ã
çããåŸæ¥ã®æ€ç¥ç³»ã«ãã€ãŠæž¬å®ããããšã
ã§ããããã®ã¿ã€ãã®è©Šéšæ¹æ³ã¯ã1978幎ïŒ
æ10æ¥ã«åºé¡ãããåºé¡ã«ä¿å±äžã®ç±³åœåºé¡
第894836å·ïŒäžŠã³ã«ãAnal.Biochem.72ïŒ
271ïŒ1976ïŒãAnal.Biochem.72ïŒ283ïŒ1976ïŒ
åã³Anal.Biochem.76ïŒ95ïŒ1976ïŒã«èšèŒã
ããŠããã
åã¯ãè£é µçŽ 掻æ§ãæããå®èœéšåãããª
ãããããè£é µçŽ æšèã®ãé µçŽ åå¿ã«é¢äžã
ãèœåã¯ã該æšèã®ããã®çµåçžæãšã®çµå
ã«ãã€ãŠåœ±é¿ãåãããçèµ·ããé µçŽ åå¿ã®
é床ã¯ãæçµçã«åŸãããæ€ç¥å¯èœãªä¿¡å·ã
çããåŸæ¥ã®æ€ç¥ç³»ã«ãã€ãŠæž¬å®ããããšã
ã§ããããã®ã¿ã€ãã®è©Šéšæ¹æ³ã¯ã1978幎ïŒ
æ10æ¥ã«åºé¡ãããåºé¡ã«ä¿å±äžã®ç±³åœåºé¡
第894836å·ïŒäžŠã³ã«ãAnal.Biochem.72ïŒ
271ïŒ1976ïŒãAnal.Biochem.72ïŒ283ïŒ1976ïŒ
åã³Anal.Biochem.76ïŒ95ïŒ1976ïŒã«èšèŒã
ããŠããã
(d) é
µçŽ 掻æ§ã«åœ±é¿ããæšèé¡
ãã®ç³»ã«ãããæšèè€åäœã¯ããã®æšèéš
åã¯ãé µçŽ é»å®³å€åã¯ä¿é²å€ã®ãããªé µçŽ 掻
æ§ã«åœ±é¿ãäžããå®èœéšåãããªããããã
é µçŽ æŽ»æ§ãå·Šå³ããæšèã®ãé µçŽ æŽ»æ§ãžã®åœ±
é¿èœã¯ãæšèè€åäœããã®çµåçžæãšçµåã
ãããšã«ãã圱é¿ãåããããã®é µçŽ åå¿ã®
é床ã¯ãæçµçã«æ€ç¥å¯èœãªä¿¡å·ãçããåŸ
æ¥ã®æ€ç¥ç³»ã«ãã€ãŠæž¬å®ã§ããããã®ã¿ã€ã
ã®è©Šéšæ¹æ³ã¯ç±³åœç¹èš±ç¬¬4134792å·ã«èšèŒã
ããŠããã
åã¯ãé µçŽ é»å®³å€åã¯ä¿é²å€ã®ãããªé µçŽ 掻
æ§ã«åœ±é¿ãäžããå®èœéšåãããªããããã
é µçŽ æŽ»æ§ãå·Šå³ããæšèã®ãé µçŽ æŽ»æ§ãžã®åœ±
é¿èœã¯ãæšèè€åäœããã®çµåçžæãšçµåã
ãããšã«ãã圱é¿ãåããããã®é µçŽ åå¿ã®
é床ã¯ãæçµçã«æ€ç¥å¯èœãªä¿¡å·ãçããåŸ
æ¥ã®æ€ç¥ç³»ã«ãã€ãŠæž¬å®ã§ããããã®ã¿ã€ã
ã®è©Šéšæ¹æ³ã¯ç±³åœç¹èš±ç¬¬4134792å·ã«èšèŒã
ããŠããã
(e) é
µçŽ æšè矀
ãã®ç³»ã«ãããŠãæšèã¯é
µçŽ ã§ãããé
µçŽ
æšèã®æŽ»æ§ã¯æšèè€åäœããã®çµåçžæãšçµ
åããããšã«ãã€ãŠåœ±é¿ãåãããåŸããã
é µçŽ æŽ»æ§ã¯ãæçµçã«æ€ç¥å¯èœãªä¿¡å·ãçã
ãåŸæ¥ã®æ€ç¥ç³»ã«ãã€ãŠæž¬å®ã§ããããã®ã¿
ã€ãã®è©Šéšæ¹æ³ã¯ãç±³åœç¹èš±ç¬¬3817837å·å
ã³4043872å·ã«èšèŒãããŠããã
æšèã®æŽ»æ§ã¯æšèè€åäœããã®çµåçžæãšçµ
åããããšã«ãã€ãŠåœ±é¿ãåãããåŸããã
é µçŽ æŽ»æ§ã¯ãæçµçã«æ€ç¥å¯èœãªä¿¡å·ãçã
ãåŸæ¥ã®æ€ç¥ç³»ã«ãã€ãŠæž¬å®ã§ããããã®ã¿
ã€ãã®è©Šéšæ¹æ³ã¯ãç±³åœç¹èš±ç¬¬3817837å·å
ã³4043872å·ã«èšèŒãããŠããã
(f) æ¶æ»
æ§è¢å
æšèé¡
ãã®ç³»ã«ãããæšèè€åäœã¯ããã®æšèéš
åã«ãããŠè¢å äœããæãããã®è¢å ã¯ãæš
èè€åäœãäžè¬ã«æäœã®ãããªãããã€ã³ã§
ãããã®çµåçžæã«ãã€ãŠçµåããããšãã
ã枬å®å¯èœãªçšåºŠã«ãŸã§æ¶æ» ããããã®è¢å
æ§æšèã¯ãæ€ç¥å¯èœãªä¿¡å·ã§ãããã®è¢å
ã§ãçŽæ¥æž¬å®ãããããã®ã¿ã€ãã®è©Šéšç³»
ã¯ãç±³åœç¹èš±ç¬¬4160016å·åã³J.Clin.Path.ã«
èšèŒãããŠããã
åã«ãããŠè¢å äœããæãããã®è¢å ã¯ãæš
èè€åäœãäžè¬ã«æäœã®ãããªãããã€ã³ã§
ãããã®çµåçžæã«ãã€ãŠçµåããããšãã
ã枬å®å¯èœãªçšåºŠã«ãŸã§æ¶æ» ããããã®è¢å
æ§æšèã¯ãæ€ç¥å¯èœãªä¿¡å·ã§ãããã®è¢å
ã§ãçŽæ¥æž¬å®ãããããã®ã¿ã€ãã®è©Šéšç³»
ã¯ãç±³åœç¹èš±ç¬¬4160016å·åã³J.Clin.Path.ã«
èšèŒãããŠããã
(g) è¢å
åå
æ§æšèé¡
ãã®ç³»ã«ãããæšèã¯ãåæ§ã«è¢å
äœã§ã
ãïŒããããªããã圱é¿ãããç¹æ§ã¯ãæšè
è€åäœããéåžžæäœã®ãããªãããã€ã³ã§ã
ããã®çµåçžæãšã®çµåã«åºã¥ãè¢å ã®ãã
ããã§ããããã®ã¿ã€ãã®è©Šéšç³»ã¯ãJ.Exp.
Med.122ïŒ1029ïŒ1965ïŒã«èšèŒãããŠããã
ãïŒããããªããã圱é¿ãããç¹æ§ã¯ãæšè
è€åäœããéåžžæäœã®ãããªãããã€ã³ã§ã
ããã®çµåçžæãšã®çµåã«åºã¥ãè¢å ã®ãã
ããã§ããããã®ã¿ã€ãã®è©Šéšç³»ã¯ãJ.Exp.
Med.122ïŒ1029ïŒ1965ïŒã«èšèŒãããŠããã
(h) ååŠçã«å±èµ·ãããè¢å
æ§æšèé¡
ãã®ç³»ã«ãããŠãæšèã¯ãå床ãè¢å
äœã§
ãããããããè¢å çºå ãããšãã«ã®ãŒæºäœ
ã«ãŸã§ååŠçã«å±èµ·ãããã¹ãè¢å äœæšèã®
èœåã¯ãæšèè€åäœããã®çµåçžæãšçµåã
ãããšã«ãã圱é¿ãåãããæšèã®ååŠçå±
èµ·ã¯ãäžè¬ã«ãè¢å äœæšèããã®å Žã§åœ¢æã
ããé«ãšãã«ã®ãŒååç©ã«æé²ããããšã«ã
ã€ãŠéæãããããã®ã¿ã€ãã®è©Šéšç³»ã¯ã
1979幎ïŒæ18æ¥ã«åºé¡ããåºé¡ã«ä¿å±ããèª
åèªèº«ã®ç±³åœåºé¡ç¬¬4580ã«èšèŒãããŠããã
ãããããããè¢å çºå ãããšãã«ã®ãŒæºäœ
ã«ãŸã§ååŠçã«å±èµ·ãããã¹ãè¢å äœæšèã®
èœåã¯ãæšèè€åäœããã®çµåçžæãšçµåã
ãããšã«ãã圱é¿ãåãããæšèã®ååŠçå±
èµ·ã¯ãäžè¬ã«ãè¢å äœæšèããã®å Žã§åœ¢æã
ããé«ãšãã«ã®ãŒååç©ã«æé²ããããšã«ã
ã€ãŠéæãããããã®ã¿ã€ãã®è©Šéšç³»ã¯ã
1979幎ïŒæ18æ¥ã«åºé¡ããåºé¡ã«ä¿å±ããèª
åèªèº«ã®ç±³åœåºé¡ç¬¬4580ã«èšèŒãããŠããã
(i) äºæäœç«äœé害æšèé¡
ä»ã®åæç³»ã¯ãç±³åœç¹èš±ç¬¬3935074å·åã³
3998943å·ã«èšèŒã®äºéæäœå ç«è©Šéšç³»ã§ã
ããæšèè€åäœã¯ïŒã€ã®ãšãããŒã
ïŒepitopeïŒãããªãããã®ïŒã€ã¯é äœååã³
æé äœåæäœãšã®å ç«åŠçåå¿ã«äžããä»ã¯
第ïŒã®æäœã«ãããçµåå¯èœã§ããããã
ããïŒã€ã®æäœãåæã«æšèè€åäœã«çµåã
ãããšã¯ã§ããªãã第ïŒã®ãšãããŒãã¯è¢å
äœã§ããããã®è¢å ã第ïŒã®æäœã®çµåã§æ¶
æ» ãããããããã¯ãããã第ïŒã®æäœã«çµ
åããããã®ç¬¬ïŒã®ãšãããŒãã®æšèäœãšè£
å©çãªç«¶äºççµååå¿ã«ãããã€ãŠãããã
åçš®ã®æ€ç¥ç³»ããåè¿°ã®ç¹èš±ã«èšèŒãããã
ããªç³»ã§å¯èœã§ãããããã«é¢é£ããè©Šéšç³»
ã¯ãç±³åœç¹èš±ç¬¬4130462å·åã³4161515å·äžŠã³
ã«è±åœç¹èš±ç¬¬1560852å·ã«èšèŒãããŠããã
3998943å·ã«èšèŒã®äºéæäœå ç«è©Šéšç³»ã§ã
ããæšèè€åäœã¯ïŒã€ã®ãšãããŒã
ïŒepitopeïŒãããªãããã®ïŒã€ã¯é äœååã³
æé äœåæäœãšã®å ç«åŠçåå¿ã«äžããä»ã¯
第ïŒã®æäœã«ãããçµåå¯èœã§ããããã
ããïŒã€ã®æäœãåæã«æšèè€åäœã«çµåã
ãããšã¯ã§ããªãã第ïŒã®ãšãããŒãã¯è¢å
äœã§ããããã®è¢å ã第ïŒã®æäœã®çµåã§æ¶
æ» ãããããããã¯ãããã第ïŒã®æäœã«çµ
åããããã®ç¬¬ïŒã®ãšãããŒãã®æšèäœãšè£
å©çãªç«¶äºççµååå¿ã«ãããã€ãŠãããã
åçš®ã®æ€ç¥ç³»ããåè¿°ã®ç¹èš±ã«èšèŒãããã
ããªç³»ã§å¯èœã§ãããããã«é¢é£ããè©Šéšç³»
ã¯ãç±³åœç¹èš±ç¬¬4130462å·åã³4161515å·äžŠã³
ã«è±åœç¹èš±ç¬¬1560852å·ã«èšèŒãããŠããã
(j) ãšãã«ã®ãŒç§»ååæšèé¡
ãã®ç³»ã§ã¯ãæšèã¯ãšãã«ã®ãŒç§»åã«ãã
ããïŒå¯Ÿã®ãããŒïŒäŸäžäœïŒåã³ã¢ã¯ã»ãã¿
ãŒïŒå容äœïŒã®ïŒæ¹ã§ããããã®çµåçžæã¯
ããã察ã®ä»ã®ãã®ãšçµåãããããããŠã
æšèè€åäœãçµåçžæãšçµåãããšãããã®
察ã®ãããŒæåã®ãšãã«ã®ãŒè¡šç€ºã¯ãã¢ã¯ã»
ãã¿ãŒæåãžã®ç§»åã«ãã€ãŠå€åãããæ®
éããããŒã¯è¢å äœã§ã¢ã¯ã»ãã¿ãŒã¯ãã®æ¶
æ» å€ã§ããããã®æ¶æ» å€ã¯åæ§ã«è¢å äœã§ã
ã€ãŠããããããã§ãªããŠãããããã®ãã
ãªæ æ§ã«ãããŠãæ€ç¥å¯èœãªä¿¡å·ã¯è¢å ã§ã
ãããä»ã®æ€ç¥ç³»ããŸãå¯èœã§ããããã®ã
ããªè©Šéšç³»ã¯ãç±³åœç¹èš±ç¬¬3996345å·ïŒ
4174384å·ïŒåã³4199559å·ã䞊ã³ã«è±åœç¹èš±
第2018424å·ã«èšèŒãããŠããã
ããïŒå¯Ÿã®ãããŒïŒäŸäžäœïŒåã³ã¢ã¯ã»ãã¿
ãŒïŒå容äœïŒã®ïŒæ¹ã§ããããã®çµåçžæã¯
ããã察ã®ä»ã®ãã®ãšçµåãããããããŠã
æšèè€åäœãçµåçžæãšçµåãããšãããã®
察ã®ãããŒæåã®ãšãã«ã®ãŒè¡šç€ºã¯ãã¢ã¯ã»
ãã¿ãŒæåãžã®ç§»åã«ãã€ãŠå€åãããæ®
éããããŒã¯è¢å äœã§ã¢ã¯ã»ãã¿ãŒã¯ãã®æ¶
æ» å€ã§ããããã®æ¶æ» å€ã¯åæ§ã«è¢å äœã§ã
ã€ãŠããããããã§ãªããŠãããããã®ãã
ãªæ æ§ã«ãããŠãæ€ç¥å¯èœãªä¿¡å·ã¯è¢å ã§ã
ãããä»ã®æ€ç¥ç³»ããŸãå¯èœã§ããããã®ã
ããªè©Šéšç³»ã¯ãç±³åœç¹èš±ç¬¬3996345å·ïŒ
4174384å·ïŒåã³4199559å·ã䞊ã³ã«è±åœç¹èš±
第2018424å·ã«èšèŒãããŠããã
(k) ä»ã®æšèé¡
æ¬çºæã§äœ¿çšã§ããåŸæ¥ããèšèŒãããŠã
ãä»ã®åäžç³»ç¹ç°ççµåè©Šéšç³»ã¯ã (i) é»å移åå€ã®ãããªéé µçŽ ç觊åªïŒç±³åœ
ç¹èš±ç¬¬4160645å·åç §ïŒïŒ (ii) éé µçŽ çååŠçºå äœïŒäžã§èšåãããã
åºé¡ã«ä¿å±ããç±³åœåºé¡ç¬¬894836å·å
ç §ãïŒïŒ (iii) ããã€ããªã³ã°ïŒchnnelingïŒãæšèé¡
ïŒè±åœç¹èš±ç¬¬2019562å·åç §ãïŒïŒ (iv) ãããŒãã€ã¯ã«ïŒpartileïŒãæšèé¡ïŒè±
åœç¹èš±ç¬¬2019562å·åç §ãïŒïŒåã³ (v) æšèåãªããœãŒã ïŒliposomeïŒç²å
ïŒç±³åœç¹èš±ç¬¬4193983å·åç §ãïŒ ã®ãããªæšèã䜿çšããŠããã
ãä»ã®åäžç³»ç¹ç°ççµåè©Šéšç³»ã¯ã (i) é»å移åå€ã®ãããªéé µçŽ ç觊åªïŒç±³åœ
ç¹èš±ç¬¬4160645å·åç §ïŒïŒ (ii) éé µçŽ çååŠçºå äœïŒäžã§èšåãããã
åºé¡ã«ä¿å±ããç±³åœåºé¡ç¬¬894836å·å
ç §ãïŒïŒ (iii) ããã€ããªã³ã°ïŒchnnelingïŒãæšèé¡
ïŒè±åœç¹èš±ç¬¬2019562å·åç §ãïŒïŒ (iv) ãããŒãã€ã¯ã«ïŒpartileïŒãæšèé¡ïŒè±
åœç¹èš±ç¬¬2019562å·åç §ãïŒïŒåã³ (v) æšèåãªããœãŒã ïŒliposomeïŒç²å
ïŒç±³åœç¹èš±ç¬¬4193983å·åç §ãïŒ ã®ãããªæšèã䜿çšããŠããã
ïŒ è©Šè¬å±€
茻å°ç·ã®æ¡æ£ã»é®ãžãå±€åã¯ãããäžå¡ãå±€
ãçšãããããªãã°ãäžå¡ãå±€äžã«è©Šè¬å±€ãèš
ããæ¹æ³ãåããã«æäŸããããæ¬çºæã®è©Šéš
å ·ã¯ã茻å°ç·æ£ä¹±ã»é®ãžãå±€åã¯äžå¡ãå±€äžã«
è©Šè¬çµæç©ãå°å·ãããã¯åŽé§ãããªã©ã®é©åœ
ãªæ¹æ³ã«ãããããããã¯å ¬ç¥ã®ãã€ã«ã 圢æ
æè¡ã®ãããããçšããããšã«ãã補é ããã
ãšãã§ããã
ãçšãããããªãã°ãäžå¡ãå±€äžã«è©Šè¬å±€ãèš
ããæ¹æ³ãåããã«æäŸããããæ¬çºæã®è©Šéš
å ·ã¯ã茻å°ç·æ£ä¹±ã»é®ãžãå±€åã¯äžå¡ãå±€äžã«
è©Šè¬çµæç©ãå°å·ãããã¯åŽé§ãããªã©ã®é©åœ
ãªæ¹æ³ã«ãããããããã¯å ¬ç¥ã®ãã€ã«ã 圢æ
æè¡ã®ãããããçšããããšã«ãã補é ããã
ãšãã§ããã
è©Šè¬å±€ããå®éã«å€éå±€ãããªãå Žåã«ã¯ã
ãã®ãããªå±€ã¯ãå¿ èŠãªãã°ãå±€éã®æµäœéé
ã蚱容ããæ¥çå€ã§èå±€é¢ä¿ã«ç¶æããããšã
ã§ãããããããªãããæ®éã¯ãïŒã€ã®å±€ãä»
ã®å±€ã«æ¥çããããã«æ¥çå€ãçšããããšã¯å¿
èŠã§ã¯ãªãããã€ã«ã 圢æè£ çœ®ãçšããäžäœç
ãªåæçŽ åã®è£œé ã«ãããŠã¯ãå±€ãå¥ã ã«äºã
圢æããããŠç©å±€ãå šäœçãªçŽ åã圢æã§ã
ãããã€ã«ã å±€ã®æ質ã¯ã寞æ³å®å®æ§ãä»äžã
ãã«å¥œé©ãªå¯å¡å€åã³é«ååããæãçµæç©ã§
ããåŸããããããæ¹æ³ã§è£œé ãããå±€ã¯ãå ž
åçã«ã¯ãè¡šé¢äžã«ã溶液åã¯æžæ¿æ¶²ããå¡åž
ããããã®è¡šé¢ããã¯ä¹Ÿç¥ãããå±€ãç©ççã«
åŒãå¥ãããšãã§ãããããããªãããå€éã®
å¥é¢åã³ç©å±€å·¥çšã®åé¡ãåé¿ã§ãã䟿å©ãªæ¹
æ³ã¯ãå¥é¢ããè¡šé¢åã¯å¿ èŠã«å¿ããŠãæ¯æå±€
ã®äžã«æåã®å±€ãå¡åžãããã®åŸãæ¢ã«å¡åžã
ããŠãããããã®äžã«çŽæ¥æ¬¡ã ãšå±€ãå¡åžãã
ããšã§ããããã®ãããªå¡åžã¯ãæã§ããã¬ãŒ
ãå¡åžå ·ã§ãåã¯æ©æ¢°ã§ã浞挬åã¯ããŒãºå¡åž
ã®ãããªææ³ãçšããŠæãããšãã§ããããã
ãæ©æ¢°å¡åžæ³ãçšããããå Žåã«ã¯ããã°ã
ã°ãå æå¿æ§åççšãã€ã«ã åã³æå çŽã®è£œé
ã§ããç¥ãããŠããããããŒå¡åžæ³ãçšããŠè¿
æ¥ããå±€ãåæã«å¡åžããããšãå¯èœã§ããã
ãã®ãããªå±€ã¯ãå¿ èŠãªãã°ãå±€éã®æµäœéé
ã蚱容ããæ¥çå€ã§èå±€é¢ä¿ã«ç¶æããããšã
ã§ãããããããªãããæ®éã¯ãïŒã€ã®å±€ãä»
ã®å±€ã«æ¥çããããã«æ¥çå€ãçšããããšã¯å¿
èŠã§ã¯ãªãããã€ã«ã 圢æè£ çœ®ãçšããäžäœç
ãªåæçŽ åã®è£œé ã«ãããŠã¯ãå±€ãå¥ã ã«äºã
圢æããããŠç©å±€ãå šäœçãªçŽ åã圢æã§ã
ãããã€ã«ã å±€ã®æ質ã¯ã寞æ³å®å®æ§ãä»äžã
ãã«å¥œé©ãªå¯å¡å€åã³é«ååããæãçµæç©ã§
ããåŸããããããæ¹æ³ã§è£œé ãããå±€ã¯ãå ž
åçã«ã¯ãè¡šé¢äžã«ã溶液åã¯æžæ¿æ¶²ããå¡åž
ããããã®è¡šé¢ããã¯ä¹Ÿç¥ãããå±€ãç©ççã«
åŒãå¥ãããšãã§ãããããããªãããå€éã®
å¥é¢åã³ç©å±€å·¥çšã®åé¡ãåé¿ã§ãã䟿å©ãªæ¹
æ³ã¯ãå¥é¢ããè¡šé¢åã¯å¿ èŠã«å¿ããŠãæ¯æå±€
ã®äžã«æåã®å±€ãå¡åžãããã®åŸãæ¢ã«å¡åžã
ããŠãããããã®äžã«çŽæ¥æ¬¡ã ãšå±€ãå¡åžãã
ããšã§ããããã®ãããªå¡åžã¯ãæã§ããã¬ãŒ
ãå¡åžå ·ã§ãåã¯æ©æ¢°ã§ã浞挬åã¯ããŒãºå¡åž
ã®ãããªææ³ãçšããŠæãããšãã§ããããã
ãæ©æ¢°å¡åžæ³ãçšããããå Žåã«ã¯ããã°ã
ã°ãå æå¿æ§åççšãã€ã«ã åã³æå çŽã®è£œé
ã§ããç¥ãããŠããããããŒå¡åžæ³ãçšããŠè¿
æ¥ããå±€ãåæã«å¡åžããããšãå¯èœã§ããã
ãã€ã«ã å±€æ質ãšããŠãã¶ããæããé«åå
å±€ïŒBlush polymer layerïŒãçšããããšãã§
ããããã®ãã€ã«ã ã¯ãïŒã€ã®æ¶²äœã®æ··åç©ã«
é«ååã溶解ããããšã«ããåºæ¿ã®äžã«åœ¢æã
ããããã®æ¶²äœã®ïŒæ¹ã¯äœæ²žç¹ã§é«ååã«å¯Ÿã
ãè¯å¥œãªæº¶åªã§ãããä»æ¹ã¯é«æ²žç¹ã§é«ååã«
察ããŠã¯é溶åªè¥ããã¯å°ãªããšã貧溶åªã§ã
ãããã®ãããªé«åå溶液ã¯ãã€ãã«åºæ¿ã®äž
ã«å¡åžããããããŠå¶åŸ¡ãããæ¡ä»¶äžã§ä¹Ÿç¥ã
ãããäœæ²žç¹æº¶åªã¯ãã容æã«èžçºãããã
ãŠãå¡åžç©ã¯è²§æº¶åªåã¯é溶åªã§ãã液äœäžã§
å€ããªã€ãŠãããèžçºãé²ããšããããããã¹
ãæ¡ä»¶äžã§é«ååã¯å€å質ã®å±€ãšãªããå€ãã®
çš®é¡ã®é«ååããæ¬çºæã§çšããããã®å€å質
ã®ãã¶ããæããé«ååå±€ã®èª¿è£œçšã«ãåç¬ã§
åã¯çµåããŠçšããããšãã§ãããå žåçãªäŸ
ãšããŠãããªã«ãŒãããŒãé¡ãããªã¢ããé¡ã
ããªãŠã¬ã¿ã³é¡ãåã³ã»ã«ããŒã¹ã¢ã»ããŒãã®
ãããªã»ã«ããŒã¹ãšã¹ãã«é¡ãæãããããæš
èè€åäœåã¯ä»ã®è©Šè¬ãå«ããããªå±€ã圢æã
ãã«ã¯ããããªãã¯ã¹ïŒæ¯æïŒåã³å å«ããã
掻æ§ç©è³ªãå«ãå¡åžæº¶æ¶²åã¯æžæ¿æ¶²ã調補ãã
ããã§è«ããããã«ããŠå¡åžãã也ç¥ããŠå¯žæ³
å®å®ãããå±€ã圢æããããšãã§ããã
å±€ïŒBlush polymer layerïŒãçšããããšãã§
ããããã®ãã€ã«ã ã¯ãïŒã€ã®æ¶²äœã®æ··åç©ã«
é«ååã溶解ããããšã«ããåºæ¿ã®äžã«åœ¢æã
ããããã®æ¶²äœã®ïŒæ¹ã¯äœæ²žç¹ã§é«ååã«å¯Ÿã
ãè¯å¥œãªæº¶åªã§ãããä»æ¹ã¯é«æ²žç¹ã§é«ååã«
察ããŠã¯é溶åªè¥ããã¯å°ãªããšã貧溶åªã§ã
ãããã®ãããªé«åå溶液ã¯ãã€ãã«åºæ¿ã®äž
ã«å¡åžããããããŠå¶åŸ¡ãããæ¡ä»¶äžã§ä¹Ÿç¥ã
ãããäœæ²žç¹æº¶åªã¯ãã容æã«èžçºãããã
ãŠãå¡åžç©ã¯è²§æº¶åªåã¯é溶åªã§ãã液äœäžã§
å€ããªã€ãŠãããèžçºãé²ããšããããããã¹
ãæ¡ä»¶äžã§é«ååã¯å€å質ã®å±€ãšãªããå€ãã®
çš®é¡ã®é«ååããæ¬çºæã§çšããããã®å€å質
ã®ãã¶ããæããé«ååå±€ã®èª¿è£œçšã«ãåç¬ã§
åã¯çµåããŠçšããããšãã§ãããå žåçãªäŸ
ãšããŠãããªã«ãŒãããŒãé¡ãããªã¢ããé¡ã
ããªãŠã¬ã¿ã³é¡ãåã³ã»ã«ããŒã¹ã¢ã»ããŒãã®
ãããªã»ã«ããŒã¹ãšã¹ãã«é¡ãæãããããæš
èè€åäœåã¯ä»ã®è©Šè¬ãå«ããããªå±€ã圢æã
ãã«ã¯ããããªãã¯ã¹ïŒæ¯æïŒåã³å å«ããã
掻æ§ç©è³ªãå«ãå¡åžæº¶æ¶²åã¯æžæ¿æ¶²ã調補ãã
ããã§è«ããããã«ããŠå¡åžãã也ç¥ããŠå¯žæ³
å®å®ãããå±€ã圢æããããšãã§ããã
è©Šè¬å±€ã®åã¿åã³ãã®ééæ§ã®åºŠåãã¯ãå®
éã®çšéã«ãã€ãŠåºç¯å²ã«å€ããããšãã§ã
ããçŽïŒãã¯ãã³ããçŽ100ãã¯ãã³ã®ä¹Ÿç¥å
ã¿ã奜éœåã§ãã€ãããããæ æ³äžã§ã¯æŽã«åº
ãå€åãããåã¿ã奜ãŸãããäŸãã°ãæ¯èŒç
倧éã®çžäºäœçšæ§ã®ç©è³ªãäŸãã°é µçŽ ã®ãããª
é«ååç©è³ªããå¿ èŠãšããããªãã°ãå°ãåã
ã®å±€ã調補ããããšã奜ãŸããã§ãããã
éã®çšéã«ãã€ãŠåºç¯å²ã«å€ããããšãã§ã
ããçŽïŒãã¯ãã³ããçŽ100ãã¯ãã³ã®ä¹Ÿç¥å
ã¿ã奜éœåã§ãã€ãããããæ æ³äžã§ã¯æŽã«åº
ãå€åãããåã¿ã奜ãŸãããäŸãã°ãæ¯èŒç
倧éã®çžäºäœçšæ§ã®ç©è³ªãäŸãã°é µçŽ ã®ãããª
é«ååç©è³ªããå¿ èŠãšããããªãã°ãå°ãåã
ã®å±€ã調補ããããšã奜ãŸããã§ãããã
é°ã€ãªã³åã³éã€ãªã³çé¢æŽ»æ§å€ã®ãããªïŒ
çš®åã¯ãã以äžã®çé¢æŽ»æ§å€ãè©Šè¬å±€ã«å å«ã
ãããããšã¯æçã§ãããäŸãã°ããããã¯ã
局圢æé åç©ã®å¡åžæ§ãåäžããããçé¢æŽ»æ§
å€ã®ãããªå©å€ããªããšæ¶²äœè©Šæã«ãã€ãŠã¯å®¹
æã«ã¯æ¿¡ããªãå±€äžã§ã®æ¿¡ãã®å€§ããåã³ç¯å²
ãé«ãããæŽã«ãéžãã åæã«ãããŠããã®å
æã«å¯ŸããŠã¯æœåšçã«æ害ã§ããç©è³ªããååŠ
åå¿åã¯ãã®ä»ã«ãã€ãŠäžæŽ»æ§ã«ãããåŸãç©
質ãå«ãŸããããšã¯å¥œãŸããããšã§ããããã
çš®åã¯ãã以äžã®çé¢æŽ»æ§å€ãè©Šè¬å±€ã«å å«ã
ãããããšã¯æçã§ãããäŸãã°ããããã¯ã
局圢æé åç©ã®å¡åžæ§ãåäžããããçé¢æŽ»æ§
å€ã®ãããªå©å€ããªããšæ¶²äœè©Šæã«ãã€ãŠã¯å®¹
æã«ã¯æ¿¡ããªãå±€äžã§ã®æ¿¡ãã®å€§ããåã³ç¯å²
ãé«ãããæŽã«ãéžãã åæã«ãããŠããã®å
æã«å¯ŸããŠã¯æœåšçã«æ害ã§ããç©è³ªããååŠ
åå¿åã¯ãã®ä»ã«ãã€ãŠäžæŽ»æ§ã«ãããåŸãç©
質ãå«ãŸããããšã¯å¥œãŸããããšã§ããããã
以äžã«ãè©Šè¬å±€ã®èª¿è£œã®ããã€ãã®å¥œãŸãã
è©Šã¿ãèšèŒããã
è©Šã¿ãèšèŒããã
(a) å€éå±€ã®è©Šã¿
ãã®è©Šã¿ã¯ã液äœè©Šæäžã®é
äœååã¯é
äœ
åçµåèœã枬å®ããããã®åäžç³»ç¹ç°ççµå
åæçŽ åã®è©Šè¬å±€ãã圢æããæ¹æ³ã«é¢ãã
ãã®ã§ãããããã®æ¹æ³ã¯ãé äœåéšïŒå
åïŒåã¯ãã®ç¹ç°ççµåé¡çžäœã«çµåããæš
èæåãããªãæšèè€åäœãšè©²æšèè€åäœãš
çžäºåå¿æ§ã®è©Šè¬ãšãå«ãçµæç©ãå å«ãã
ããããšã«ãã€ãŠè¡ãªãããããã®è©Šè¬ã¯ã
äŸãã°ãé äœåã«å¯Ÿããç¹ç°ççµåçžæåã³
æšèè€åäœãšçžäºåå¿ããŠé äœåéšååã¯ã
ã®ç¹ç°ççµåé¡çžäœããæšèæåãåæãã
æåãšããæãã
åçµåèœã枬å®ããããã®åäžç³»ç¹ç°ççµå
åæçŽ åã®è©Šè¬å±€ãã圢æããæ¹æ³ã«é¢ãã
ãã®ã§ãããããã®æ¹æ³ã¯ãé äœåéšïŒå
åïŒåã¯ãã®ç¹ç°ççµåé¡çžäœã«çµåããæš
èæåãããªãæšèè€åäœãšè©²æšèè€åäœãš
çžäºåå¿æ§ã®è©Šè¬ãšãå«ãçµæç©ãå å«ãã
ããããšã«ãã€ãŠè¡ãªãããããã®è©Šè¬ã¯ã
äŸãã°ãé äœåã«å¯Ÿããç¹ç°ççµåçžæåã³
æšèè€åäœãšçžäºåå¿ããŠé äœåéšååã¯ã
ã®ç¹ç°ççµåé¡çžäœããæšèæåãåæãã
æåãšããæãã
è©Šè¬é¡ã¯ãè©Šéšå
·ã®èª¿è£œæéäžã®å®è³ªçãª
çžäºåå¿ãå¯èœã§ãããããŠå°æ©ã«åå¿ããª
ãããããã®æº¶æ¶²ã®åœ¢ã§äœ¿çšããããšãã§ã
ãã奜ãŸããæ æ§ã«ãããŠã¯ããã第ïŒã®è©Š
è¬ãæ°Žæ§æµžæŒ¬ãçšããå±€ã«å å«ãããããã
ãã®ä»ã®è©Šè¬é¡çšã«ã¯ããã«ãšã³ãã¢ã»ã
ã³ãã¯ãããã«ã ãå¡©åã¡ãã¬ã³ïŒã¡ãã¬ã³
ã¯ããªãïŒãïœâãããããŒã«åã³äºå¡©åãš
ãã¬ã³ïŒãšãã¬ã³ãžã¯ããªãïŒã®ãããªé©åœ
ãªææ©æº¶åªãçšããããããã®å±€ã¯ãã®ææ©
溶åªãèžçºãããŠå®çãããã
çžäºåå¿ãå¯èœã§ãããããŠå°æ©ã«åå¿ããª
ãããããã®æº¶æ¶²ã®åœ¢ã§äœ¿çšããããšãã§ã
ãã奜ãŸããæ æ§ã«ãããŠã¯ããã第ïŒã®è©Š
è¬ãæ°Žæ§æµžæŒ¬ãçšããå±€ã«å å«ãããããã
ãã®ä»ã®è©Šè¬é¡çšã«ã¯ããã«ãšã³ãã¢ã»ã
ã³ãã¯ãããã«ã ãå¡©åã¡ãã¬ã³ïŒã¡ãã¬ã³
ã¯ããªãïŒãïœâãããããŒã«åã³äºå¡©åãš
ãã¬ã³ïŒãšãã¬ã³ãžã¯ããªãïŒã®ãããªé©åœ
ãªææ©æº¶åªãçšããããããã®å±€ã¯ãã®ææ©
溶åªãèžçºãããŠå®çãããã
ãã®å¥œãŸããæ
æ§ã®äŸã¯ãβâã¬ã©ã¯ãã·
ã«ãŠã³ããªããšãã³âé äœååã¯é äœåé¡çž
äœè€åäœãβâã¬ã©ã¯ãã·ããŒãŒåã³é äœå
ã«å¯Ÿããæè¡æž ãé©çšããããšã«ãã€ãŠã液
äœè©Šæäžã®é äœååã¯é äœåçµåèœã枬å®ã
ãããã®åäžç³»ç¹ç°ççµåè©Šéšå ·ã調補ãã
æ¹æ³ã§ãã€ãŠããã®æ¹æ³ã¯(a)βâã¬ã©ã¯ãã·
ããŒãŒåã³é äœåã«å¯Ÿããæè¡æž ãæ°Žæ§æ¶²äœ
äžã§é©çšãããããŠ(b)ã€ãã§Î²âã¬ã©ã¯ãã·
ã«ãŠã³ããªããšãã³âé äœååã¯é äœåé¡çž
äœè€åäœãã¢ã»ãã³äžã§é©çšããããšããæ
ãã
ã«ãŠã³ããªããšãã³âé äœååã¯é äœåé¡çž
äœè€åäœãβâã¬ã©ã¯ãã·ããŒãŒåã³é äœå
ã«å¯Ÿããæè¡æž ãé©çšããããšã«ãã€ãŠã液
äœè©Šæäžã®é äœååã¯é äœåçµåèœã枬å®ã
ãããã®åäžç³»ç¹ç°ççµåè©Šéšå ·ã調補ãã
æ¹æ³ã§ãã€ãŠããã®æ¹æ³ã¯(a)βâã¬ã©ã¯ãã·
ããŒãŒåã³é äœåã«å¯Ÿããæè¡æž ãæ°Žæ§æ¶²äœ
äžã§é©çšãããããŠ(b)ã€ãã§Î²âã¬ã©ã¯ãã·
ã«ãŠã³ããªããšãã³âé äœååã¯é äœåé¡çž
äœè€åäœãã¢ã»ãã³äžã§é©çšããããšããæ
ãã
(b) å€é åè©Šè¬å±€
å€é åè©Šè¬å±€ã¯ã(a)çšããããç¹ç°ççµå
æ§ã®åæç³»ã®è©Šè¬ã®ããã€ããããããå šéš
ã§ã¯ãªããã第ïŒåã¯äžå±€é åã«å å«ãã
ãã(b)æ®äœã®è©Šè¬é¡ã第ïŒã®åã¯äžå±€é åã«
å å«ãããã(c)äŸãã°ä¹Ÿç¥ããŠãåã ã®é å
ãå®çããããããŠ(d)ããããäºãã«ç©å±€é¢
ä¿ãããããŠèå±€ç¶ã«åºçããããšã«ãã€ãŠ
調補ãããã
æ§ã®åæç³»ã®è©Šè¬ã®ããã€ããããããå šéš
ã§ã¯ãªããã第ïŒåã¯äžå±€é åã«å å«ãã
ãã(b)æ®äœã®è©Šè¬é¡ã第ïŒã®åã¯äžå±€é åã«
å å«ãããã(c)äŸãã°ä¹Ÿç¥ããŠãåã ã®é å
ãå®çããããããŠ(d)ããããäºãã«ç©å±€é¢
ä¿ãããããŠèå±€ç¶ã«åºçããããšã«ãã€ãŠ
調補ãããã
第ïŒå±€åã³ç¬¬ïŒå±€ã¯ããããäžå¯Ÿã®å¯Ÿåé¢
ãæããã第ïŒå±€ã®ïŒã€ã®é¢ã¯ç¬¬ïŒã®å±€ã®ïŒ
ã€ã®é¢ãšç©å±€é¢ä¿ã«ããããããŠè©Šæã¯è©²äž¡
å±€ã®ããããã®ä»ã®é¢ã«é©çšããããç©å±€é¢
ä¿ãšããã®ã¯ã液äœã§ããããšã¬ã¹ã§ããã
ãšããããã®å±€ã®éãªãåã€ãé¢ã®éãæµäœ
ãééã§ããããšãæå³ããããã®ãããªå±€
ã¯ãäºãã«é£æ¥ããŠããŠããããä»åšå±€ã«ã
ã€ãŠåé¢ãããŠããŠãããããããªãä»åšå±€
ããå šãŠã®å±€éã®ééã劚害ãããã®ã§ãã€
ãŠã¯ãªããªãã
ãæããã第ïŒå±€ã®ïŒã€ã®é¢ã¯ç¬¬ïŒã®å±€ã®ïŒ
ã€ã®é¢ãšç©å±€é¢ä¿ã«ããããããŠè©Šæã¯è©²äž¡
å±€ã®ããããã®ä»ã®é¢ã«é©çšããããç©å±€é¢
ä¿ãšããã®ã¯ã液äœã§ããããšã¬ã¹ã§ããã
ãšããããã®å±€ã®éãªãåã€ãé¢ã®éãæµäœ
ãééã§ããããšãæå³ããããã®ãããªå±€
ã¯ãäºãã«é£æ¥ããŠããŠããããä»åšå±€ã«ã
ã€ãŠåé¢ãããŠããŠãããããããªãä»åšå±€
ããå šãŠã®å±€éã®ééã劚害ãããã®ã§ãã€
ãŠã¯ãªããªãã
(c) åçµä¹Ÿç¥æ³
ãã®æ¹æ³ã¯ãäžå±€ã®åæçŽ åã«ãããå
±å
ã§ããªãè©Šè¬é¡ãå å«ãããããããè©Šè¬é
ã®åå¿ãé²æ¢ããæäœããæããäŸãã°ãè©Š
è¬é¡ã®ç¬¬ïŒã®çŸ€ãåçµä¹Ÿç¥æ³ã«ãããé«æž©ã«
ãããŠå¡åžããåŠçå±€ãèšãããããåšèŸºé°
å²æ°äžã§ç¬¬ïŒã®çŸ€ãšåå¿ãããã®ãå«ãè©Šè¬
é¡ã®ç¬¬ïŒã®çŸ€ããé©çšãããããŠçŽ åãæ¥é
ã«åçµããããåçµã¯ãææå°æ©ãªåå¿ãé²
æ¢ããåçµä¹Ÿç¥ã«ããæ°Žã®ç¶ããŠèµ·ããé€å»
ã¯ãã®å±€ã宀枩ã«ãŸã§æ»ããããšãã®å°æ©ãª
åå¿ãé²æ¢ããã
ã§ããªãè©Šè¬é¡ãå å«ãããããããè©Šè¬é
ã®åå¿ãé²æ¢ããæäœããæããäŸãã°ãè©Š
è¬é¡ã®ç¬¬ïŒã®çŸ€ãåçµä¹Ÿç¥æ³ã«ãããé«æž©ã«
ãããŠå¡åžããåŠçå±€ãèšãããããåšèŸºé°
å²æ°äžã§ç¬¬ïŒã®çŸ€ãšåå¿ãããã®ãå«ãè©Šè¬
é¡ã®ç¬¬ïŒã®çŸ€ããé©çšãããããŠçŽ åãæ¥é
ã«åçµããããåçµã¯ãææå°æ©ãªåå¿ãé²
æ¢ããåçµä¹Ÿç¥ã«ããæ°Žã®ç¶ããŠèµ·ããé€å»
ã¯ãã®å±€ã宀枩ã«ãŸã§æ»ããããšãã®å°æ©ãª
åå¿ãé²æ¢ããã
奜ãŸããæ
æ§ã«ãããŠã¯ãè©Šè¬é¡ã®ïŒçŸ€
ã¯ã氎溶液ã®åœ¢ã§ãå±€ã«æ·»å ã也ç¥ããŠãã
ãã氎溶液ã®åœ¢ã§è©Šè¬é¡ã®ç¬¬ïŒã®çŸ€ãæ·»å ã
ãã®ã¡æ¥éã«åçµãããæ°Žãé€å»ããããã«
åçµä¹Ÿç¥ãè¡ãªãããããã®æ¹æ³ã¯ãæ°Žã«ã®
ã¿æº¶ããããã€ãã®è©Šè¬é¡ãå å«ããããã
ããè©Šè¬éã®çžäºåå¿ãé²æ¢ããå Žåã«é©çš
ããããããã«ããã®æ¹æ³ã«ãããŠã¯ãææ©
溶åªã¯äœ¿çšãããªãããšããã®ã¯ãããçš®ã®
ææ©æº¶åªã¯ãããã€ãã®è©Šè¬é¡ïŒäŸãã°ãé µ
çŽ é¡ïŒãšå¥œãŸãããªãåå¿ãèµ·ãå¯èœæ§ãã
ãããã§ããã
ã¯ã氎溶液ã®åœ¢ã§ãå±€ã«æ·»å ã也ç¥ããŠãã
ãã氎溶液ã®åœ¢ã§è©Šè¬é¡ã®ç¬¬ïŒã®çŸ€ãæ·»å ã
ãã®ã¡æ¥éã«åçµãããæ°Žãé€å»ããããã«
åçµä¹Ÿç¥ãè¡ãªãããããã®æ¹æ³ã¯ãæ°Žã«ã®
ã¿æº¶ããããã€ãã®è©Šè¬é¡ãå å«ããããã
ããè©Šè¬éã®çžäºåå¿ãé²æ¢ããå Žåã«é©çš
ããããããã«ããã®æ¹æ³ã«ãããŠã¯ãææ©
溶åªã¯äœ¿çšãããªãããšããã®ã¯ãããçš®ã®
ææ©æº¶åªã¯ãããã€ãã®è©Šè¬é¡ïŒäŸãã°ãé µ
çŽ é¡ïŒãšå¥œãŸãããªãåå¿ãèµ·ãå¯èœæ§ãã
ãããã§ããã
ãã®æ¹æ³ã¯ãå
šãŠã®è©Šè¬é¡ãåäžå±€çŽ åå
ã«èšããããåäžç³»ç¹ç°ççµåè©Šéšçšã®è©Šè¬
é¡ãçšããçŽ åã®åœ¢æãå¯èœã«ããã
ã«èšããããåäžç³»ç¹ç°ççµåè©Šéšçšã®è©Šè¬
é¡ãçšããçŽ åã®åœ¢æãå¯èœã«ããã
(d) äºå圢æé¯äœæ³
è©Šæé
äœåãšçµåçžæïŒããã§ã¯æäœ
âAbâã«ãã€ãŠäŸç€ºãããïŒã«çµåãããã
ã®æšèåé äœåéã®ç«¶åã¯ãåŒïŒ é äœå AbïŒé äœå ïŒ ïŒ æšèâé äœå AbïŒæšèâé äœå ïŒ Ab ã«ãã€ãŠãŸãšããããšãã§ããã
âAbâã«ãã€ãŠäŸç€ºãããïŒã«çµåãããã
ã®æšèåé äœåéã®ç«¶åã¯ãåŒïŒ é äœå AbïŒé äœå ïŒ ïŒ æšèâé äœå AbïŒæšèâé äœå ïŒ Ab ã«ãã€ãŠãŸãšããããšãã§ããã
äžã«ç€ºãããç³»ã«ãããŠãæäœåã³æšèè€
åäœã¯ãè©Šæãå°å ¥ãããŸã§ã¯åé¢ããŠä¿æ
ããããèšèŒããçºæã®ãã®æ æ§ã¯ã以äžã®
åŒïŒ é äœå AbïŒé äœå ïŒ ïŒ AbïŒæšèâé äœå æšèâé äœå ã«ãã€ãŠç€ºãããããã«ãé äœåãšã®éåå¿
åã³å平衡ãçšãããã®ã§ãããã§ã眮æã
ããæšèè€åäœã¯è©Šæé äœåæ¿åºŠã«é¢ä¿ã
ãããã®å©ç¹ã¯ãå šãŠã®è©Šè¬æåãïŒã€ã®å
å«ãããåªäœäžã«çµåããããè©Šéšãããã¹
ãè©Šæã®æ·»å ã®ã¿ãå¿ èŠãšããç³»ãæäŸã§ã
ããšããããšã§ããã
åäœã¯ãè©Šæãå°å ¥ãããŸã§ã¯åé¢ããŠä¿æ
ããããèšèŒããçºæã®ãã®æ æ§ã¯ã以äžã®
åŒïŒ é äœå AbïŒé äœå ïŒ ïŒ AbïŒæšèâé äœå æšèâé äœå ã«ãã€ãŠç€ºãããããã«ãé äœåãšã®éåå¿
åã³å平衡ãçšãããã®ã§ãããã§ã眮æã
ããæšèè€åäœã¯è©Šæé äœåæ¿åºŠã«é¢ä¿ã
ãããã®å©ç¹ã¯ãå šãŠã®è©Šè¬æåãïŒã€ã®å
å«ãããåªäœäžã«çµåããããè©Šéšãããã¹
ãè©Šæã®æ·»å ã®ã¿ãå¿ èŠãšããç³»ãæäŸã§ã
ããšããããšã§ããã
ãã®ããã«ããã®æ¹æ³ã¯ã液äœè©Šæäžã®é
äœåã枬å®ããåäžç³»ç¹ç°ççµåè©Šéšå ·ã®è©Š
è¬å±€ã®èª¿è£œæ¹æ³ãæäŸãããã®ã§ããããã
ã®æ¹æ³ã¯ã(a)æšèè€åäœã§ãã€ãŠãé äœåå
ã¯ãã®ç¹ç°ççµåé¡çžäœã«çµåãããæšèæ
åããæãè€åäœãšãã®é äœåã«å¯Ÿããç¹ç°
ççµåçžæãšã®éã«é¯äœã圢æãïŒãããŠã
(b)ãã®é¯äœãé©çšããããšããæ§æãããã
ãã®æ¹æ³ã§ã¯ãé¯äœã®åœ¢æã¯ãæšèè€åäœãš
ãã®ããã®ç¹ç°ççµåçžæãäŒåããããè€
åäœãçµåçžæåã³é¯äœããã平衡ç¶æ ã«å°
éããããããã«ããããšããæãã
äœåã枬å®ããåäžç³»ç¹ç°ççµåè©Šéšå ·ã®è©Š
è¬å±€ã®èª¿è£œæ¹æ³ãæäŸãããã®ã§ããããã
ã®æ¹æ³ã¯ã(a)æšèè€åäœã§ãã€ãŠãé äœåå
ã¯ãã®ç¹ç°ççµåé¡çžäœã«çµåãããæšèæ
åããæãè€åäœãšãã®é äœåã«å¯Ÿããç¹ç°
ççµåçžæãšã®éã«é¯äœã圢æãïŒãããŠã
(b)ãã®é¯äœãé©çšããããšããæ§æãããã
ãã®æ¹æ³ã§ã¯ãé¯äœã®åœ¢æã¯ãæšèè€åäœãš
ãã®ããã®ç¹ç°ççµåçžæãäŒåããããè€
åäœãçµåçžæåã³é¯äœããã平衡ç¶æ ã«å°
éããããããã«ããããšããæãã
æŽã«è©³çŽ°ã«ããã°ããã®å±€ã¯ãäžãããã
è€åäœããã®ããããã®æè¡æž ãšãšãã«çæ
éãäŸãã°15åãã€ã³ããŠããŒãããŠèª¿è£œã
ãããã€ãã§ãä»ã®è©Šè¬é¡ãæ·»å ããããã
ãŠæŽã«äžå®æéãã€ã³ããŠããŒãããããã
ã®ããã«åœ¢æããã溶液ã¯ã€ãã§æŸçœ®ãã
ãã
è€åäœããã®ããããã®æè¡æž ãšãšãã«çæ
éãäŸãã°15åãã€ã³ããŠããŒãããŠèª¿è£œã
ãããã€ãã§ãä»ã®è©Šè¬é¡ãæ·»å ããããã
ãŠæŽã«äžå®æéãã€ã³ããŠããŒãããããã
ã®ããã«åœ¢æããã溶液ã¯ã€ãã§æŸçœ®ãã
ãã
ïŒ æ¯æå±€
ããã§æ¢ã«è¿°ã¹ãããŠããããã«ãäžäœçãª
åæçŽ åã¯æ¯æäœããå«ããæ¯æäœã¯å è¥ãã
ã¯ä»ã®ãšãã«ã®ã«å¯Ÿããäžéæãåéæåã¯é
æã§ãã€ãŠããããç¹å®ã®çŽ åçšã«éžå®ããã
æ¯æäœã¯ãä¿¡å·æ€ç¥ã«é¢ãæå³ãããã¢ãŒãã«
ç¡é¢ä¿ã«éžæãããã ããã奜ãŸããæ¯æäœ
ã¯ãããªã¹ãã¬ã³åã¯åçš®ã®ãã©ã¹ããã¯æã§
ã§ããæ¯æäœãå«ãŸããã
åæçŽ åã¯æ¯æäœããå«ããæ¯æäœã¯å è¥ãã
ã¯ä»ã®ãšãã«ã®ã«å¯Ÿããäžéæãåéæåã¯é
æã§ãã€ãŠããããç¹å®ã®çŽ åçšã«éžå®ããã
æ¯æäœã¯ãä¿¡å·æ€ç¥ã«é¢ãæå³ãããã¢ãŒãã«
ç¡é¢ä¿ã«éžæãããã ããã奜ãŸããæ¯æäœ
ã¯ãããªã¹ãã¬ã³åã¯åçš®ã®ãã©ã¹ããã¯æã§
ã§ããæ¯æäœãå«ãŸããã
ïŒ å€éå±€çŽ åã®èª¿è£œ
æŽã«ãæ¬çºæã¯ãè©Šæäžã®é
äœååã¯ãã®é
äœåçµåèœã«å¿çããè©Šè¬ãå å«ãæ€ç¥å¯èœãª
å¿çãäžããè©Šè¬å±€ã茻å°ç·ã®æ¡æ£ã»é®ãžã
å±€ãåã³æ¯æå±€ãæãåå±€ã察åããé¢ãæã
ãã¿ã€ãã§ãã€ãŠã液äœè©Šæå ã®é äœååã¯é
äœåçµåèœã®æ€ç¥çšå€éå±€åæçŽ åã®èª¿è£œæ¹æ³
ãæäŸãããã®ã§ããã®æ¹æ³ã¯ã(1)ã(a)é äœ
åãè©Šè¬å±€ã®è©Šè¬é¡åã³ãããã®çžäºåå¿ã®ç
æç©ã«å¯ŸããŠã¯äžééæ§ã§ïŒãã€ã(b)é äœåã
è©Šè¬å±€ã®è©Šè¬é¡åã³ãããã®çžäºåå¿ã®çæç©
ã«å¯ŸããŠã¯äžæŽ»æ§ã§ãã茻å°ç·æ¡æ£ã»é®ãžãå±€
ã®è¡šé¢ã«æ¯æå±€ã®è¡šé¢ãåºçãããããŠã(2)茻
å°ç·æ¡æ£ã»é®ãžãå±€ã®å¯ŸåããïŒå察åŽã®ïŒé¢
ã«è©Šè¬å±€ã®è¡šé¢ãåºçããå·¥çšããæ§æãã
ãã
äœåçµåèœã«å¿çããè©Šè¬ãå å«ãæ€ç¥å¯èœãª
å¿çãäžããè©Šè¬å±€ã茻å°ç·ã®æ¡æ£ã»é®ãžã
å±€ãåã³æ¯æå±€ãæãåå±€ã察åããé¢ãæã
ãã¿ã€ãã§ãã€ãŠã液äœè©Šæå ã®é äœååã¯é
äœåçµåèœã®æ€ç¥çšå€éå±€åæçŽ åã®èª¿è£œæ¹æ³
ãæäŸãããã®ã§ããã®æ¹æ³ã¯ã(1)ã(a)é äœ
åãè©Šè¬å±€ã®è©Šè¬é¡åã³ãããã®çžäºåå¿ã®ç
æç©ã«å¯ŸããŠã¯äžééæ§ã§ïŒãã€ã(b)é äœåã
è©Šè¬å±€ã®è©Šè¬é¡åã³ãããã®çžäºåå¿ã®çæç©
ã«å¯ŸããŠã¯äžæŽ»æ§ã§ãã茻å°ç·æ¡æ£ã»é®ãžãå±€
ã®è¡šé¢ã«æ¯æå±€ã®è¡šé¢ãåºçãããããŠã(2)茻
å°ç·æ¡æ£ã»é®ãžãå±€ã®å¯ŸåããïŒå察åŽã®ïŒé¢
ã«è©Šè¬å±€ã®è¡šé¢ãåºçããå·¥çšããæ§æãã
ãã
ïŒã€ã®æ
æ§ã«ãããŠã¯ã茻å°ç·æ¡æ£ã»é®ãžã
å±€ã®ïŒã€ã®é¢ã«æ¯æå±€ã®é¢ãåºçããããšã¯ã
ãã®æ¯æå±€ã®ãã®é¢ã«èŒ»å°ç·æ¡æ£ã»é®ãžãå±€ã
圢æããããšãå«ããä»ã®æ æ§ã§ã¯ã茻å°ç·æ¡
æ£ã»é®ãžãå±€ã®ïŒã€ã®é¢ã«æ¯æå±€ã®ïŒã€ã®é¢ã
åºçããããšã¯ã茻å°ç·æ¡æ£ã»é®ãžãå±€ã圢æ
ãããã®åŸãæ¯æå±€ã®é¢ã«ãããããŠåœ¢æãã
ã茻å°ç·æ¡æ£ã»é®ãžãå±€ãåºçããããšããæ
ãã
å±€ã®ïŒã€ã®é¢ã«æ¯æå±€ã®é¢ãåºçããããšã¯ã
ãã®æ¯æå±€ã®ãã®é¢ã«èŒ»å°ç·æ¡æ£ã»é®ãžãå±€ã
圢æããããšãå«ããä»ã®æ æ§ã§ã¯ã茻å°ç·æ¡
æ£ã»é®ãžãå±€ã®ïŒã€ã®é¢ã«æ¯æå±€ã®ïŒã€ã®é¢ã
åºçããããšã¯ã茻å°ç·æ¡æ£ã»é®ãžãå±€ã圢æ
ãããã®åŸãæ¯æå±€ã®é¢ã«ãããããŠåœ¢æãã
ã茻å°ç·æ¡æ£ã»é®ãžãå±€ãåºçããããšããæ
ãã
ïŒ æ€ç¥å¯èœãªå¿ç
æ¢ã«èšããããã«ãæè¿éçºãããåäžç³»ç¹
ç°ççµåè©Šéšç³»ã®å€ãã¯ã液äœè©Šæäžã®åæäž
ã®é äœåã®ååšåã¯éã«é¢ä¿ããè²å€åãååŠ
çºå ãåã¯è¢å ã®ãããªæ€ç¥å¯èœãªå¿çãäžã
ããåã¯äžããããã«å®¹æã«é©åãããããšã
ã§ããã
ç°ççµåè©Šéšç³»ã®å€ãã¯ã液äœè©Šæäžã®åæäž
ã®é äœåã®ååšåã¯éã«é¢ä¿ããè²å€åãååŠ
çºå ãåã¯è¢å ã®ãããªæ€ç¥å¯èœãªå¿çãäžã
ããåã¯äžããããã«å®¹æã«é©åãããããšã
ã§ããã
ãæ€ç¥å¯èœãªçš®ïŒspeciesïŒããšããçšèªåã³
ããã§çšããããåæ§ã®çšèªã¯ãååãååŠåº
ïŒããªãã¡ãååã®äžéšïŒåã¯ããèªèº«ãçŽæ¥ã
éæ¥ã«æ€ç¥å¯èœã§ããååç©ãè¡šããããŸãã
ããã§äœ¿ããããæ€ç¥å¯èœãªå¿çããªãçšèªå
ã³åæ§ã®çšèªã¯ããã®ãããªçš®ã®ååšã®æ€ç¥å¯
èœãªè¡šçŸïŒçŸããïŒãæå³ãããäŸãšããŠã¯ã
è¢å ãçå ãååŠçºå ãå¯èŠé åã«è²å€åãã
ãããããå åžåã«ãããå€åãåã¯å¯èŠã¹ã
ã¯ãã«ã«ãããåå°ã玫å€é åè¥ããã¯èµ€å€é
åã«ããããããªå¯èŠé åå€ã§ã®å åžååã¯å
å°ã«é¢é£ããå€åãªã©ã®é»ç£æ³¢ä¿¡å·ãæããã
ããåœæ¥è ã«ã¯æçœãªããã«ãããã§çšããã
ããããªãæ€ç¥å¯èœãªå¿çãã®èªã¯ãæãåºã
æå³ã§æå³ãããŠãããé»ç£æ³¢ä¿¡å·ã®ä»ã«ã
ãæ€ç¥å¯èœãªå¿çããªãèªã¯ãç³»ã®ãã©ã¡ãŒã¿
ã®èŠ³å¯å¯èœãªãããªãå€åããæå³ãããã®ã§
ããããã®äŸãšããŠã¯ãåå¿å€ã®å€åãããã¯
åºçŸãè©Šéšç³»ã«ãããæåã®èŠ³å¯å¯èœãªæåºã
ããã¯ãè©Šè¬ç³»ã§ããè©Šéšè©Šæäžã§ãããä»ã®
ãããªããã©ã¡ãŒã¿ã®å€åããæããããšãã§
ããããã®ãããªä»ã®æ€ç¥å¯èœãªå¿çã¯ãé»æ°
ååŠçå¿çåã³ç±é枬å®çãªå¿çãå«ããæŽ
ã«ããã®æ€ç¥å¯èœãªå¿çã¯ãçŽæ¥æèŠããšãã
ãŠèŠ³å¯ã§ãããŸãã¯ãåå å 床èšã玫å€ç·æç¥
æ©åšãè¢å èšãè¢å åå å 床èšåã³ä»ã®åæ§ã®
æç¥ç³»ã®ãããªè£å©ãšãªãæ€ç¥æ段ãçšããŠèŠ³
å¯ããããšãã§ãããã®ã§ãããæãŸããã¯ã
ãã®ãããªæ€ç¥å¯èœæ§ã¯ãããã§æå³ãããŠã
ãåæã®åºç€ã§ããåæ察象ç©ã®çžäºäœçšãã
çããæ¡æ£æ§çæç©ã®éã«åœ±é¿ãäžããããšãª
ãå šéã®æ€ç¥å¯èœãªçš®ã«éœåããä»äžããããš
ãã§ããã
ããã§çšããããåæ§ã®çšèªã¯ãååãååŠåº
ïŒããªãã¡ãååã®äžéšïŒåã¯ããèªèº«ãçŽæ¥ã
éæ¥ã«æ€ç¥å¯èœã§ããååç©ãè¡šããããŸãã
ããã§äœ¿ããããæ€ç¥å¯èœãªå¿çããªãçšèªå
ã³åæ§ã®çšèªã¯ããã®ãããªçš®ã®ååšã®æ€ç¥å¯
èœãªè¡šçŸïŒçŸããïŒãæå³ãããäŸãšããŠã¯ã
è¢å ãçå ãååŠçºå ãå¯èŠé åã«è²å€åãã
ãããããå åžåã«ãããå€åãåã¯å¯èŠã¹ã
ã¯ãã«ã«ãããåå°ã玫å€é åè¥ããã¯èµ€å€é
åã«ããããããªå¯èŠé åå€ã§ã®å åžååã¯å
å°ã«é¢é£ããå€åãªã©ã®é»ç£æ³¢ä¿¡å·ãæããã
ããåœæ¥è ã«ã¯æçœãªããã«ãããã§çšããã
ããããªãæ€ç¥å¯èœãªå¿çãã®èªã¯ãæãåºã
æå³ã§æå³ãããŠãããé»ç£æ³¢ä¿¡å·ã®ä»ã«ã
ãæ€ç¥å¯èœãªå¿çããªãèªã¯ãç³»ã®ãã©ã¡ãŒã¿
ã®èŠ³å¯å¯èœãªãããªãå€åããæå³ãããã®ã§
ããããã®äŸãšããŠã¯ãåå¿å€ã®å€åãããã¯
åºçŸãè©Šéšç³»ã«ãããæåã®èŠ³å¯å¯èœãªæåºã
ããã¯ãè©Šè¬ç³»ã§ããè©Šéšè©Šæäžã§ãããä»ã®
ãããªããã©ã¡ãŒã¿ã®å€åããæããããšãã§
ããããã®ãããªä»ã®æ€ç¥å¯èœãªå¿çã¯ãé»æ°
ååŠçå¿çåã³ç±é枬å®çãªå¿çãå«ããæŽ
ã«ããã®æ€ç¥å¯èœãªå¿çã¯ãçŽæ¥æèŠããšãã
ãŠèŠ³å¯ã§ãããŸãã¯ãåå å 床èšã玫å€ç·æç¥
æ©åšãè¢å èšãè¢å åå å 床èšåã³ä»ã®åæ§ã®
æç¥ç³»ã®ãããªè£å©ãšãªãæ€ç¥æ段ãçšããŠèŠ³
å¯ããããšãã§ãããã®ã§ãããæãŸããã¯ã
ãã®ãããªæ€ç¥å¯èœæ§ã¯ãããã§æå³ãããŠã
ãåæã®åºç€ã§ããåæ察象ç©ã®çžäºäœçšãã
çããæ¡æ£æ§çæç©ã®éã«åœ±é¿ãäžããããšãª
ãå šéã®æ€ç¥å¯èœãªçš®ã«éœåããä»äžããããš
ãã§ããã
åæçµæãæ€ç¥å¯èœãªå€åãšããŠåŸãããã®
ã¡ããã®å€åã¯ãéåžžãåå°ãéå åã¯è¢å 枬
å çšã®è£ 眮ãèšããããŠããé åã«è©ŠéšçŽ åã
éãããšã«ãã€ãŠæž¬å®ãããããã®ãããªè£ 眮
ã§ã¯ãå ã®ãããªãšãã«ã®ãŒæãåœãŠãããã«
ãªã€ãŠããããã®å ã¯ã€ãã§çŽ åèé¢ããæ€ç¥
åšã«åãåå°ããããåæçµæã¯ããã®ãããª
çµæãçã¿ã ãããé åå ã«å®å šã«å ¥ãçŽ åã®
é åã§æ€ç¥ããããåå°åå å 床æ³ã®äœ¿çšã¯ã
äŸãã°ãçŽ åã®å±€äžãããã¯å±€äžã«æ®çããŠã
ãè¡çåã¯å°¿æ²æŸ±ç©ã®ãããªæ®æ»ãããããå
ã¯ç°ç¶ãªå°¿ã®è²ãããããå åŠç劚害ãå¹æç
ã«åé¿ããããšãã§ããã®ã§ãããã€ãã®ç¶æ³
ã«ãããŠã¯æçã§ãããåŸæ¥ã®è¢å åå å 床æ³
ã®ææ³ããŸãçšããããšãã§ãããäžè¬ã«ãçŽ
200ã900nmã®ç¯å²ã«ãããé»ç£æ°èŒ»å°ç·ã¯ã
ãã®ãããªæž¬å®ã«æçšã§ããããšãèŠåºãã
ããããããè©Šè¬å±€ãééã§ããçŽ åå ã§çæ
ããçæç©ãå®éã§ããå šãŠã®èŒ»å°ç·ã¯çšãã
ããšãã§ãããå€çš®ã®æ€éæ³ããåæã«å¯Ÿãã
å¯Ÿç §ãäžããããã«çšããããšãã§ãããïŒäŸ
ãšããŠãåæäžã«ããé äœåã®æšæºæº¶æ¶²ã®è©Šæ
ããè©Šæ液ãåæã®ç€ºå·®æž¬å®ããããããã«çœ®
ãããéšçœ²ã«è¿æ¥ããŠãé©çšããããšãã§ã
ãã
ã¡ããã®å€åã¯ãéåžžãåå°ãéå åã¯è¢å 枬
å çšã®è£ 眮ãèšããããŠããé åã«è©ŠéšçŽ åã
éãããšã«ãã€ãŠæž¬å®ãããããã®ãããªè£ 眮
ã§ã¯ãå ã®ãããªãšãã«ã®ãŒæãåœãŠãããã«
ãªã€ãŠããããã®å ã¯ã€ãã§çŽ åèé¢ããæ€ç¥
åšã«åãåå°ããããåæçµæã¯ããã®ãããª
çµæãçã¿ã ãããé åå ã«å®å šã«å ¥ãçŽ åã®
é åã§æ€ç¥ããããåå°åå å 床æ³ã®äœ¿çšã¯ã
äŸãã°ãçŽ åã®å±€äžãããã¯å±€äžã«æ®çããŠã
ãè¡çåã¯å°¿æ²æŸ±ç©ã®ãããªæ®æ»ãããããå
ã¯ç°ç¶ãªå°¿ã®è²ãããããå åŠç劚害ãå¹æç
ã«åé¿ããããšãã§ããã®ã§ãããã€ãã®ç¶æ³
ã«ãããŠã¯æçã§ãããåŸæ¥ã®è¢å åå å 床æ³
ã®ææ³ããŸãçšããããšãã§ãããäžè¬ã«ãçŽ
200ã900nmã®ç¯å²ã«ãããé»ç£æ°èŒ»å°ç·ã¯ã
ãã®ãããªæž¬å®ã«æçšã§ããããšãèŠåºãã
ããããããè©Šè¬å±€ãééã§ããçŽ åå ã§çæ
ããçæç©ãå®éã§ããå šãŠã®èŒ»å°ç·ã¯çšãã
ããšãã§ãããå€çš®ã®æ€éæ³ããåæã«å¯Ÿãã
å¯Ÿç §ãäžããããã«çšããããšãã§ãããïŒäŸ
ãšããŠãåæäžã«ããé äœåã®æšæºæº¶æ¶²ã®è©Šæ
ããè©Šæ液ãåæã®ç€ºå·®æž¬å®ããããããã«çœ®
ãããéšçœ²ã«è¿æ¥ããŠãé©çšããããšãã§ã
ãã
以äžã®äŸã¯ãæ¬çºæãéçºããã«åœã€ãŠè¡ãªã
ããå®éšãèšèŒããããããã®å®æœäŸã¯å¥œãŸãã
æ æ§ã瀺ãããæ¬çºæã®ç¯å²ãå¶éãããã®ãšè§£
éãããã¹ãã§ã¯ãªãã
ããå®éšãèšèŒããããããã®å®æœäŸã¯å¥œãŸãã
æ æ§ã瀺ãããæ¬çºæã®ç¯å²ãå¶éãããã®ãšè§£
éãããã¹ãã§ã¯ãªãã
äŸ ïŒ
ã¢ãã«ç³»ã®æ¯èŒ
æ¬çºæã®é®ãžãå±€ã®å¹æãè©äŸ¡ããããã«ãè©Š
è¬å±€ãšæ¯æå±€ã®éã«ãäžè¿°ãã茻å°ç·ã®æ¡æ£ã»é®
ãžãå±€ãåãããã®åã³åããªããã®äž¡æ¹ã®çŽ å
ã調補ããããã®ã¢ãã«ç³»ã«ãããè©Šè¬å±€ã¯ãã
ãèªèº«ãæ€ç¥å¯èœãªå¿çãããªãã¡ãè¢å ãçºã
ãè©Šè¬æº¶æ¶²ã«ãã€ãŠèª¿è£œããããããããããã®
äŸã¯ãä»ã®ç¹å®é äœåã«éå®ãããªãæ¯èŒäŸãå
ããã®ã§ããã
è¬å±€ãšæ¯æå±€ã®éã«ãäžè¿°ãã茻å°ç·ã®æ¡æ£ã»é®
ãžãå±€ãåãããã®åã³åããªããã®äž¡æ¹ã®çŽ å
ã調補ããããã®ã¢ãã«ç³»ã«ãããè©Šè¬å±€ã¯ãã
ãèªèº«ãæ€ç¥å¯èœãªå¿çãããªãã¡ãè¢å ãçºã
ãè©Šè¬æº¶æ¶²ã«ãã€ãŠèª¿è£œããããããããããã®
äŸã¯ãä»ã®ç¹å®é äœåã«éå®ãããªãæ¯èŒäŸãå
ããã®ã§ããã
çŽ åã®èª¿è£œ
å
šãŠã0.5cmÃ1.0cmã®å¯žæ³ãæãããã®ããã€
ãã¯ããªãšã¹ãã«ã§ä»ã¯ã²ã«çµåãã€ã«ã ã§ãã
æ¯æå±€ãçšããŠãäž¡æ¹ã®ã¿ã€ãã®çŽ åã調補ã
ããè©Šéšå ·ïŒ¡åã³ïŒ¢ã¯ã茻å°ç·æ¡æ£ã»é®ãžãå±€ãš
è©Šè¬å±€ã®éã«æ¯æå±€ãåãïŒè©Šéšå ·ïŒ¢ã¯å€é åè©Š
è¬å±€ãåãããè©Šéšå ·ïŒ£ã«ãããŠã¯ãè©Šè¬å±€ãæ¯
æå±€åã³èŒ»å°ç·æ¡æ£ã»é®ãžãå±€ã®éã«ãããè©Šéš
å ·ïŒ€ã¯ãè©Šè¬å±€åã³æ¯æå±€ã®éã«èŒ»å°ç·æ¡æ£ã»é®
ãžãå±€ãæãããããæ¬çºæã®äŸã§ããã
ãã¯ããªãšã¹ãã«ã§ä»ã¯ã²ã«çµåãã€ã«ã ã§ãã
æ¯æå±€ãçšããŠãäž¡æ¹ã®ã¿ã€ãã®çŽ åã調補ã
ããè©Šéšå ·ïŒ¡åã³ïŒ¢ã¯ã茻å°ç·æ¡æ£ã»é®ãžãå±€ãš
è©Šè¬å±€ã®éã«æ¯æå±€ãåãïŒè©Šéšå ·ïŒ¢ã¯å€é åè©Š
è¬å±€ãåãããè©Šéšå ·ïŒ£ã«ãããŠã¯ãè©Šè¬å±€ãæ¯
æå±€åã³èŒ»å°ç·æ¡æ£ã»é®ãžãå±€ã®éã«ãããè©Šéš
å ·ïŒ€ã¯ãè©Šè¬å±€åã³æ¯æå±€ã®éã«èŒ»å°ç·æ¡æ£ã»é®
ãžãå±€ãæãããããæ¬çºæã®äŸã§ããã
è©Šéšå
·ïŒ¡ã¯ãæ¯æå±€ã®ïŒã€ã®é¢ã«ã¢ã¬ããŒã¹çµ
æç©ã®è©Šè¬å±€ãã€ã«ã ã圢æãä»ã®é¢ã«TiO2é¡
æçµæç©ãã€ããŠèŒ»å°ç·æ¡æ£ã»é®ãžãå±€ã圢æã
ãŠèª¿è£œãããã¢ã¬ããŒã¹çµæç©ã¯ä»¥äžé åãæã
ãã
æç©ã®è©Šè¬å±€ãã€ã«ã ã圢æãä»ã®é¢ã«TiO2é¡
æçµæç©ãã€ããŠèŒ»å°ç·æ¡æ£ã»é®ãžãå±€ã圢æã
ãŠèª¿è£œãããã¢ã¬ããŒã¹çµæç©ã¯ä»¥äžé åãæã
ãã
æ å é
ã¢ã¬ããŒã¹ 1.5g
ããªãã³ïŒžâ100ïŒ10ïŒ
ïœïŒïœïŒ 500.0ÎŒ
1MïŒmolarïŒãã€ã·ã³ïŒPH8.3ïŒ 10.0
H2O 40.0ml
ããªãã³ïŒTritonïŒã¯ããã€ã©ãã«ãã€ã¢ã»
ãã³ã·ã«ãŽã¢ãã¢ã®ããŒã ã»ã¢ã³ãã»ããŒã¹ç€Ÿ
ïŒRohmïŒHassãPhiladelphiaãPAïŒã«ãã€ãŠè²©
売ãããŠããäžé£ã®äººå·¥ã®ææ©çé¢æŽ»æ§å€ã«å¯Ÿã
ãåæšã§ããããã€ã·ã³ã¯ïŒ®ïŒNâ²âãã¹âïŒïŒ
âããããã·ãšãã«ïŒâã°ãªã·ã³ã§ãããTiO2
é¡æçµæç©ã¯ä»¥äžã®ããã«åœ¢æãããïŒ æå é TiO2 2.5ïœ PVP 2.5ïœ ã¯ãããã«ã 44.5ïœ ãžãªã¯ãã«ãã¿ã¬ãŒã 0.5ïœ è©Šéšå ·ïŒ¢ã®èª¿è£œã¯ãããªããã«ãããªãã³
ïŒPVPïŒçµæç©ãæ¯æå±€ãšæ¥è§Šããé¢ãšã¯å察åŽ
ã®ã¢ã¬ããŒã¹ãã€ã«ã ã®é¢ã«ãã€ã«ã ãšããŠã€ã
ãããããšãå ããã°ãäžè¿°ããããã«ãè©Šéšå ·
ã®ãããšåäžã§ããããã®PVPçµæç©ã¯ãã
ã€ã«ã ã圢æããããã¯ãã¢ã¬ããŒã¹ãã€ã«ã ãš
çµåããã€ãŠå€é åè©Šè¬å±€ã圢æãããããã¯ä»¥
äžã®ããã«ããŠã€ããããïŒ æå é PVP 5.0ïœ ã¯ãããã«ã 45.0ïœ è©Šéšå ·ïŒ£ã¯ãã¢ã¬ããŒã¹çµæç©ã®è©Šè¬å±€ãæ¯æ
å±€ã®ïŒæ¹ã®é¢ã«åœ¢æããŠèª¿è£œãããã¢ã¬ããŒã¹çµ
æç©ã¯è©Šéšå ·ïŒ¡åã³ïŒ¢ã§äœ¿ã€ããããšåäžã§ãã€
ããè©Šéšå ·ïŒ¡åã³ïŒ¢ã§çšãããšåãTiO2çµæç©
ãçšããæ¯æå±€ã«æ¥è§Šããé¢ãšã¯å察åŽã®ã¢ã¬ã
ãŒã¹ãã€ã«ã ã®é¢äžã«ãã€ã«ã ã圢æããã
ãã³ã·ã«ãŽã¢ãã¢ã®ããŒã ã»ã¢ã³ãã»ããŒã¹ç€Ÿ
ïŒRohmïŒHassãPhiladelphiaãPAïŒã«ãã€ãŠè²©
売ãããŠããäžé£ã®äººå·¥ã®ææ©çé¢æŽ»æ§å€ã«å¯Ÿã
ãåæšã§ããããã€ã·ã³ã¯ïŒ®ïŒNâ²âãã¹âïŒïŒ
âããããã·ãšãã«ïŒâã°ãªã·ã³ã§ãããTiO2
é¡æçµæç©ã¯ä»¥äžã®ããã«åœ¢æãããïŒ æå é TiO2 2.5ïœ PVP 2.5ïœ ã¯ãããã«ã 44.5ïœ ãžãªã¯ãã«ãã¿ã¬ãŒã 0.5ïœ è©Šéšå ·ïŒ¢ã®èª¿è£œã¯ãããªããã«ãããªãã³
ïŒPVPïŒçµæç©ãæ¯æå±€ãšæ¥è§Šããé¢ãšã¯å察åŽ
ã®ã¢ã¬ããŒã¹ãã€ã«ã ã®é¢ã«ãã€ã«ã ãšããŠã€ã
ãããããšãå ããã°ãäžè¿°ããããã«ãè©Šéšå ·
ã®ãããšåäžã§ããããã®PVPçµæç©ã¯ãã
ã€ã«ã ã圢æããããã¯ãã¢ã¬ããŒã¹ãã€ã«ã ãš
çµåããã€ãŠå€é åè©Šè¬å±€ã圢æãããããã¯ä»¥
äžã®ããã«ããŠã€ããããïŒ æå é PVP 5.0ïœ ã¯ãããã«ã 45.0ïœ è©Šéšå ·ïŒ£ã¯ãã¢ã¬ããŒã¹çµæç©ã®è©Šè¬å±€ãæ¯æ
å±€ã®ïŒæ¹ã®é¢ã«åœ¢æããŠèª¿è£œãããã¢ã¬ããŒã¹çµ
æç©ã¯è©Šéšå ·ïŒ¡åã³ïŒ¢ã§äœ¿ã€ããããšåäžã§ãã€
ããè©Šéšå ·ïŒ¡åã³ïŒ¢ã§çšãããšåãTiO2çµæç©
ãçšããæ¯æå±€ã«æ¥è§Šããé¢ãšã¯å察åŽã®ã¢ã¬ã
ãŒã¹ãã€ã«ã ã®é¢äžã«ãã€ã«ã ã圢æããã
è©Šéšå
·ïŒ€ã¯ãä»ã®è©Šéšå
·ã§çšãããšåäžã®
TiO2é¡æçµæç©ãæ¯æå±€ã®äžã«å¡åžããŠèŒ»å°ç·
æ¡æ£ã»é®ãžãå±€ã圢æããã€ãã§ãä»ã®è©Šéšå ·ã§
çšãããšåäžã®ã¢ã¬ããŒã¹çµæç©ããæ¯æå±€ãšæ¥
觊ããé¢ãšã¯å察åŽã®ã¢ã¬ããŒã¹å±€ã®äžã«å¡ã€ãŠ
調補ããã
TiO2é¡æçµæç©ãæ¯æå±€ã®äžã«å¡åžããŠèŒ»å°ç·
æ¡æ£ã»é®ãžãå±€ã圢æããã€ãã§ãä»ã®è©Šéšå ·ã§
çšãããšåäžã®ã¢ã¬ããŒã¹çµæç©ããæ¯æå±€ãšæ¥
觊ããé¢ãšã¯å察åŽã®ã¢ã¬ããŒã¹å±€ã®äžã«å¡ã€ãŠ
調補ããã
å ããŠã0.5Ã1.0cmã®ãã¯ãããã³31ETçŽ
ïŒWhatmanãInc.ãClifton.N.J.07014ïŒãšåå°æ§
ãã€ã©ãŒããªãšã¹ãã«ïŒ3M CompanyãSt.
PaulãMN55144ïŒãäžç·ã«ç©å±€ããŠè©Šéšå ·ïŒ¥ã
圢æããã圢æãããè©Šéšå ·ã«ã¯è©Šè¬ã¯å šãååš
ããªãã
ïŒWhatmanãInc.ãClifton.N.J.07014ïŒãšåå°æ§
ãã€ã©ãŒããªãšã¹ãã«ïŒ3M CompanyãSt.
PaulãMN55144ïŒãäžç·ã«ç©å±€ããŠè©Šéšå ·ïŒ¥ã
圢æããã圢æãããè©Šéšå ·ã«ã¯è©Šè¬ã¯å šãååš
ããªãã
åææ¹æ³
äžè¿°ããããã«èª¿è£œããè©Šéšå
·ããããããã
è¢å èšå ã§è©Šéšå ·ãæ°Žå¹³ã«äœçœ®ã¥ããã«é©ããæ©
械ä¿ææ²»å ·ã®äžã«æ¿å ¥ãããïŒâããããã·âã¯
ããªã³âïŒâã«ã«ããªããµããªãïŒHCCïŒ30ÎŒ
ã®ïŒæ»Žã®æ°Žæº¶æ¶²ãè¢å èšã®æ²»å ·ã«çœ®ãçŽåã«åè©Š
éšå ·ã®äžã«çœ®ãããçšããåHCC溶液ã¯ã0.2ã
2.0ÎŒMæ¿åºŠã®ç¯å²ã«ãã€ãã
è¢å èšå ã§è©Šéšå ·ãæ°Žå¹³ã«äœçœ®ã¥ããã«é©ããæ©
械ä¿ææ²»å ·ã®äžã«æ¿å ¥ãããïŒâããããã·âã¯
ããªã³âïŒâã«ã«ããªããµããªãïŒHCCïŒ30ÎŒ
ã®ïŒæ»Žã®æ°Žæº¶æ¶²ãè¢å èšã®æ²»å ·ã«çœ®ãçŽåã«åè©Š
éšå ·ã®äžã«çœ®ãããçšããåHCC溶液ã¯ã0.2ã
2.0ÎŒMæ¿åºŠã®ç¯å²ã«ãã€ãã
è¡šé¢ã®é¢ãã90床ã®ãšããã§çŽ åã®è¡šé¢ããã€
æ³¢é·405nmã®å±èµ·å æºãçããããã«è¢å èšã調
æŽããæ³¢é·450nmã§æŸå°ãããå 枬å®ãããçŽ å
è¡šé¢ã®æ°Žå¹³é¢ãã90ãã®è§åºŠã«ãããŠãè¢å ã®å
é¢æž¬å ãè¡ãªã€ããã€ãã§ãåè©Šæã®è¢å ã枬å®
ããã
æ³¢é·405nmã®å±èµ·å æºãçããããã«è¢å èšã調
æŽããæ³¢é·450nmã§æŸå°ãããå 枬å®ãããçŽ å
è¡šé¢ã®æ°Žå¹³é¢ãã90ãã®è§åºŠã«ãããŠãè¢å ã®å
é¢æž¬å ãè¡ãªã€ããã€ãã§ãåè©Šæã®è¢å ã枬å®
ããã
çµ æ
åHCCè©Šæã«é¢ããç¯å²ïŒ²åã³ããã¯ã°ã©ã³
ãã«å¯Ÿããä¿¡å·ã®æ¯ïŒïŒ³ïŒïŒ¢ïŒãããããããåŒ
ïŒåã³ïŒïŒ (1) ïŒFmâFb (2) ïŒïŒ¢ïŒFmïŒFb ïŒããã§ãFbåã³Fmã¯ãããããããã©ã³ã¯
åã³HCC溶液ã«é¢ããè¢å ä¿¡å·ã§ãããïŒ ãçšããŠæž¬å®ããã
ãã«å¯Ÿããä¿¡å·ã®æ¯ïŒïŒ³ïŒïŒ¢ïŒãããããããåŒ
ïŒåã³ïŒïŒ (1) ïŒFmâFb (2) ïŒïŒ¢ïŒFmïŒFb ïŒããã§ãFbåã³Fmã¯ãããããããã©ã³ã¯
åã³HCC溶液ã«é¢ããè¢å ä¿¡å·ã§ãããïŒ ãçšããŠæž¬å®ããã
è©Šéšå
·ïŒ¡åã³ïŒ¢ãçšããŠåŸãããããŒã¿ã¯ç Žç·
ã§æãããæ²ç·ã«ãã€ãŠå³ïŒåã³ïŒã®äž¡æ¹ã«ç€ºã
ããè©Šéšå ·ïŒ£åã³ïŒ€ãçšããŠåŸãããããŒã¿ã¯ã
å®ç·ã§æãããæ²ç·ã«ãã€ãŠå³ïŒåã³ïŒã®äž¡æ¹ã«
瀺ãããè©Šéšå ·ïŒ¥ãçšããŠåŸãããããŒã¿ã¯ãä»®
æ³ç·ã§æãããæ²ç·ã«ããå³ïŒåã³ïŒã®äž¡æ¹ã§ç€º
ããã
ã§æãããæ²ç·ã«ãã€ãŠå³ïŒåã³ïŒã®äž¡æ¹ã«ç€ºã
ããè©Šéšå ·ïŒ£åã³ïŒ€ãçšããŠåŸãããããŒã¿ã¯ã
å®ç·ã§æãããæ²ç·ã«ãã€ãŠå³ïŒåã³ïŒã®äž¡æ¹ã«
瀺ãããè©Šéšå ·ïŒ¥ãçšããŠåŸãããããŒã¿ã¯ãä»®
æ³ç·ã§æãããæ²ç·ã«ããå³ïŒåã³ïŒã®äž¡æ¹ã§ç€º
ããã
å³ïŒã¯ãåç³»ã«å¯ŸããHCCæ¿åºŠã®é¢æ°ãšããŠ
ç¯å²ã®ããããã瀺ãããã¯ãããã³31ETïŒè©Šéš
å ·ïŒ¥ïŒãšã¯å¥ã«ãïŒã€ã®å¥åã®å¿çããTiO2ç³»
ã«ã€ããŠèŠ³æž¬ããããæ¯æäœã®äžã«TiO2ãåã
ããã®ïŒè©Šéšå ·ïŒ¡åã³ïŒ¢ïŒã¯ãã²ã«çµåïŒã²ã«ã
ã³ãïŒåã¯ããªãšã¹ãã«ã«ããããããæ¯æäœã®
äžåŽã«TiO2ãåãããã®ïŒè©Šéšå ·ïŒ£åã³ïŒ€ïŒã
ãããã²ã«çµååã¯ããªãšã¹ãã«ã«ãããããã
HCCãšã®æ¥è§Šã§äœãç¯å²ã瀺ããŠããããã¯ã
ããã³31ETïŒè©Šéšå ·ïŒ¥ïŒã¯TiO2ç³»ãããããã
ãç¯å²ã瀺ããŠããã
ç¯å²ã®ããããã瀺ãããã¯ãããã³31ETïŒè©Šéš
å ·ïŒ¥ïŒãšã¯å¥ã«ãïŒã€ã®å¥åã®å¿çããTiO2ç³»
ã«ã€ããŠèŠ³æž¬ããããæ¯æäœã®äžã«TiO2ãåã
ããã®ïŒè©Šéšå ·ïŒ¡åã³ïŒ¢ïŒã¯ãã²ã«çµåïŒã²ã«ã
ã³ãïŒåã¯ããªãšã¹ãã«ã«ããããããæ¯æäœã®
äžåŽã«TiO2ãåãããã®ïŒè©Šéšå ·ïŒ£åã³ïŒ€ïŒã
ãããã²ã«çµååã¯ããªãšã¹ãã«ã«ãããããã
HCCãšã®æ¥è§Šã§äœãç¯å²ã瀺ããŠããããã¯ã
ããã³31ETïŒè©Šéšå ·ïŒ¥ïŒã¯TiO2ç³»ãããããã
ãç¯å²ã瀺ããŠããã
ä¿¡å·ïŒããã¯ã°ã©ã³ãïŒïŒ³ïŒïŒ¢ïŒæ¯ããå³ïŒã§
瀺ãããŠããããã«ãHCCæ¿åºŠã«å¯ŸããŠããã
ããããšããäžæ¹ã®è©Šéšå ·ïŒ¡åã³ïŒ¢ãä»æ¹ã®è©Šéš
å ·ïŒ£åã³ïŒ€ãšã®éã§åãçŸè±¡ãã¿ããããHCC
溶液ãå容ããå±€ãé®æããæ¯æäœé éšã«TiO2
ãåãããã®ã¯ã倧ããªïŒ³ïŒïŒ¢æ¯ã瀺ããæ¯æäœ
ã®äžã«TiO2ãåãããã®ã¯ãå°ããæ¯ã瀺ãã
ãããŠãã¯ãããã³31ETïŒè©Šéšå ·ïŒ¥ïŒã®ãã®ã¯äž
éã§ããã
瀺ãããŠããããã«ãHCCæ¿åºŠã«å¯ŸããŠããã
ããããšããäžæ¹ã®è©Šéšå ·ïŒ¡åã³ïŒ¢ãä»æ¹ã®è©Šéš
å ·ïŒ£åã³ïŒ€ãšã®éã§åãçŸè±¡ãã¿ããããHCC
溶液ãå容ããå±€ãé®æããæ¯æäœé éšã«TiO2
ãåãããã®ã¯ã倧ããªïŒ³ïŒïŒ¢æ¯ã瀺ããæ¯æäœ
ã®äžã«TiO2ãåãããã®ã¯ãå°ããæ¯ã瀺ãã
ãããŠãã¯ãããã³31ETïŒè©Šéšå ·ïŒ¥ïŒã®ãã®ã¯äž
éã§ããã
äŸ ïŒ
ããªãã€ãªã³çšåºè³ªæšèåè¢å
å
ç«è©ŠéšçŽ å
ããªãã€ãªã³ãïŒïŒïŒâãžã¡ãã«ããµã³ãã³ã
ã¡ã«ã¯ã€ã³ããã¯ã¹ã第ïŒçã1196é ïŒ1976ïŒå
ç §ãã¯ãåæ¯ã®æ²»çã«æçšãªè¬å€ã§ããã倧åã®
æ£è ã«ãããŠãæ²»çç¯å²ã®è¡æž äžæ¿åºŠã¯10ã
20ÎŒgïŒmlã«ããããæ¯æ§ãæ®ãã©ããŸã€ãŠ
35ÎŒgïŒmlãè¶ ããè¡æ¶²äžæ¿åºŠã§ãããããã
ã¡ã«ã¯ã€ã³ããã¯ã¹ã第ïŒçã1196é ïŒ1976ïŒå
ç §ãã¯ãåæ¯ã®æ²»çã«æçšãªè¬å€ã§ããã倧åã®
æ£è ã«ãããŠãæ²»çç¯å²ã®è¡æž äžæ¿åºŠã¯10ã
20ÎŒgïŒmlã«ããããæ¯æ§ãæ®ãã©ããŸã€ãŠ
35ÎŒgïŒmlãè¶ ããè¡æ¶²äžæ¿åºŠã§ãããããã
è€åäœã®èª¿è£œ
βâã¬ã©ã¯ãã·ã«âãŠã³ããªããšãã³âæšèå
ããªãã€ãªã³ïŒÎ²âGUTïŒè€åäœããå³ïŒã«ç€º
ããåå¿åŒã«ãã調補ããããã®åæçµè·¯ããïŒ
âãïŒâïŒïŒâβâã¬ã©ã¯ãã·ã«ã¯ããªã³âïŒâ
ã«ã«ãããµããïŒãããã«ãããªãã€ãªã³(4)ãïœ
ïŒïŒã調補ããããã®ä»¥äžã®æ¹æ³ã§äŸç€ºããã
ããªãã€ãªã³ïŒÎ²âGUTïŒè€åäœããå³ïŒã«ç€º
ããåå¿åŒã«ãã調補ããããã®åæçµè·¯ããïŒ
âãïŒâïŒïŒâβâã¬ã©ã¯ãã·ã«ã¯ããªã³âïŒâ
ã«ã«ãããµããïŒãããã«ãããªãã€ãªã³(4)ãïœ
ïŒïŒã調補ããããã®ä»¥äžã®æ¹æ³ã§äŸç€ºããã
ïŒâïŒïŒâã¢ãããããã«ïŒããªãã€ãªã³(2)
ïŒâïŒïŒâã«ã«ããã·ãããã«ïŒããªãã€ãªã³
(1)ãCookçãRos.Commun.Chem.Path.
Pharmacol.13(3)ïŒ497â505ïŒ1976ïŒã2.66gïŒ0.01ã¢
ã«ïŒãã¯ãããã«ã 20mlãåã³æ¿ç¡«é žïŒmlã®æ··å
ç©ãã¢ã«ãŽã³é°å²æ°äž50âã§æ¹æãããããã«ã
1.3gã®åºäœãããªãŠã ã¢ãžããå°ããã€90åéã
ããŠæ·»å ãããOrganic Reactions 47ïŒ28
ïŒ1967ïŒåç §ããåå¿æ··åç©ãå·åŽããæžå§äžã§æº¶
åªãé€å»ãããæ®æ»ãå åéã®çé žãããªãŠã 溶
液ãšãã€ããã«ããŠPHã7.5ã«ããã10gã®ã»ã©ã€
ãïŒFisher Scientific Co.ãPittsburghã
PensylvaniaïŒãæ·»å ãæ°Žãèžçºãããããã»ã©
ã€ãïŒCeliteïŒã¯ããçš®ã®ã±ã€è»åã®è£œåã®åæš
ã§ãããå«æµžã»ã©ã€ããããšã¿ããŒã«âïŒã¢ãŒã©
ã«æ°Žæ§ã®éçé žããªãšãã«ã¢ã³ã¢ããŠã ïŒïŒïŒ
ïŒïŒ¶ïŒïŒ¶ïŒäžã§èª¿è£œããã200gã®ã·ãªã«ã²ã«ïŒE.
Merck Co.ãDarmstadtãWest GermanyïŒã®
ã«ã©ã é éšã«çœ®ãããã«ã©ã ããã®æº¶åªã§æº¶åºã
15mlãã€ã®åç»ãéãããç»åNo.171ã225ãäžç·
ã«ããŠèžçºãã500mgã®çœè²ç²æ«ãåŸããããã
ã¢ã³ã¢ããŠã åã®CMâã»ãã¢ããã¯ã¹
ïŒPharmacia Fine ChemicalsãPiscatawayã
New JerseyãUSAïŒã®ã«ã©ã ãçšããŠãåã³ã
ã¯ãããã°ã©ãã€ãŒåŠçãã0.5ã¢ãŒã©ã«ã®éç
é žã¢ã³ã¢ããŠã ã§æº¶åºãããåºå®¹ç©ã¯ïŒcmÃ50cm
ã§ïŒ10mlãã€ã®ç»åãéãããç»åNo.65ã110ã
åããŠèžçºãã250mgã®çœè²åºäœãåŸããããã
çšå¡©é žã«æº¶è§£ãã€ãã§åã³èžçºããããã
(1)ãCookçãRos.Commun.Chem.Path.
Pharmacol.13(3)ïŒ497â505ïŒ1976ïŒã2.66gïŒ0.01ã¢
ã«ïŒãã¯ãããã«ã 20mlãåã³æ¿ç¡«é žïŒmlã®æ··å
ç©ãã¢ã«ãŽã³é°å²æ°äž50âã§æ¹æãããããã«ã
1.3gã®åºäœãããªãŠã ã¢ãžããå°ããã€90åéã
ããŠæ·»å ãããOrganic Reactions 47ïŒ28
ïŒ1967ïŒåç §ããåå¿æ··åç©ãå·åŽããæžå§äžã§æº¶
åªãé€å»ãããæ®æ»ãå åéã®çé žãããªãŠã 溶
液ãšãã€ããã«ããŠPHã7.5ã«ããã10gã®ã»ã©ã€
ãïŒFisher Scientific Co.ãPittsburghã
PensylvaniaïŒãæ·»å ãæ°Žãèžçºãããããã»ã©
ã€ãïŒCeliteïŒã¯ããçš®ã®ã±ã€è»åã®è£œåã®åæš
ã§ãããå«æµžã»ã©ã€ããããšã¿ããŒã«âïŒã¢ãŒã©
ã«æ°Žæ§ã®éçé žããªãšãã«ã¢ã³ã¢ããŠã ïŒïŒïŒ
ïŒïŒ¶ïŒïŒ¶ïŒäžã§èª¿è£œããã200gã®ã·ãªã«ã²ã«ïŒE.
Merck Co.ãDarmstadtãWest GermanyïŒã®
ã«ã©ã é éšã«çœ®ãããã«ã©ã ããã®æº¶åªã§æº¶åºã
15mlãã€ã®åç»ãéãããç»åNo.171ã225ãäžç·
ã«ããŠèžçºãã500mgã®çœè²ç²æ«ãåŸããããã
ã¢ã³ã¢ããŠã åã®CMâã»ãã¢ããã¯ã¹
ïŒPharmacia Fine ChemicalsãPiscatawayã
New JerseyãUSAïŒã®ã«ã©ã ãçšããŠãåã³ã
ã¯ãããã°ã©ãã€ãŒåŠçãã0.5ã¢ãŒã©ã«ã®éç
é žã¢ã³ã¢ããŠã ã§æº¶åºãããåºå®¹ç©ã¯ïŒcmÃ50cm
ã§ïŒ10mlãã€ã®ç»åãéãããç»åNo.65ã110ã
åããŠèžçºãã250mgã®çœè²åºäœãåŸããããã
çšå¡©é žã«æº¶è§£ãã€ãã§åã³èžçºããããã
æ®æ»ãã¡ã¿ããŒã«ããåçµæ¶ãã300â以äžã§
ã¯æº¶èããªãæ·¡è€è²ã®éç¶æ¶ãšããŠ90mgã®å¡©é žå¡©
ïŒåçïŒïŒ ïŒãåŸãã
ã¯æº¶èããªãæ·¡è€è²ã®éç¶æ¶ãšããŠ90mgã®å¡©é žå¡©
ïŒåçïŒïŒ ïŒãåŸãã
åæïŒC10H16N5ClO2ãšããŠã®èšç®å€ïŒïŒ£ã
43.88ïŒïŒšã5.89ïŒïŒ®ã25.59 å®æž¬å€ïŒïŒ£ã43.77ïŒïŒšã5.88ïŒïŒ®ã
25.46 èµ€å€åžåã¹ãã¯ãã«ïŒKClïŒïŒ1695cm-1
ãš1655cm-1 ïŒã¢ããã«ã«ããã«ïŒã
43.88ïŒïŒšã5.89ïŒïŒ®ã25.59 å®æž¬å€ïŒïŒ£ã43.77ïŒïŒšã5.88ïŒïŒ®ã
25.46 èµ€å€åžåã¹ãã¯ãã«ïŒKClïŒïŒ1695cm-1
ãš1655cm-1 ïŒã¢ããã«ã«ããã«ïŒã
ïŒâãïŒâïŒïŒâβâã¬ã©ã¯ãã·ã«ã¯ããªã³â
ïŒâã«ã«ãããµããïŒãããã«ãâããªãã€ãª
ã³(4) 24gã®æ°Žé žåã«ãªãŠã ã80mlã®æ°Žã240mlã®ã¡
ã¿ããŒã«ãš20gïŒ0.035ããªã¢ã«ïŒã®ãšãã«ã»ïŒâ
βâã¬ã©ã¯ãã·ã«ã¯ããªã³âïŒâã«ã«ããã·ã¬ãŒ
ãïŒBurd et alãClin.Chem.23ïŒ1402ïŒ1977ïŒïŒ
ãå«ãåå¿æ··åç©ã調補ãããåå¿æ··åç©ã15æ
é50âã§æ¹æãããå·åŽæãæžå§äžã§ã¡ã¿ããŒã«
ãé€å»ããããã®æ¿çž®æ°Žæº¶æ¶²ããæ¿å¡©é žã§PH2.0
ã«é žæ§ã«ãããçœè²æ²æŸ±ãéããå·æ°Žã§æŽæµãã
ç±æ°Žããåçµæ¶åãããçµæ¶ãéããã¢ã»ãã³ã§
æŽæµãã80âã§ïŒæé也ç¥ãããçœè²çµæ¶ãšããŠ
12gã®ïŒâβâã¬ã©ã¯ãã·ã«ã¯ããªã³âïŒâã«ã«
ãã³é žãåŸããèç¹250ã255âã
ïŒâã«ã«ãããµããïŒãããã«ãâããªãã€ãª
ã³(4) 24gã®æ°Žé žåã«ãªãŠã ã80mlã®æ°Žã240mlã®ã¡
ã¿ããŒã«ãš20gïŒ0.035ããªã¢ã«ïŒã®ãšãã«ã»ïŒâ
βâã¬ã©ã¯ãã·ã«ã¯ããªã³âïŒâã«ã«ããã·ã¬ãŒ
ãïŒBurd et alãClin.Chem.23ïŒ1402ïŒ1977ïŒïŒ
ãå«ãåå¿æ··åç©ã調補ãããåå¿æ··åç©ã15æ
é50âã§æ¹æãããå·åŽæãæžå§äžã§ã¡ã¿ããŒã«
ãé€å»ããããã®æ¿çž®æ°Žæº¶æ¶²ããæ¿å¡©é žã§PH2.0
ã«é žæ§ã«ãããçœè²æ²æŸ±ãéããå·æ°Žã§æŽæµãã
ç±æ°Žããåçµæ¶åãããçµæ¶ãéããã¢ã»ãã³ã§
æŽæµãã80âã§ïŒæé也ç¥ãããçœè²çµæ¶ãšããŠ
12gã®ïŒâβâã¬ã©ã¯ãã·ã«ã¯ããªã³âïŒâã«ã«
ãã³é žãåŸããèç¹250ã255âã
1.45gïŒ0.004ã¢ã«ïŒã®ïŒâβâã¬ã©ã¯ãã·ã«ã¯
ããªã³âïŒâã«ã«ãã³é žã404mgïŒ0.004ã¢ã«ïŒã®
ããªãšãã«ã¢ãã³ãåã³40mlã®ä¹Ÿç¥ãžã¡ãã«ãã«
ã ã¢ããã®æ··åç©ããã¢ã«ãŽã³é°å²æ°ã§æ¹æããª
ããâ10âã«å·åŽãããããã«ã546mlïŒ0.004ã¢
ã«ïŒã®ã€ãœããã«ã¯ããããŒã¡ãŒãïŒAldrich
Chemical Co.ãMilwaukeeãWisconsinïŒãå
ããŠæ··åç¡æ°Žç©(3)ã圢æããã10ååŸãæŽã«404
mgã®ããªãšãã«ã¢ãã³ãš949mgïŒ0.004ã¢ã«ïŒã®ïŒ
âïŒïŒâã¢ãããããã«ïŒããªãã€ãªã³(2)ããã©
ã¹ã³ã«å ãããâ10âã§30åéæ¹æããåŸãåå¿
æ··åç©ã宀枩ã«æãããããã10gã®ã·ãªã«ã²ã«
ãšåãããé«ç空äžã§DMFãé€å»ãããå«æµžã
ããã·ãªã«ã²ã«ã170gã®ã·ãªã«ã²ã«ã®ã«ã©ã ã®
é éšã«çœ®ããã«ã©ã ãç¡æ°Žãšã¿ããŒã«ã§æº¶åºã15
mlã®ç»åãéãããç»åNo.41ã475ãäžç·ã«ããŠ
èžçºããã545mgã®é»è²åºäœãåŸãããããæ°Žã«
溶解ããåŸãéãã20mlã®äœç©ã«ãŸã§æ¿çž®ã
ããçæããå°éã®æ²æŸ±ã¯å»æ£ããã液ãã»ã
ã¢ããã¯ã¹LHâ20ã²ã«ïŒPharmacia Fine
ChemicalsãPiscatawayãNew JerseyïŒã®2.5
cmÃ57cmã«ã©ã ãçšããã¯ã©ããã°ã©ãã€ãŒã«ã
ã€ãŠç²Ÿè£œããæ°Žã§æº¶åºãã15mlã®ç»åãéããã
ã»ãã¢ããã¯ã¹ïŒSephadexïŒã¯ãæ¶æ©ããã¹ã
ã©ã³ã§ã€ããã芪氎æ§ãã€äžæº¶æ§ã®ã¯ãããã°ã©
ãçšåªäœã®åååã§ãããç»åNo.18ã23ãäžç·ã«
ããŠãèžçºãããããããŠæ®æ»ãæ°Žã§åçµæ¶ã
ãŠãæ·¡é»è²ã§èç¹190ã192âã®æšèè€åäœ(4)55mg
ïŒåçïŒïŒ ïŒãåŸãã
ããªã³âïŒâã«ã«ãã³é žã404mgïŒ0.004ã¢ã«ïŒã®
ããªãšãã«ã¢ãã³ãåã³40mlã®ä¹Ÿç¥ãžã¡ãã«ãã«
ã ã¢ããã®æ··åç©ããã¢ã«ãŽã³é°å²æ°ã§æ¹æããª
ããâ10âã«å·åŽãããããã«ã546mlïŒ0.004ã¢
ã«ïŒã®ã€ãœããã«ã¯ããããŒã¡ãŒãïŒAldrich
Chemical Co.ãMilwaukeeãWisconsinïŒãå
ããŠæ··åç¡æ°Žç©(3)ã圢æããã10ååŸãæŽã«404
mgã®ããªãšãã«ã¢ãã³ãš949mgïŒ0.004ã¢ã«ïŒã®ïŒ
âïŒïŒâã¢ãããããã«ïŒããªãã€ãªã³(2)ããã©
ã¹ã³ã«å ãããâ10âã§30åéæ¹æããåŸãåå¿
æ··åç©ã宀枩ã«æãããããã10gã®ã·ãªã«ã²ã«
ãšåãããé«ç空äžã§DMFãé€å»ãããå«æµžã
ããã·ãªã«ã²ã«ã170gã®ã·ãªã«ã²ã«ã®ã«ã©ã ã®
é éšã«çœ®ããã«ã©ã ãç¡æ°Žãšã¿ããŒã«ã§æº¶åºã15
mlã®ç»åãéãããç»åNo.41ã475ãäžç·ã«ããŠ
èžçºããã545mgã®é»è²åºäœãåŸãããããæ°Žã«
溶解ããåŸãéãã20mlã®äœç©ã«ãŸã§æ¿çž®ã
ããçæããå°éã®æ²æŸ±ã¯å»æ£ããã液ãã»ã
ã¢ããã¯ã¹LHâ20ã²ã«ïŒPharmacia Fine
ChemicalsãPiscatawayãNew JerseyïŒã®2.5
cmÃ57cmã«ã©ã ãçšããã¯ã©ããã°ã©ãã€ãŒã«ã
ã€ãŠç²Ÿè£œããæ°Žã§æº¶åºãã15mlã®ç»åãéããã
ã»ãã¢ããã¯ã¹ïŒSephadexïŒã¯ãæ¶æ©ããã¹ã
ã©ã³ã§ã€ããã芪氎æ§ãã€äžæº¶æ§ã®ã¯ãããã°ã©
ãçšåªäœã®åååã§ãããç»åNo.18ã23ãäžç·ã«
ããŠãèžçºãããããããŠæ®æ»ãæ°Žã§åçµæ¶ã
ãŠãæ·¡é»è²ã§èç¹190ã192âã®æšèè€åäœ(4)55mg
ïŒåçïŒïŒ ïŒãåŸãã
åæïŒC26H29N5O11ãšããŠã®èšç®å€ïŒïŒ£ã
53.15ïŒïŒšã4.98ïŒïŒ®ã11.92ã
53.15ïŒïŒšã4.98ïŒïŒ®ã11.92ã
å®æž¬å€ïŒïŒ£ã52.65ïŒïŒšã5.01ïŒïŒ®ã
11.80 βâã¬ã©ã¯ãã·ã«ã¯ããªã³âããªãã€ãªã³å ±åœ¹
äœ(4)ãïœïŒïŒã®äžèšããåæã¯ãåºçºç©è³ªã®ïŒâ
ïŒïŒâã«ã«ããã·ãããã«ïŒããªãã€ãªã³(1)ãïœ
ïŒïŒã以äžã®ãããªé©åœãªïŒâïŒÏâã«ã«ããã·
ã¢ã«ãã«ïŒããªãã€ãªã³ã§çœ®ãæããããšã«ãã€
ãŠãïœïŒïŒãïŒã®å Žåã®æšèè€åäœãåŸãããã«
å€åœ¢ããããšãã§ããã
11.80 βâã¬ã©ã¯ãã·ã«ã¯ããªã³âããªãã€ãªã³å ±åœ¹
äœ(4)ãïœïŒïŒã®äžèšããåæã¯ãåºçºç©è³ªã®ïŒâ
ïŒïŒâã«ã«ããã·ãããã«ïŒããªãã€ãªã³(1)ãïœ
ïŒïŒã以äžã®ãããªé©åœãªïŒâïŒÏâã«ã«ããã·
ã¢ã«ãã«ïŒããªãã€ãªã³ã§çœ®ãæããããšã«ãã€
ãŠãïœïŒïŒãïŒã®å Žåã®æšèè€åäœãåŸãããã«
å€åœ¢ããããšãã§ããã
ïœ ã¢ã«ãã¬ã³
ïŒ ãšãã¬ã³
ïŒ ããã¬ã³
ïŒ ãã³ãã¬ã³
ïŒ ããã·ã¬ã³
æè¡æž
ã®èª¿è£œ
Res.Comm.Chem.Path.Pharmacol.13ïŒ497â
505ïŒ1976ïŒã§ã¯ãã¯ïŒCookïŒçã«ãã€ãŠèšèŒã
ããŠããããã«ããŠèª¿è£œãããããªãã€ãªã³å ç«
è€åäœã§å ç«ããããŠãµã®ããæè¡æž ãéããã
505ïŒ1976ïŒã§ã¯ãã¯ïŒCookïŒçã«ãã€ãŠèšèŒã
ããŠããããã«ããŠèª¿è£œãããããªãã€ãªã³å ç«
è€åäœã§å ç«ããããŠãµã®ããæè¡æž ãéããã
çŽ åã®èª¿è£œ
ãããã®å®éšã§çšããããã«èª¿è£œããçŽ åã¯ã
å³ïŒã§ç€ºãã圢æ ãæããŠãããæ¯æå±€ïŒã¯ããª
ã¹ãã¬ã³è£œã§ãããäžééæ§ã®èŒ»å°ç·æ¡æ£ã»é®ãž
ãå±€ïŒã¯ä»¥äžã®é åçµæïŒ ã¹ãã¬ã³ïŒç¡æ°Žãã¬ã€ã³é žïŒ50ïŒ50å ±éåäœãå
åé50000ïŒ 10g ããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååé1000ïŒ 6g äºé žåãã¿ã³ 10g ã¢ã»ãã³ 34g ãæããçµæç©ããæãã
å³ïŒã§ç€ºãã圢æ ãæããŠãããæ¯æå±€ïŒã¯ããª
ã¹ãã¬ã³è£œã§ãããäžééæ§ã®èŒ»å°ç·æ¡æ£ã»é®ãž
ãå±€ïŒã¯ä»¥äžã®é åçµæïŒ ã¹ãã¬ã³ïŒç¡æ°Žãã¬ã€ã³é žïŒ50ïŒ50å ±éåäœãå
åé50000ïŒ 10g ããªãšãã¬ã³ã°ãªã³ãŒã«ïŒååé1000ïŒ 6g äºé žåãã¿ã³ 10g ã¢ã»ãã³ 34g ãæããçµæç©ããæãã
ãã®çµæç©ãããªã¹ãã¬ã³æ¯æå±€ïŒã®äžã«æ¹¿æœ€
åã§0.02ã€ã³ãå¡ããã€ãã§å®€æž©ã§ä¹Ÿç¥ããã
åã§0.02ã€ã³ãå¡ããã€ãã§å®€æž©ã§ä¹Ÿç¥ããã
ãŒã©ãã³äžå¡ãå±€ïŒã¯äžééæ§ã®èŒ»å°ç·æ¡æ£ã»
é®ãžãå±€ïŒã®è¡šé¢ã«å¯çããŠå€é åè©Šè¬å±€ïŒïŒã®
ïŒã€ã®é åã圢æãããäžå¡ãå±€ã¯ä»¥äžã®çµæïŒ ãŒã©ãã³ 5g 0.1Mãã€ã·ã³ç·©è¡å€ïŒPHïŒ 1.1ïŒ 45g ãæããçµæç©ããæãã
é®ãžãå±€ïŒã®è¡šé¢ã«å¯çããŠå€é åè©Šè¬å±€ïŒïŒã®
ïŒã€ã®é åã圢æãããäžå¡ãå±€ã¯ä»¥äžã®çµæïŒ ãŒã©ãã³ 5g 0.1Mãã€ã·ã³ç·©è¡å€ïŒPHïŒ 1.1ïŒ 45g ãæããçµæç©ããæãã
ãã®çµæç©ãå±€ïŒã®äžã«æ¹¿æœ€åã§0.005ã€ã³ã
å¡åžããã€ãã§37âã§ä¹Ÿç¥ããã
å¡åžããã€ãã§37âã§ä¹Ÿç¥ããã
æäœåã³é
µçŽ å«æéïŒã¯ã以äžã®çµæïŒ
0.8Mãã€ã·ã³ç·©è¡æ¶²ïŒPH8.5ïŒäžã®ïŒïŒ
ïŒïŒ·ïŒ
ïŒã¢ã¬ããŒã¹LGT 1.5ml 10ïŒ ããªãã³ïŒžâ100ïŒïŒ·ïŒïŒ¶ïŒ 30ÎŒ 1Mãã€ã·ã³ã0.1MMgCl2ãPH8.5 300ÎŒ ããªãã€ãªã³ã«å¯Ÿããæè¡æž 464ÎŒ βâã¬ã©ã¯ãã·ããŒãŒïŒ177UïŒmlïŒ 430ÎŒ ïŒåèžçããæ°Ž 276ÎŒ ãæããçµæç©ãã調補ããã
ïŒã¢ã¬ããŒã¹LGT 1.5ml 10ïŒ ããªãã³ïŒžâ100ïŒïŒ·ïŒïŒ¶ïŒ 30ÎŒ 1Mãã€ã·ã³ã0.1MMgCl2ãPH8.5 300ÎŒ ããªãã€ãªã³ã«å¯Ÿããæè¡æž 464ÎŒ βâã¬ã©ã¯ãã·ããŒãŒïŒ177UïŒmlïŒ 430ÎŒ ïŒåèžçããæ°Ž 276ÎŒ ãæããçµæç©ãã調補ããã
ã¢ã¬ããŒã¹LGTã¯ã40â以äžã®äœãçŒã
ïŒgrillingïŒæž©åºŠãæããã¢ã¬ããŒã¹ç©è³ªã§ããªãµ
ãŒãã»ãããã¯ãã»ãã€ããžãšã³ã»ãªãã»ãã€ã«
ã¹ã»ã©ãã©ããªãŒãºã»ã€ã³ã³ãŒãã¬ãŒããã
ïŒReseach Products Division of Miles
LaboratoriesãInc.ïŒïŒãããŒã»ãªãŒã»ããã¯ã¹
2000ïŒP.O.Box 2000ïŒããšã«ã¯ããŒãïŒElkhartïŒã
ã€ã³ãžã¢ã46515ïŒIndiana 46515ïŒã«ãã€ãŠè²©å£²
ãããŠããããã®çµæç©ãå±€ïŒã®äžã«æ¹¿æœ€åã§
0.02ã€ã³ãå¡åžãã€ãã§37âã§ä¹Ÿç¥ããããã
ã¯ãå€é åè©Šè¬å±€ïŒïŒã®äžéé åã§ããã
ïŒgrillingïŒæž©åºŠãæããã¢ã¬ããŒã¹ç©è³ªã§ããªãµ
ãŒãã»ãããã¯ãã»ãã€ããžãšã³ã»ãªãã»ãã€ã«
ã¹ã»ã©ãã©ããªãŒãºã»ã€ã³ã³ãŒãã¬ãŒããã
ïŒReseach Products Division of Miles
LaboratoriesãInc.ïŒïŒãããŒã»ãªãŒã»ããã¯ã¹
2000ïŒP.O.Box 2000ïŒããšã«ã¯ããŒãïŒElkhartïŒã
ã€ã³ãžã¢ã46515ïŒIndiana 46515ïŒã«ãã€ãŠè²©å£²
ãããŠããããã®çµæç©ãå±€ïŒã®äžã«æ¹¿æœ€åã§
0.02ã€ã³ãå¡åžãã€ãã§37âã§ä¹Ÿç¥ããããã
ã¯ãå€é åè©Šè¬å±€ïŒïŒã®äžéé åã§ããã
è€åäœå«æå±€ïŒïŒã以äžã®é
åçµæïŒ
βâGUTè€åäœ 69.2ÎŒ
CHCl3ïŒ1.93mlïŒäžã®ïŒïŒ
ïŒïŒ·ïŒïŒ¶ïŒPVPïŒååé
360000ïŒ 2.90g ããªãã³ïŒžâ100 5ÎŒ ãæããçµæç©ãã調補ããã
360000ïŒ 2.90g ããªãã³ïŒžâ100 5ÎŒ ãæããçµæç©ãã調補ããã
ãã®çµæç©ãå±€ïŒã®äžã«æ¹¿æœ€åã¿ã§0.005ã€ã³
ãå¡åžã宀枩ã§ä¹Ÿç¥ãããããã¯ãå€é åè©Šè¬å±€
ïŒïŒã®æäžéšã®é åã§ãããå±€ïŒïŒã®é²åºããäž
éšè¡šé¢ã¯ããããžè©Šæãé©çšããããããèªã¿å€
ãåŸãããè¡šé¢ã§ããã
ãå¡åžã宀枩ã§ä¹Ÿç¥ãããããã¯ãå€é åè©Šè¬å±€
ïŒïŒã®æäžéšã®é åã§ãããå±€ïŒïŒã®é²åºããäž
éšè¡šé¢ã¯ããããžè©Šæãé©çšããããããèªã¿å€
ãåŸãããè¡šé¢ã§ããã
åææ¹æ³
è¬å€æº¶æ¶²ã®35ÎŒç»åãäžè¿°ã®ããã«ããŠèª¿è£œ
ãããåæçŽ åã®é²åºé¢ã«æ»Žäžããã
ãããåæçŽ åã®é²åºé¢ã«æ»Žäžããã
宀枩ã§çºçããè¢å
ãïŒåéãåæçŽ åãæ°Žå¹³
äœçœ®ããããã«é©ããæ©æ¢°çä¿æå ·ãåããè¢å
èšã®äžã§æž¬å®ãããè¢å èšãã405nmã§å±èµ·å æº
ãäžããŠããããè¡šã«90ãã§åœããæŸåºãããå
ã450nmã®æ³¢ã§æ€ç¥ããã¹ã調æŽãããè¢å ã®å
é¢æž¬å ã¯ãããïŒpadïŒãã90ãã®ãšããã§è¡ãªã€
ãã
äœçœ®ããããã«é©ããæ©æ¢°çä¿æå ·ãåããè¢å
èšã®äžã§æž¬å®ãããè¢å èšãã405nmã§å±èµ·å æº
ãäžããŠããããè¡šã«90ãã§åœããæŸåºãããå
ã450nmã®æ³¢ã§æ€ç¥ããã¹ã調æŽãããè¢å ã®å
é¢æž¬å ã¯ãããïŒpadïŒãã90ãã®ãšããã§è¡ãªã€
ãã
åæãããæ¿åºŠç¯å²ã¯ä»¥äžã®éãã§ãã€ãã
ç¯å² ããªãã€ãªã³
æ²»çåŠçç¯å² 10ã20ÎŒgïŒml
調ã¹ãããæäžéå¿çç¯å² ïŒã41ÎŒgïŒml
調ã¹ãããæäžéå¿çç¯å²ã¯æ²»ççç¯å²ãã«ã
ãŒããŠããã
ãŒããŠããã
çµ æ
äžè¿°ããæ¹æ³ã§åŸãããããŒã¿ã¯å³ïŒã«ãã€ãŠ
å³ã§ç€ºããåé¡åäœãããªããã«ïŒmVïŒã®çšèª
ã§ç€ºããïŒããªããã«ã¯ïŒãã«ãã®ååã®äžã§ã
ããæäžå¿çæ²ç·ãå³ïŒããïŒåç¹ã§å³ïŒã«ç€ºã
ãããŒã¿ããäœæããã
å³ã§ç€ºããåé¡åäœãããªããã«ïŒmVïŒã®çšèª
ã§ç€ºããïŒããªããã«ã¯ïŒãã«ãã®ååã®äžã§ã
ããæäžå¿çæ²ç·ãå³ïŒããïŒåç¹ã§å³ïŒã«ç€ºã
ãããŒã¿ããäœæããã
è å¯
åŸãããããŒã¿ã¯ãæ¬çºæã«ãã€ãŠèª¿è£œããäž
äœçãªåæçŽ åãååšããããªãã€ãªã³ã®æ¿åºŠç¯
å²ã«å¿çããå®éæ€ç¥å¯èœãªä¿¡å·ãäžããããšã
瀺ããããªãã€ãªã³ã®æ¿åºŠãå¢å€§ãããšãããã
ãã®åæçŽ åã®è¢å ã«ãããŠã¯ãè¬å€äŸåã®å¢å
ãæãã
äœçãªåæçŽ åãååšããããªãã€ãªã³ã®æ¿åºŠç¯
å²ã«å¿çããå®éæ€ç¥å¯èœãªä¿¡å·ãäžããããšã
瀺ããããªãã€ãªã³ã®æ¿åºŠãå¢å€§ãããšãããã
ãã®åæçŽ åã®è¢å ã«ãããŠã¯ãè¬å€äŸåã®å¢å
ãæãã
å³ïŒãïŒã¯ãäŸïŒã«èšèŒãããå®éšããåŸãã
ãããŒã¿ã®ã°ã©ãã§ãããå³ïŒã¯ãäŸïŒã§çšãã
ããå ±åœ¹äœã調補ã«çšããæ¹æ³ã®è¡šç€ºã§ãããå³
ïŒã¯ãäŸïŒã«èšèŒãããããã«ããŠèª¿è£œããããª
ãã€ãªã³åæçŽ åã®æé¢å³ã§ãããå³ïŒãïŒã¯ã
äŸïŒã«èšèŒãããå®éšããåŸãããããŒã¿ã®ã°ã©
ãã§ããã
ãããŒã¿ã®ã°ã©ãã§ãããå³ïŒã¯ãäŸïŒã§çšãã
ããå ±åœ¹äœã調補ã«çšããæ¹æ³ã®è¡šç€ºã§ãããå³
ïŒã¯ãäŸïŒã«èšèŒãããããã«ããŠèª¿è£œããããª
ãã€ãªã³åæçŽ åã®æé¢å³ã§ãããå³ïŒãïŒã¯ã
äŸïŒã«èšèŒãããå®éšããåŸãããããŒã¿ã®ã°ã©
ãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ è©Šæäžã®é äœååã¯é äœåã«çµåããèœåã«
å¿çããŠæ€ç¥å¯èœãªå¿çãäžããè©Šè¬ãå å«ãã
è©Šè¬å±€ïŒèŒ»å°ç·æ£ä¹±ã»é®ãžãå±€ïŒåã³æ¯æå±€ãæ
ããåã®ã液äœè©Šæäžã®é äœååã¯é äœåã«çµå
ããèœåãæ€ç¥ããããã®å€éå±€åæçŽ åã§ãã€
ãŠã 茻å°ç·æ£ä¹±ã»é®ãžãå±€ãã(a)è©Šè¬å±€ãšæ¯æå±€ã®
éã«ä»åšãããããïŒ(b)é äœåãè©Šè¬å±€äžã«ååš
ããè©Šè¬åã³ãããã®çžäºåå¿ã®çæç©ã«å¯Ÿãäž
ééæ§ã§ïŒãã€ã(c)é äœåãè©Šè¬å±€äžã«ååšãã
è©Šè¬åã³ãããã®çžäºåå¿ã®çæç©ã«å¯ŸãäžæŽ»æ§
ã§ããããšãç¹åŸŽãšããå€éå±€åæçŽ åã ïŒ èŒ»å°ç·æ£ä¹±ã»é®ãžãå±€ããäžéæã§ãæ¯èŒç
èãããããŠçœè²åã¯æ·¡ãè²ã®é¡æãå«æããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å€éå±€åæçŽ åã ïŒ é¡æãäºé žåãã¿ã³ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®å€éå±€åæçŽ åã ïŒ é¡æãç¡«é žããªãŠã ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®å€éå±€åæçŽ åã ïŒ é¡æãé žåäºéã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®å€éå±€åæçŽ åã ïŒ é¡æãé žåãã°ãã·ãŠã ã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®å€éå±€åæçŽ åã ïŒ é¡æãäºé žåãžã«ã³ããŠã ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®å€éå±€åæçŽ åã ïŒ èŒ»å°ç·æ£ä¹±ã»é®ãžãå±€ããç¡æ°Žç©æš¹èããæ
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å€éå±€åæçŽ åã ïŒ èŒ»å°ç·æ£ä¹±ã»é®ãžãå±€ããåã¿0.0002ã0.02
ã€ã³ãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å€éå±€
åæçŽ åã ïŒïŒ é¡æãã茻å°ç·æ£ä¹±ã»é®ãžãå±€å šäœã«åäž
ã«åæ£ãããŠããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å€
éå±€åæçŽ åã ïŒïŒ è©Šè¬å±€ããè©Šæäžã®é äœååã¯é äœåã«çµ
åããèœåã®ååšã®é¢æ°ã§ããæ€ç¥å¯èœãªå¿çã
çãããåäžç³»ç¹ç°ççµååæç³»çšã®è©Šè¬ãå«ã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å€éå±€åæçŽ åã ïŒïŒ åäžç³»ç¹ç°ççµååæç³»ããé µçŽ åå¿ã«é¢
äžããæšèãå«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®
å€éå±€åæçŽ åã ïŒïŒ æšèããé µçŽ ã«å¯Ÿããåºè³ªã§ããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€éå±€åæçŽ åã ïŒïŒ é µçŽ ããåºè³ªæšèã«äœçšããŠæ€ç¥å¯èœãªç
æç©ãçããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€é
å±€åæçŽ åã ïŒïŒ æšèãé µçŽ ã®è£æ¬ ååæïŒé å矀ïŒã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€éå±€åæçŽ åã ïŒïŒ è£æ¬ ååæããã¢ãé µçŽ ãšäžç·ã«ãªã€ãŠé µ
çŽ ã圢æã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€
éå±€åæçŽ åã ïŒïŒ æšèãé µçŽ ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé
èšèŒã®å€éå±€åæçŽ åã ïŒïŒ è©Šè¬å±€ãã (i) é äœåãšçµåããæäœã (ii) é äœååã¯ãã®çµåæ§é¡çžäœãšæšèãšã®è€å
äœã 䞊ã³ã«ã (iii) æšèãšçžäºäœçšããŠãæäœã«çµåãããšãã«
ã¯ãçµåããªããšãã«æ¯ã¹ãŠãç°ãªã€ããæ€ç¥
å¯èœãªå¿çãçããæ€ç¥ç³» ãå«ã¿ããã®ããšã«ãã€ãŠãæ€ç¥å¯èœãªå¿çã液
äœè©Šæäžã®é äœåã®ååšã®é¢æ°ã§ããè©Šè¬çµæç©
ããæãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å€éå±€åæ
çŽ åã ïŒïŒ æ€ç¥ç³»ããæšèãé¢äžããé µçŽ ååŠåå¿ã«
ããããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€éå±€å
æçŽ åã ïŒïŒ æšèããé µçŽ ã«å¯Ÿããåºè³ªã§ããããã€æ€
ç¥ç³»ãé µçŽ ãå«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®
å€éå±€åæçŽ åã ïŒïŒ æšèããé µçŽ ã®è£æ¬ ååæã§ãæ€ç¥ç³»ãé
å矀ãšäžç·ã«ãªã€ãŠè©²é µçŽ ã圢æããã¢ãé µçŽ ã
å«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€éå±€åæçŽ
åã ïŒïŒ æ€ç¥ç³»ããæŽã«ãé µçŽ æŽ»æ§ã®æ瀺è¬ãå«ã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€éå±€åæçŽ åã ïŒïŒ æšèãããã©ãã³ã¢ããã³ãžãã¯ã¬ãªãã
ã§ãã¢ãé µçŽ ãã¢ãã°ã«ã³ãŒã¹ãªãã·ããŒãŒã§ã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€éå±€åæçŽ
åã ïŒïŒ æ€ç¥ç³»ããæŽã«ãã°ã«ã³ãŒã¹ãªãã·ããŒãŒ
掻æ§ã®æ瀺è¬ãå«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒ
ã®å€éå±€åæçŽ åã ïŒïŒ æ瀺è¬ããã°ã«ã³ãŒã¹ããã«ãªãã·ããŒ
ãŒãåã³éé žåæ°ŽçŽ ã«å¯Ÿãåè²åå¿ããç©è³ªãå«
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®å€éå±€åæçŽ
åã ïŒïŒ æšèããé µçŽ ã§ãã€ãŠããã€æ€ç¥ç³»ãé µçŽ
掻æ§ã®æ瀺è¬ãå«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒ
ã®å€éå±€åæçŽ åã ïŒïŒ è©Šè¬å±€ãã (a) è©Šæäžã®é äœååã¯é äœåã«çµåããèœåã®
ååšã®é¢æ°ã§ããæ€ç¥å¯èœãªå¿çãçããåäž
ç³»ç¹ç°ççµåæ§åæç³»çšã®è©Šè¬ïŒåã³ (b) è©Šè¬ãå å«ããåºäœã®æ äœïŒããæãã 茻å°ç·æ£ä¹±ã»é®ãžãå±€ããç¡æ°Žç©æš¹èã«å å«ãã
ãé¡æããæã€ãŠããŠã該局ãïŒ (a) è©Šè¬å±€ãšæ¯æå±€ã®éã«ä»åšãããããïŒ (b) é äœåãè©Šè¬å±€ã®è©Šè¬ãåã³ãããã®çžäºå
å¿ã®çæç©ã«å¯ŸããŠäžééæ§ã§ïŒäžŠã³ã« (c) é äœåãè©Šè¬å±€ã®è©Šè¬åã³ãããã®çžäºåå¿
ã®çæç©ã«å¯ŸããŠäžæŽ»æ§ã§ãã ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å€éå±€åæçŽ åã ïŒïŒ è©Šæäžã®é äœååã¯é äœåã«çµåããèœå
ã«å¿çããŠæ€ç¥å¯èœãªå¿çãäžããè©Šè¬ãå å«ã
ãè©Šè¬å±€ã茻å°ç·æ£ä¹±ã»é®ãžãå±€åã³æ¯æå±€ãæ
ããåã®ã液äœè©Šæäžã®é äœååã¯é äœåã«çµå
ããèœåãæ€ç¥ããããã®å€éå±€åæçŽ åã®è£œé
æ¹æ³ã§ãã€ãŠããã®æ¹æ³ãã (1) æ¯æå±€ã®è¡šé¢ãã (a) é äœåãè©Šè¬å±€ã®è©Šè¬åã³ãããã®çžäºå
å¿ã®çæç©ã«å¯ŸããŠãäžééæ§ã§ããããã
ãŠã (b) é äœåãè©Šè¬å±€ã®è©Šè¬ãåã³ãããã®çžäº
åå¿ã®çæç©ã«å¯ŸããŠäžæŽ»æ§ã§ãã 茻å°ç·æ£ä¹±ã»é®ãžãå±€ã®è¡šé¢ã«åºçããå·¥çšã (2) ã€ãã§ã該詊è¬å±€ã®è¡šé¢ã茻å°ç·æ£ä¹±ã»é®ãž
ãå±€ã®å察åŽã®é¢ã«åºçããå·¥çšããæã ããšãç¹åŸŽãšããæ¹æ³ã
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28080581A | 1981-07-06 | 1981-07-06 | |
| US280805 | 1981-07-06 | ||
| US369632 | 1982-04-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5817365A JPS5817365A (ja) | 1983-02-01 |
| JPS6348312B2 true JPS6348312B2 (ja) | 1988-09-28 |
Family
ID=23074731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11667682A Granted JPS5817365A (ja) | 1981-07-06 | 1982-07-05 | äžééæ§ã®èŒ»å°ç·æ£ä¹±ã»é®ãžãå±€ãæããå€éå±€åæçŽ å |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS5817365A (ja) |
| ZA (1) | ZA824747B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5818167A (ja) * | 1981-07-24 | 1983-02-02 | Fuji Photo Film Co Ltd | åæãã€ã«ã åã³ãããçšããåææ¹æ³ |
| JPS61245057A (ja) * | 1985-04-23 | 1986-10-31 | Fuji Photo Film Co Ltd | äžäœåå€å±€åæèŠçŽ |
| JPH0672885B2 (ja) * | 1985-10-17 | 1994-09-14 | ã³ãã«æ ªåŒäŒç€Ÿ | åæçŽ å |
| JPH0672884B2 (ja) * | 1985-10-17 | 1994-09-14 | ã³ãã«æ ªåŒäŒç€Ÿ | åæçŽ å |
| JP3622532B2 (ja) * | 1998-10-13 | 2005-02-23 | æŸäžé»åšç£æ¥æ ªåŒäŒç€Ÿ | é µçŽ å ç«åæçšè©Šè¬åã³ãããçšããåææ¹æ³ |
| JP3684458B2 (ja) * | 2002-10-11 | 2005-08-17 | æ ªåŒäŒç€Ÿåµæé»å | åè²è©ŠéšçŽ |
-
1982
- 1982-07-02 ZA ZA824747A patent/ZA824747B/xx unknown
- 1982-07-05 JP JP11667682A patent/JPS5817365A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ZA824747B (en) | 1983-06-29 |
| JPS5817365A (ja) | 1983-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0069281B1 (en) | Multilayer analytical element; method for its preparation and its use in analytical methods | |
| US4461829A (en) | Homogeneous specific binding assay element and lyophilization production method | |
| US4363874A (en) | Multilayer analytical element having an impermeable radiation nondiffusing reflecting layer | |
| US4442204A (en) | Homogeneous specific binding assay device and preformed complex method | |
| FI87695B (fi) | Analyselement med flera avdelningar och med en koncentrationszon foer en detekterbar signal | |
| US4447526A (en) | Homogeneous specific binding assay with carrier matrix incorporating specific binding partner | |
| EP0212603B1 (en) | Multizone analytical element having labeled reagent concentration zone | |
| JP3009155B2 (ja) | å ç«ã¯ãããã°ã©ãã€ãŒåææ¹æ³ | |
| EP0119623B1 (en) | Multilayer analytical element for non-isotopic assay | |
| US5212060A (en) | Dry test strip comprising a dextran barrier for excluding erythrocytes | |
| US4447529A (en) | Preparing homogeneous specific binding assay element to avoid premature reaction | |
| US5958339A (en) | Format for immunoassay in thin film | |
| EP0051213B1 (en) | Homogeneous specific binding assay device, method for preparing it and analytical method using the device | |
| US4366243A (en) | Stabilization of glucose oxidase apoenzyme | |
| US5266460A (en) | Method of preparing immunological analytical element | |
| JPS6348312B2 (ja) | ||
| WO1997038312A1 (en) | Diagnostic test device utilizing filaments containing reagents | |
| NO161286B (no) | Analytisk multilagelement for paavisning av en ligand i eller den ligandbindende kapasitet av en vaeskeproeve, og detsanvendelse ved analytiske metoder. | |
| USH1664H (en) | Analytical element for immunoassay and method for its preparation |